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   VI 
Summary 
 
 Bone loss caused by trauma or disease often renders the use of bone graft 
materials to facilitate bone healing.  Autografts are still the gold standard treatment 
option. However, there are several drawbacks that are associated with the use of 
autografts such as patient site morbidity and limited availability of healthy bone 
especially in younger patients and elderly patients who might suffer from osteoporosis. 
As such, the use of bone graft substitutes (such as coralline hydroxyapatite (HA), 
bioglass, calcium-based materials etc.) provides an attractive alternative.  However, such 
materials usually act as passive scaffolding, leading to the lack of bone remodeling.  A 
myriad of research has focused on developing tissue-engineered bone grafts with the aim 
to replace the use of autologous bone grafts and improving on the clinical performance of 
the current state of bone graft substitutes. In this project, it was hypothesized that 
biomimetic mineralized nanofibrous scaffolds (NFS) mimicking natural extracellular 
matrix (ECM) provided efficient cell attachment and enhanced osteogenic differentiation 
to promote bone regeneration.  
 
 Structurally, bone encompasses fiber bundles that are made up of collagenous 
nanofibrils laced with HA nanocrystals. Electrospinning was used to produce the NFS to 
mimic the structure of the bone nanofibrils.  The choice polymer used to fabricate the 
NFS was poly-l-lactide acid (PLLA).  A biomimetic approach of nano-hydroxyapatite (n-
HA) mineralization was employed on the NFS to attempt to mimic the native ECMin 
bone.  Co-blending type I collagen (Col) with PLLA had shown to enhance n-HA 
deposition, due to the presence of nucleation sites for n-HA mineralization.  Such rapid n-




HA deposition was achieved at room temperature. It was demonstrated that mineralized 
NFS enhanced early cell capture of osteoblasts within 30 minutes.      
 
 The osteogenic differentiation potential of bone marrow derived mesenchymal 
stem cells (BM-MSCs) was achieved by manipulating the physical, biochemical and 
environmental conditions.  The nanoscale topography on the mineralized NFS was able 
to stimulate osteogenic BM-MSC differentiation without the use of any osteogenic 
supplements.  Cell mineralization, a late osteogenic differentiation marker, which usually 
occurred on day 28 in culture, was seen after 14 days on mineralized NFS, where the 
BM-MSCs secreted bone nodules.  The Ca/P ratio of the bone nodules was comparable to 
that of native HA in bone.   
 
 Since cells are subjected to different nanotextures within a 3D ECM niche in vivo, 
3D NFS (nanoyarns) can be an effective carrier for rapid cell capture, which can provide 
an in-situ therapeutic bone graft option for bone regeneration.  Mineralized nanoyarns 
were enriched with bone marrow aspirate and the cell capture rate was 80%.  Biomimetic 
mineralized nanoyarns could augment bone healing due to its high resemblance to the 
native bone fibrils as seen in a rabbit model. Speckles of bone was observed within the 
defect site, suggesting that the presence of n-HA alone could elicit an osteoinductive 
bone formation process.  Therefore, this study suggested that there was great potential for 
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phosphate groups from nano HA. Although the absorption band (1086 cm-1) from (a) 
PLLA overlapped with the vibration bands of the phosphate groups, the relative 
intensities of the phosphate groups were greater in (b) and (c).  Peaks at 1637 and 866 
cm-1 referred to carbonate groups from n-HA. Peaks at 1661 and 1544 cm-1 referred to 
amide I and II groups from collagen 
 
Fig. 3.4:  Water contact angles of PLLA, mineralized PLLA, PLLA/Col, mineralized 
PLLA/Col and Collagen nanofibers (control). Significant difference between different 
groups were denoted as * (p<0.05) 
 
Fig. 3.5:  Cell attachment on PLLA, PLLA+n-HA, PLLA/Col, PLLA/Col+n-HA and 
TCP (control) from 10 minutes to 60 minutes at room temperature. Significant difference 
between different groups were denoted as * (p<0.05) 
 
Fig. 3.6:  Cell proliferation on PLLA, PLLA+n-HA, PLLA/Col, PLLA/Col+n-HA and 
TCP (control) from day 1 to day 7. Significant difference between different groups were 
denoted as * (p<0.05) 
 
Fig. 3.7: SEM images of cells growing on mineralized nanofibers (a) PLLA+ n-HA  for 1 
day; (b) PLLA+ n-HA  for 4 days;  (c) PLLA+ n-HA  for 7 days;  (d) PLLA/Col+ n-HA  
for 1 day; (e) PLLA/Col+ n-HA  for 7 days 
 
Fig. 3.8: Total protein assay of cells on PLLA, PLLA+n-HA, PLLA/Col, PLLA/Col+n-
HA and TCP (control) from day 1 to day 7. Significant difference between different 




groups were denoted as * (p<0.05).  Results shown have been normalized by the cell 
numbers 
 
Fig. 3.9: Alkaline phosphatase (ALP) expression of cells on PLLA, PLLA+n-HA, 
PLLA/Col, PLLA/Col+n-HA and TCP (control) from day 1 to day 7.   Results shown 
have been normalized by the cell numbers 
 
Fig. 3.10: E-modulus for PLLA, PLLA+n-HA, PLLA/Col+n-HA nanofibrous scaffold 
and various scaffold with cells after 1-day and 4-day of culture.  Significant difference 
between different groups were denoted as * (p<0.05) 
 
Fig. 4.1: SEM images of mineralized (a) PLLA and (d) PLLA/Col fibers. AFM images 
depicting the nanotexturing of mineralized fibers (b) PLLA+n-HA, (c) 3D surface 
topography of (b) PLLA+n-HA, (e) PLLA/Col+n-HA and (f) 3D surface topography of 
(e) PLLA/Col+n-HA. (Arrows represent n-HA on the fibers) 
 
Fig. 4.2: Cell morphology of BM-MSC on tissue culture plastic (TCP) in either normal 
media or osteogenic media. (a) after 1 day in normal media, (b)  after 1 day in osteogenic 
media, (c) after 4 days in normal media, (d) after 4 days in osteogenic media 
 
Fig. 4.3: Cell proliferation on various nanofiber substrates after 1 to 28 days of culture in 
normal and osteogenic media. Significant difference between different groups were 
denoted as * (p<0.05) 
 
Fig. 4.4: Protein concentration of various nanofiber substrates after 1 and 7 days of 
culture in normal and osteogenic media. Significant difference between different groups 
were denoted as * (p<0.05) 
 
Fig. 4.5: CD29 staining of various substrates after 14 days of culture. Blue denotes 
DAPI-stained cell nucleus and green denotes CD29 expression. Scale bar for x10 is 300 
µm  
 
Fig. 4.6: Alkaline phosphatase (ALP) expression on various nanofiber substrates after 1 
and 7 days of culture in normal and osteogenic media. Significant difference between 
different groups were denoted as * (p<0.05) 
 
Fig. 4.7: Osteocalcin staining of various substrates after 21 days of culture.  Blue denotes 
DAPI-stained cell nucleus and green denotes osteocalcin expression. Scale bars for x10 
and x60 are 300 µm and 50 µm respectively  
 
Fig. 4.8: Osteocalcin intensities of various substrates after 21 days of culture.  Significant 
difference between different groups were denoted as * (p<0.05) 
 
Fig. 4.9: MSC morphologies on mineralized and non-mineralized substrates after 14 days 
of culture in normal media at various magnifications. (a) to (d) PLLA, (e) to (h) 
PLLA+n-HA, (i) to (l) PLLA/Col and (m) to (p) PLLA/Col+n-HA  





Fig. 4.10: MSC morphologies on mineralized and non-mineralized substrates after 14 
days of culture in osteogenic media. (a) to (d) PLLA, (e) to (h) PLLA+n-HA, (i) to (l) 
PLLA/Col and (m) to (p) PLLA/Col+n-HA  
Fig. 4.11: EDX spectra of mineralized PLLA after 14 days in normal media 
 
Fig. 4.12: MSC morphologies on mineralized and non-mineralized substrates after 21 
days of culture in normal media. (a) to (d) PLLA, (e) to (h) PLLA+n-HA, (i) to (l) 
PLLA/Col and (m) to (p) PLLA/Col+n-HA  
 
Fig. 4.13: MSC morphologies on mineralized and non-mineralized substrates after 21 
days of culture in osteogenic media. (a) to (d) PLLA, (e) to (h) PLLA+n-HA, (i) to (l) 
PLLA/Col and (m) to (p) PLLA/Col+n-HA  
 
Fig. 4.14: Absorbance level of alizarin red stains of various substrates after 14 and 28 
days of culture in normal and osteogenic media. * denotes significant difference between 
the groups. Note that the absorbance levels have been normalized with the substrates 
without cells 
 
Fig. 4.15: Alizarin red staining of various substrates after 14 days of culture in normal 
and osteogenic media. Scalebar: 100 µm 
 
Fig. 4.16: Alizarin red staining of various substrates after 28 days of culture in normal 
and osteogenic media. Scalebar: 100 µm 
 
Fig. 4.17: Von kossa images of various substrates after 28 days of culture in normal and 
osteogenic media. Scalebar: 100 µm 
 
Fig. 5.1: 3D pure PLLA/Col nanoyarn. (a) Gross image and (b) to (c) SEM micrographs 
of pure nanoyarn at different magnifications.  Arrowheads denote the bundles of yarns 
(collection of nanofibers). 
 
Fig. 5.2: 3D mineralized PLLA/Col nanoyarn. (a) Gross image, (b) to (e) SEM 
micrographs of mineralized nanoyarn at different magnifications and (f) SEM micrograph 
of native bone [277].   Note that n-HA is uniformly distributed on individual fibers.  The 
yarn structure is maintained after n-HA mineralization as represented by the arrowheads 
in (c) 
 
Fig. 5.3: Commercial product (mineralized collagen fibers). (a): Gross image and (b) to 
(g) are the SEM micrographs at different magnifications  
 
Fig. 5.4: Percentage of cell capture in 3D mineralized nanoyarn scaffolds after 20 
minutes of incubation in rabbit bone marrow.  Note that cells were captured in scaffolds 
in in vitro settings 
 




Fig. 5.5: Nucleated cell count using the hemocytometer. (a) Control: 5 mL of marrow 
without flushing through the scaffold. (b) Effluent: Residual marrow left after flushing 
through the scaffold 
 
 
Fig. 5.6: Colony-forming units-alkaline phosphatase positive (CFU-AP) after 13 days of 
culture.  Gross images of (a) control (without flushing through the scaffold), (b) effluent 
(after flushing through the scaffold) and light micrographs of CFU-AP colonies in (c) 
control and (d) effluent samples 
 
Fig. 5.7: Immunostaining of 3D mineralized nanoyarn scaffolds with primary antibody 
CD 44. (a) to (c) Surface of scaffold (x10), (d) to (f) Surface of scaffold (x60), and (g)-(i) 
Cross-section of scaffold (x60).  Note that there are more nucleated cells (blue DAPI-
stained) cells on the surface than in the cross-section region of the scaffold  
 
Fig. 5.8: Immunostaining of 3D mineralized nanoyarn scaffolds without the primary 
antibody CD 44. (a) to (c) Surface of scaffold (x10) and (d) to (f) Cross-section of 
scaffold (x10). Green signals (b) and (e) are very much weaker compared to samples (Fig. 
5.7) which were incubated with CD44 MSC marker 
 
Fig. 5.9: 3D confocal imaging of the surface of the scaffold with CD44 at magnification 
of 60x 
 
Fig. 5.10: SEM micrographs of mineralized nanoyarns which were inoculated with bone 
marrow and then incubated for 20 minutes. (a) to (j) show the surface and (k) to (t) show 
the cross-section of scaffold.  Note that the fibers were inoculated with cells and cell 
morphological changes (e.g. cell stretching) was observed in both the surface and cross-
section regions of the scaffolds after 20 minutes of incubation. 
 
Fig. 5.12: Micro-CT images of segmental ulnar defect site of the rabbit where 3D 
mineralized nanoyarn enriched bone marrow cells was implanted. Bone formation was 
evident throughout the defect site. 
 
Fig. 6.1: 3D nanoyarn scaffolds. (a) Gross image of 3D scaffold used for implantation. 
(b)-(c) SEM micrographs of pure PLLA/Col nanoyarn scaffold, (d) to (h) SEM 
micrograph of mineralized PLLA/Col nanoyarn scaffold and (i) native bone fibrils [1].  
Arrows denote bundles of fibers (collection of fibers in yarn formation). Note that yarn 
bundles remain intact after n-HA mineralization  
 
Fig. 6.2: Representative ulnar radiographs.  Sequential radiographs depict bone formation 
immediately after implantation (Week 0), 2 weeks, 1 month, 6 weeks, 2 months and 3 
months after implantation. (a)-(f) PLLA/Col, (g)-(l) PLLA/Col+n-HA, (m)-(r) 
PLLA/Col+n-HA+BMP-2 and (s)-(x) blank control. Arrows represent new bone 
formation 
 
Fig. 6.3: 3D Micro-CT images after three months of implantation 





Fig. 6.4: Percentage of bone volume based on Micro-CT after 3 months of implantation 
 
Fig. 6.5: Histology images after three months of implantation. (a) to (c) PLLA/Col, (d) to 
(f) PLLA/Col +n-HA and (g) to (i) PLLA/Col+n-HA +BMP-2. Note that some brown 
minerals were seen in (i).  Abbreviations – multi-nucleated giant cell (MNGC), blood 
vessel (BV), lymphoid aggregates (LYM), bone marrow (BM) 
 
Fig. 6.6: Histology of new bone formation. (a) and (b) bone consists of mature bone 
(pink) and immature bone (cartilage) [H&E], (c) chondrocytes within lacunae, 
surrounding with blood vessels (capillaries) [H&E] and (d) mineralized bone (brown 
specks) surrounding with osteoid seams where osteoblasts (OB) were laying down new 
bone [von kossa] 
 
Fig. 6.7: Histology of different cell types which were present in all material groups. Note 
that the graft was engulfed by (a) macrophages, (b) multi-nucleated giant cells (MNGCs) 
and (c) lymphocytes (LYM) in the presence of red blood cells (RBCs).  Hydroxyapatite 
(HA) from the graft could also be seen 
 
Fig. 7.1: Co-axial electrospinning setup.  The inset picture shows the special apparatus 
(inner and outer dopes) for the fabrication of core-shell nanofibers Reprinted from [2], 
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ALP: Alkaline phosphatase 
 
AFM: Atomic Force Microscopy 
 
ANOVA: Analysis of Variance 
 
ARS: Alizarin red staining 
 
BM-MSCs: Bone Marrow derived Mesenchymal Stem Cells 
 
BCA: Bicinchoninic Acid 
 
BET: Brunauer, Emmett and Teller analysis 
 
α-TCP: Alpha-Tricalcium Phosphate 
 
β-TCP: Beta-Tricalcium Phosphate 
 
BM: Bone marrow 
 
BMP: Bone Morphogenetic Protein 
 
BSA: Bovine Serum Albumin 
 
Ca-P: Calcium Phosphate 
  
CFU-F: Colony Forming Unit-Fibroblasts 
 
CFU-AP: Colony Forming Unit-Alkaline Phosphatase positive 
 
COL: Collagen  
 
CBAF-1: Core-Binding Alpha Factor-1 
 
DAPI: 4’,6-diamidino-2-phenylindole, dihydrochloride 
 
DBM: Demineralized Bone Matrix  
 
DCPD: Dicalcium Phosphate Dihydrate 
 
DEX: Dexamethasone 





DMEM: Low Glucose Dulbecco’s Modified Eagle’s Medium  
 
ECM: Extracellular Matrix 
 
EDX or EDS: Energy Dispersive X-ray Spectroscopy 
 
FBS: Fetal Bovine Serum 
 
FGF: Fibroblast Growth Factor 
 
FTIR: Fourier Transform Infrared Spectroscopy 
 
FDA: Food and Drug Administration 
 








IGF-1: Insulin-like Growth Factor 1 
 
LYM: Lymphocyte  
 
MicroCT: Microcomputed tomography  
 
MNGC: Multi-Nucleated Giant Cell 
 
MSCs: Mesenchymal Stem Cells 
 
n-HA: Nano-Hydroxyapatite  
 
NFS: Nanofiber Scaffolds 
 




PLGA: Poly (D,L)-lactic-co-glycolic Acid  
 








rhBMP: Recombinant Bone Morphogenetic Protein 
 
RT: Room Temperature 
 
SEM: Scanning Electron Microscopy 
 
TCP: Tissue Culture Polystyrene 
 
TEM: Transmission Electron Microscopy 
 
TGA: Thermal Gravimetric Analysis 
 
TGF-β: Transforming Growth Factor-β  
 
VEGF: Vascular Endothelial Growth Factor 
 
VK: Von kossa 
 
XRD: X-ray Diffraction 
 
3D: Three-dimensional  
 
2D: Two-dimensional 
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 Bone is the second most common transplantation tissue after blood.   Globally, at 
least 2.2 million of bone grafting procedures are performed annually and approximately 
500,000 of such procedures are done in the U.S. alone [3-5]. Fig. 1.1 shows the 
orthopaedic industry by market segments in the U.S [6].  As seen in Fig. 1.2, it is 
estimated that the orthopaedic market is set to generate revenues of over US$20 billion in 
2010. The U.S., being the biggest player, is said to contribute 59% of the total world 
orthopaedic market share [6].   
 
Fig. 1.1: Orthopaedic industry by market segments in the U.S. (Reprinted from [6], 
Copyright 2008, with permission from Frost & Sullivan) 
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Fig. 1.2: Revenue forecasts in the orthopaedic market (U.S.) from 2003-2013.  (Reprinted 
from [6], Copyright 2008, with permission from Frost & Sullivan) 
 
 The bone graft market alone is valued over US$2.5 billion [7]. Fig. 1.3  shows the 
overview of the revenue forecasts of bone grafts in the U.S., with allografts being the 
most popular choice [6]. This class of material is estimated to have a compound annual 
growth rate (CAGR) of 22.8%.   






























Fig. 1.3: Revenue of various segments of the orthopaedic market in the U.S., showing the 
compound annual growth rate (CAGR) for each segment. (Reprinted from [6], Copyright 
2008, with permission from Frost & Sullivan) 
 
CAGR 22.8% 
CAGR 19.6% CAGR 26.2% 
CAGR 14.6% 
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 Allografts are obtained from humans other than the patient’s own tissue and the 
main advantages of allografts are their natural nanostructural assembly and the avoidance 
of donor site morbidity. Thorough disease screening needs to be done in order to reduce 
the risk of viral or bacterial infection transmission.  Freeze-dried allografts usually have 
little osteogenesis as most of the osteogenic cells are destroyed, therefore synthetic bone 
grafts (usually calcium phosphate-based) provide an alternative bone graft option.  
Growth factors [e.g. bone morphogenetic protein-2 or -7 (BMP-2, BMP-7)] can be 
incorporated to improve their osteoinductive capabilities.  The main drawbacks of these 
synthetic materials are that they are brittle, possess low mechanical strength, and 
depending on their fabrication methods, they can be highly crystalline (due to sintering at 
very high temperatures of more than 1000ºC).  In addition, their structural and 




 The ideal bone graft should possess the three properties namely osteoconductivity, 
osteogenicity and osteoinductivity [8]. Osteoconductive graft materials provide 
biocompatible scaffolding that helps support new bone formation and growth. Osteogenic 
bone materials contain cellular elements (osteoprogenitor cells) which are at some stage 
of osteoblastic differentiation and these cells are able to synthesize new bone at the fusion 
site to form new bone directly. Lastly, osteoinductive graft materials facilitate the 
recruitment and differentiation of stem cells into osteoblasts.  Understanding the 
composition, architectural, biophysical and mechanical properties of native bone would 
provide great insights in designing bone grafts for various applications. 
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 Nanostructured materials are gaining new impetus owing to the advancements in 
material fabrication techniques, their unique properties (their nanosize/assembly/pattern 
effects on cellular behaviour) and breakthroughs in stem cell biology. The isolation of 
mesenchymal stem cells (MSCs) from various tissue sources has resulted in the interest 
to study the multiple differentiation lineages for various therapeutic treatments.  The 
explosion in tissue engineering research has revolutionized our understanding in 
modulating stem cell fate and behavior, translating into potential clinical applications for 
regenerative medicine.  Such nanostructured materials mimic the subtleties of 
extracellular matrix (ECM) proteins, creating artificial microenvironments which 
resemble the native niches in the body.   
 
 The understanding of material science, stem cell biology and signaling pathways 
(e.g. mitogen-activated protein kinase (MAPK) and phosphatidyl inositol-3-kinase 
(PI3K) etc.) is important to expedite expansion and differentiation of stem cells into 
tissue-specific lineages without changing the plasticity nature of the stem cells. Various 
biomaterial fabrication techniques aim to construct a microenvironment or niche similar 
to that in the body.  During trauma and disease conditions, loss of tissue may occur and 
instead of being in homeostasis state, the stem cells migrate out of the niche and start 
their proliferative and differentiation work at the damaged site. Stem cells stored in the 
niche are exposed to an array of soluble chemokines, cytokines, growth factors, as well as 
insoluble transmembrane receptor ligands and ECM proteins [9].  
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 In tissue engineering, material design is of utmost importance.  Attempts have 
been made to fabricate scaffolds to mimic the chemical composition and structural 
properties of ECM because a tissue-engineered scaffold with these characteristics will 
have a better chance at enhancing tissue regeneration in the body.  Structural proteins for 
example collagen are in the nanometer range and this nanotopography is said to affect 




 There is a central concept that cells attach and organize well on fibers that have 
diameters smaller than that of the diameter of the cells [10].  One of the key components 
of bone tissue engineering is the concept of ECM.  ECM not only provides the structural 
and functional aspects of bone, it also provides key regulatory signals for cell 
proliferation and differentiation by cell-receptor interactions, mediating the diffusion of 
soluble growth factors and transmitting and attenuating mechanical signals [11].   
 
 
Since the conceptual approach is to mimic native ECM, electrospinning technique 
is often employed to fabricate nanofibrous scaffolds (NFS).  The nanofibrous meshwork 
mimics the protein nanofibrils in the native ECM.  Moreover, the high surface area-to-
volume ratio and its high porosity (with small pore sizes) allow efficient nutrient delivery, 
gas exchange and waste excretion.  One of the characteristics of nanoscale scaffolds is 
the enhanced absorption of biomolecules such as vitronectin on the scaffolds due to a 
high surface area-to-volume ratio [12], which is important for e.g. wound healing, 
thereby creating a more favorable environment for cellular interaction.  In addition, 
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biomineralization was significantly increased on NFS compared to solid-walled scaffolds 
[13].  For instance, when osteoblasts (bone cells) were seeded on both types of scaffolds, 
early bone markers such as runt-related transcription factor 2 (RUNX-2) protein and 
alkaline phosphatase (ALP) and middle-stage bone marker bone sialoprotein were higher 
on the NFS than on solid-walled scaffolds.  Furthermore, the nanofibrous substrates 
seemed to promote protein adsorption such as fibronectin and vitronectin. Integrins that 
were associated with fibronectin (αvβ3), vitronectin (αvβ3) and collagen-binding (α2β1) 
were also enhanced on NFS compared to solid-walled scaffolds.  This implied that 
substrates had an influence on osteoblastic phenotype and cellular signaling, suggesting 
the superiority of NFS over solid-walled materials [13].  
 
 
 To mimic the nanocomposite nature of bone, efforts to develop newer 
compositions of synthetic bone graft substitutes to resemble the nano-hydroxyapatite (n-
HA) and collagen fibrils composition of natural bone have been attempted. Collagen 
(Col), as one of the ECM proteins, plays critical role in bone mineralization, thus Col is a 
prime candidate material for tissue-engineered graft material.  Type I Col has proven to 
be a good substrate for the binding of BMPs [14] and is also chemotactic to fibroblasts, 
because of its high affinity cell-binding domains [15]. Collectively, the activation of type 
I Col-specific integrins is said to have an osteogenic response to a bone cell line [16] and 
human bone marrow stem cells (BM-MSCs) [17] . In addition, collagen has been used in 
several commercial products such as Collapat II (Biomet Inc.), Collagraft (Zimmer Inc.) 
and Healos (DePuy Spine Inc.).  Note that the above-mentioned commercial products are 
not tissue-engineering NFS.  As collagen has a rapid adsorption rate and possess weak 
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mechanical strength, other polymers are often incorporated to enhance the mechanical 
properties of the material constructs. Besides, polymers lack cell recognition signals [18], 
and the addition of collagen provides the necessary binding sites for cell-material 
interactions.  Polymer and collagen can be co-blended and then fabricated into NFS using 
the electrospinning method.  In electrospinning, a high voltage field is applied to 
electrically-charge a liquid (the material of interest can range from polymers, collagen 
and salts that can be fully dissolved in the appropriate solvents), resulting in nanofibers. 
Calcium salts such HA [19], β-tricalcium phosphate (β-TCP) and calcium carbonate 




 The importance of closely mimicking the natural composition (collagen and n-
HA) of bone can be delineated in several studies [19,21,22].  For instance, enhanced 
mineral deposition (57% higher) was observed when osteoblasts were grown on poly-l-
lactic acid/Collagen/HA (PLLA/Col/HA) nanofibers compared to PLLA/HA nanofibers, 
suggestive of the synergistic effect of collagen and HA in driving osteogenic 
differentiation and bone mineralization [22]. Many studies have shown that BM-MSCs 
are capable of differentiating towards an osteoblastic lineage [11,23,24].  It was shown 
that when MSCs were cultured on HA surfaces, osteo-specific genes were up-regulated 
[24,25].  Not only the viability of human MSCs was not affected,  the expression of ALP, 
osteogenic genes and calcium mineralization of the MSCs were elevated when the cells 
were cultured on blended poly(lactic-co-glycolic) acid (PLGA) and n-HA nanofibers [26]. 
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It was speculated that when the cells interacted with HA, potent inductive substances 
were released. Using this conditioned media after the initial culture, uncommitted MSCs 
were then cultured without the presence of HA and the upregulation of osteo-specific 
genes were observed [24].  Biological factors are often considered as they are said to 
meliorate cellular functions.  The use of growth factors such as bone morphogenetic 
protein (BMP), fibroblast growth factor (FGF) [14,27,28] and osteogenic supplements 
(e.g. dexamethasone, β-glycerophosphate, ascorbic acid, vitamin D) [29,30] aims to 
induce osteogenic differentiation. Nanoscale disorder is capable of stimulating osteogenic 
stem cell differentiation without the use of chemical treatments [31].  Such geometric 
cues have demonstrated a dominant effect on adhesion, spreading, growth and 




 The unmet medical needs include unreliable fusion and non-union, leading to 
implant or graft failure. For single-level lumbar fusion, the non-union rate is about 10-
40% and this rate increases when multiple levels of fusion are attempted [4,5].  Large 
segmental bone defects (size larger than critical size defect) are difficult to treat, because 
of the extensive loss of bone and in many cases, the periosteum is also damaged [32].  
The critical-size defect is said to be the smallest bone defect size that does not heal 
spontaneously on its own [33].  For instance, defects measuring 20 mm in length are 
considered as the size of a critical size defect in rabbit femurs [34]. The size of such 
defects which do not heal spontaneously is said to be dependent on the skeletal location, 
bone structure and presence/absence of vascular supply, acting load or stress, age, gender, 
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species, general health of the animal or individual [33].  The periosteum is an outer 
membrane encircling bone and serves as a reservoir of osteoprogenitor cells.  During 
trauma or diseased conditions, compromised bone is often inevitable and thus, the bone’s 
natural load-bearing capacity can be greatly hindered [32]. Other reasons contributing to 
the undesirable performance of most biomaterials include the poor surface interaction 
with the host tissue, resulting in the lack of adequate tissue formation around the 
biomaterials [35].    As some materials act only as passive scaffolding, insufficient 
remodeling occurs [35].  Moreover, current bone graft systems are not suitable for large 
bony defects of more than 5cm.  The existing materials are often not available in 
sufficiently large quantities (e.g. autografts), and/or provide no load-bearing capability.  
Furthermore, current bone graft systems are usually blended systems and mimic native 
bone only at a micro-level.   In this respect, the ultimate success of any bone graft healing 
is determined by whether the bones will grow together to form a solid bone mass.  
 
 




Biomimetic mineralized NFS mimicking natural ECM provide efficient cell 
attachment and enhance osteogenic differentiation to promote bone regeneration.  
 
 (a) Electrospinning can be employed to fabricate nano-scale architectures in 
 tissue-engineered bone grafts to resemble the natural ECM structure.  
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 (b) The incorporation of collagen in NFS will improve n-HA mineralization on 
 the fibers to mimic natural bone fibrils without the need for pre-treatment of the 
 NFS. 
 
 (c) The presence of n-HA will improve the mechanical properties of mineralized 
NFS. 
 
(d) The nanotexture features of mineralized NFS can provide nanotopographical 
 cues and biomolecular cell signals for cell-scaffold interactions to improve
 osteoblast attachment and osteogenic differentiation.   
 
 (e) The nanoscale topography on mineralized NFS can stimulate osteogenic BM-
 MSC differentiation without chemical supplements. 
 
 (f) Since cells are subjected to different nanotextures within a 3D ECM niche in 
 vivo, 3D NFS can be an effective carrier for rapid cell capture, which can provide 
 an in-situ therapeutic bone graft option for bone regeneration.  
 
 (g) Biomimetic mineralized nanoyarns can improve bone healing due to its high 
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• Utilizing electrospinning technique to fabricate PLLA and blended PLLA and 
Type I collagen (PLLA/Col) and employing a biomimetic approach of 
mineralization on the NFS to achieve efficient attachment of osteoblasts and 
osteogenic differentiation on mineralized fibers. 
 
• Confirm the osteogenic differentiation potential of BM-MSCs by inducing BM-
MSCs towards an osteogenic lineage in vitro by manipulating the physical, 
biochemical and environmental conditions. 
 
• Utilizing electrospinning technique to fabricate 3D NFS (nanoyarns) and 
employing a biomimetic approach of mineralization on the NFS to achieve 
efficient cell attachment from bone marrow aspirate. 
 
• Demonstrate the efficiency and efficacy of the biomimetic nanoyarn with or 




1.4 Research rationale and strategy 
 
 Biodegradable electrospun NFS namely PLLA and blended PLLA/Type I 
collagen (PLLA/Col) were fabricated using the electrospinning technique.  The NFS were 
further modified by n-HA deposition to obtain mineralized PLLA and PLLA/Col 
scaffolds to enhance osteogenic differentiation of osteoblasts and BM-MSCs. 
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Electrospraying of n-HA with polymeric NFS was not considered as the n-HA-reinforced 
NFS did not resemble the native bone fibrils [36,37]. The mineralized and non-
mineralized PLLA/Col NFS were then used as bone grafts in a rabbit model, where rabbit 
bone marrow aspirates were incorporated for the rich and fast capture of cells in a 3D 
material construct to promote bone healing.  The rationale of using mineralized and non-
mineralized NFS/cell composites as bone grafts for bone healing in this study are as 
follows: 
• Rapid n-HA deposition on NFS can be achieved at room temperature without the 
need of pre-treatment or surface modifications of the NFS. 
 
• The biomimetic n-HA resembles the composition of native n-HA in bone. 
 
• Mineralized NFS resembles the structure and composition of native bone fibrils.  
 
• The architecture of the NFS mimics the nano-scale protein fiber meshwork in 
native ECM.  The high surface area-to-volume ratio of NFS is efficient for cell 
adhesion, proliferation, migration and differentiation. 
 
• The n-HA on NFS can provide nanotopographical cues for early cell attachment 
and osteogenic differentiation of osteoblasts and BM-MSCs.  
 
• BM-MSCs have the potential of improving bone regeneration by differentiating 
into the phenotypes of bone cells and/or enhancing repair by providing a 
microenvironment that enhances the in-situ regeneration of local cells. 
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• Mineralized NFS can serve as a rapid cell capture substrate and carrier for in-situ 
clinical applications such as the application of bone marrow aspirates. 
 
• The rapid and rich cell capture from bone marrow by mineralized NFS can be 
achieved at room temperature to emulate the temperature in a surgical suite. 
 
• Autologous BM-MSCs will not elicit immune rejection after transplantation, 
unlike allogeneic BM-MSCs with immunosuppressive properties.  
 
• The NFS has a high porosity (at least 80%) which is necessary for the efficient 
nutrient delivery, gas exchange and waste excretion after implantation. 
 
• The NFS provide as an attractive alternative to autologous bone grafts, thereby 
circumventing donor site morbidity.  
 
 
1.5 Work scope 
 
 In this dissertation, a comprehensive literature review is presented in Chapter 2 
which includes the bone healing process, current treatments, properties of BM-MSCs and 
electrospun NFS for bone regeneration.  As described in Section 1.3, the objectives will 
be carried out in three phases as seen in the Fig. 1.4. Table 1.1 summarizes the project 
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scopes from Chapters 3 to 6.  Conclusions and recommendations for future work are 
described in Chapter 7 of this dissertation. 
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Fig. 1.4: Flowchart illustrating the outline and flow of the research 
Phase I 
Fabrication of 2D nanofibrous scaffolds (NFS)  
Phase II 
Development of 3D nanofibrous scaffolds (nanoyarns)  
Objective (a): Utilize the electrospinning technique to fabricate 
PLLA and blended PLLA and Type I collagen (PLLA/Col) and 
employing a biomimetic approach of mineralization on the 
NFS. 
Objective (b): Understand the cellular behavior of osteoblasts. 




Investigation of the efficiency and efficacy of the 3D nanofibrous 
scaffolds (nanoyarns) in a rabbit model 
Objective (a): Utilize the electrospinning technique to fabricate 
PLLA and blended PLLA and Type I collagen (PLLA/Col) and 
employing a biomimetic approach of mineralization on the 
NFS. 
Objective (b): Evaluate the cell attachment efficiency on 
mineralized 3D nanoyarns. 
 
Objective (a): Demonstrate efficiency and efficacy of the 
biomimetic nanoyarn as a potential bone graft in a segmental 
ulnar bone defect in a rabbit model. 
 
Unmet Medical Needs  
• Unreliable fusion and non-union, leading to implant or graft failure.  
• Undesirable performance of most biomaterials includes poor surface 
interaction with the host tissue, resulting in the lack of adequate tissue 
formation around the biomaterials. 
• Current calcium phosphate-based grafts are usually blended systems and do 
not resemble the structural and composition of native bone. 
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Table 1.1: Overview of project scope 
 
Hypothesis Objectives Descriptions Thesis Chapter 
(1) Electrospinning 




bone grafts to 
resemble the natural 





collagen in NFS will 
improve n-HA 
mineralization on 
the fibers to mimic 
natural bone fibrils 
without the need for 
pre-treatment of the 
NFS. 
 
(3) The presence of 























fabricate PLLA and 
blended PLLA and 






the NFS to achieve 
efficient attachment 











(2) Mineralized and 
non-mineralized 
NFS were further 
characterized for 
their material 





characteristics etc.  
 
(3) The viability 
and cellular 
behaviour of 




The nanoscale Confirm the BM-MSCs were Chapter 4 
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MSCs by inducing 
BM-MSCs towards 
an osteogenic 
lineage in vitro. 
induced towards an 
osteogenic lineage 













a 3D ECM niche in 
vivo, 3D NFS can be 
an effective carrier 
for rapid cell 
capture, which can 
provide an in-situ 
therapeutic bone 






















(2) Demonstrate the 
efficiency and 




composite in a 
rabbit model.  
(1) PLLA and  
blended PLLA/Col 




of PLLA/Col was 
employed and the 
material properties 
such as morphology, 





(3) Rabbit bone 
marrow was 
aspirated and used 
for rapid cell 
capture in the 
mineralized 
PLLA/Col nanoyarn 
and implanted in a 







healing due to its 
high resemblance to 




efficacy of the 
biomimetic 
nanoyarn as a 
potential bone graft 
in a rabbit model. 
 
Animal studies were 
conducted to 
demonstrate the 
capability of the 
nanoyarns as bone 
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 Degenerative bone disorders such as osteoporosis, osteoarthritis (OA) and Paget’s 
disease are common in the elderly and often lead to fractures of the bone.  It is estimated 
that 40% of women over the age of 50 will experience an osteoporotic fracture.  
Consequently, joint diseases are prevalent in older patients, of which half of all chronic 
conditions will be associated with patients aged 65 years and above [38].   Paget’s disease 
is a localized disorder of bone remodeling, affecting 2-3% of those over the age of 60 in 
the U.S [39]. Bone disorders such as osteogenesis imperfecta (OI) or brittle-bone disease, 
fibrous dysplasia are some examples which also call for therapeutic treatments.   The 
prevalence of OI was reported to range from 1 per 10,000 to 1 per 20,000 live births [40].  
In such instances, bone grafts are employed to treat the ramifications of these diseases 
that is, to replace the loss of the natural bone.   Other cases which involve the use of bone 
grafts are trauma caused by either accidents or falls, and injuries due to sports.  
Conventional biomaterials which involve metals, ceramics and non-degradable polymers 
are permanent implants as these materials do not get resorb in the body.  Yet, the risk of 
implant failure is prevalent and remnants of the failed implant will elicit an inflammatory 
response, hampering bone repair.  This calls for a new generation of materials for bone 
applications, particularly tissue-engineered bone grafts which will be dealt with in this 
chapter. 
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2.1.1 Bone functions, structure and composition  
 
 Bone is a type of dense connective tissue that has several functions namely to 
perform mechanical, biological and chemical functions such as structural support, 
protection, movement, blood production, protection and storage of growth factors and 
mineral ion homeostasis.   Bone encompasses of several hierarchical levels over many 
length scales as seen in Fig. 2.1 [41]. They can be broadly classified into five levels 
namely: (1) macrostructure (cancellous and cortical bone), (2) microstructure (osteons 
with Haversian canals ranging from 10 to 500 µm), sub-microstructure (lamella ranging 
from 1-10 µm), nanostructure (collagen fiber assemblies of collagen fibrils ranging from 
a few hundred nanometers to 1 µm) and sub-nanostructure (bone mineral crystals 
embedded within collagen and non-collagenous proteins that are below few hundred 
nanometers) levels. 
 
Fig. 2.1: Bone hierarchical architecture from macrostructure (cortical and cancellous 
bone), microstructure (osteons with Haversian canals), sub-microstructure (lamella), 
nanostructure (collagen fiber assemblies of collagen fibrils) and sub-nanostructure (bone 
mineral crystals embedded within collagen and non-collagenous proteins) levels. 
(Reprinted from [41] , Copyright 1998, with permission from Elsevier Limited)  
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 As previously mentioned, bone is a nanocomposite with an intricate hierarchical 
structure, assembled through the orderly deposition of n-HA within a type I collagenous 
fibril matrix. Two-third of bone by weight is nanophase HA, which is the mineral 
constituent of bone [42].  Type I collagen is the main structural protein, contributing up 
to 30% of the dry weight of bone  and 90-95% of the non-mineral (organic) content 
[42,43].  Collagen molecules are triple helices with a length of about 300 nm.  The HA 
mineral crystals are embedded parallel to each other and parallel to the collagen fibrils, in 
a regularly repeating, staggered conformation (Fig. 2.2).  Bone is a nanocomposite where 
cells reside on ridges, grooves, pores and fibers of the ECM.  Besides collagen, non-
collagenous proteins such as osteocalcin, osteopontin, osteonectin, bone sialoprotein etc. 
are part of the composition of bone.  Other components also consist of calcium, 
phosphate, hydroxyl, carbonate, fluorine, sodium, magnesium, silicon, zinc and 
aluminum ions [42]. 
 




 The explosion in research towards designing nanocomposites for bone grafts are 
directed at polymeric nano-scale materials which closely mimicking the native bone 
Hydroxyapatite crystals  
(thickness: 2-4nm) 
Collagen molecules in triple-
helices (300nm in length) 
67nm 
1-1.5nm 
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structure.  One can envisage that cellular interactions and behavior such as adhesion, 
proliferation and differentiation on these nanotextured materials will be tremendously 




2.1.2 Bone regeneration in vivo 
 
 In bone remodeling, osteoclasts resorption precedes osteoblastic bone formation, 
thus the resorbed lacunae are filled with new bone produced by the osteoblasts.  Fig. 2.3 
shows the three phases of bone remodeling namely, initiation, transition and termination. 
Briefly, in the initiation stage, osteoclastic precursors are recruited followed by 
osteoclastic differentiation.  In the transition phase, the multi-nucleated osteoclasts then 
resorb bone, which in turn induce osteoblastic differentiation.  Secreted or membrane-
bound molecules produced by osteoclasts act on osteoblastic precursors in order to 
stimulate bone formation. Some of the coupling effects can be seen in Table 2.1.  In the 
resorbed lacunae, osteoclast apoptosis occur.  Lastly, bone formation by the osteoblasts 
and osteocyte formation in the osteoid occur in the termination phase.  Osteoblasts then 
become quiescent in the presence of sclerostin which is secreted through the osteocyte 
canaliculi. In addition, the osteoclastic differentiation is suppressed presumably by 
osteoprotegerin (OPG) produced by osteoblasts [44].      
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Fig. 2.3: Three phases in bone remodeling. In the initiation stage, hematopoietic 
precursors are recruited.  Osteoblast lineage cells (blue) which express osteoclastogenic 
ligands (e.g. RANKL) elicit osteoclast differentiation. The osteoclasts (red) then form 
multi-nucleated cells to resorb bone. In the transition phase, osteoclastic resorption is 
followed by bone formation via coupling factors (e.g. membrane-bound molecules 
[yellow lollipops] and factors [yellow triangles]. Lastly in the termination stage, 
osteoblasts lay down new bone in the resorbed lacunae and forming a layer of lining cells 
over the newly-formed bone. Osteocytes (star-shaped) and canaliculi (blue lines) are 
within the bone matrix (gray) (Reprinted from [44], Copyright 2008, with permission 




Table 2.1: Potential coupling factors produced by osteoclasts during the transition phase. 
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2.1.3 Acute healing in vivo 
 
 When bone undergoes trauma, leading to fractures, a combination of 
intramembranous and endochondral ossification takes place [45].  Subsequently, callus 
formation occurs.  Immobilization by fixation prevents excessive motion at the fracture 
site, thereby minimizing the possibility of non-union.   Intramembranous ossification 
happens when bone is formed directly without first forming cartilage from committed 
osteoprogenitor and undifferentiated MSCs that reside in the periosteum, further away 
from the fracture site.  This results in callus formation.   The bone marrow’s contribution 
is vital during the early healing phase when the endothelial cells become polymorphic 
cells, thereby expressing an osteoblastic phenotype [46].     
 
 
 Endochondral ossification involves the recruitment, proliferation and 
differentiation of undifferentiated MSCs into cartilage which then gets calcified and 
subsequently replaced by bone.  There are briefly six phases, namely (1) haematoma 
formation and inflammation, (2) angiogenesis and cartilage formation, (3) calcification of 
cartilage, (4) removal of cartilage, (5) bone formation and finally (6) bone remodeling.  
This type of fracture healing is contributed from the adjacent to the fracture periosteum 




There are several signaling molecules and cells that are involved in the initiation 
of the repair cascade such as pro-inflammatory cytokines, growth factors, platelets and 
MSCs [47] .  Table 2.2 shows the list of signaling molecules that are involved in fracture 
healing. 
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Table 2.2:  Various signaling molecules involved during fracture healing.  


















Chemotactic effect on other 
inflammatory cells, 
stimulation of extracellular 
matrix synthesis, 
angiogenesis, recruitment of 
endogenous fibrogenic cells 
to the injury site, and 




















Potent mitogenic and 
chemotactic for bone 
forming cells, chemotactic 
for macrophages 
 





















(at later stages) 
Mitogenic for mesenchymal 





Targeted cells: mesenchymal 



















mesenchymal cells into 
chondrocytes and osteoblasts 
and osteoprogenitor cells 
into osteoblasts 
 
Targeted cells: mesenchymal 













Angiogenic and mitogenic 
for mesenchymal and 
epithelial cells, osteoblasts, 
chondrocytes 
Expressed 
from the early 
stages until 
osteoblasts 
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chondrocytes 
 
α-FGF mainly effects 
chondrocyte proliferation, β-
FGF (more potent) involved 
in chondrocytes 
maturation and bone 
resorption 
 
Targeted cells: mesenchymal 
and epithelial cells, 














bone and cartilage 
formation) 
 
IGF-I: mesenchymal and 
osteoprogenitor cells 
recruitment and proliferation, 
expressed 
throughout fracture healing 
 
IGF-II: cell proliferation and 
protein synthesis during 
endochondral ossification 
 
Targeted cells: MSCs, 








Degradation of the cartilage 
and bone allowing the 
invasion of blood vessels 
during 
the final stages of 
endochondral ossification 





- Potent stimulators of 












- Formation of larger vessel 
structures, development of 
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 The expression profile of the various signaling molecules from the time of 
fracture to bone remodeling can be seen in Fig. 2.4.  Certain growth factors such as bone 
morphogenetic protein-2 (BMP-2), FGF, transforming growth factor-β (TGF-β1) and 
insulin-like growth factor (IGF) were expressed from the onset of injury to the bone 
remodeling phase. 
 
Fig. 2.4:  Temporal expression patterns of various signaling molecules involved in 
fracture healing. Dashed lines represent differences in opinions by the scientists in terms 
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2.1.4 Factors for bone regeneration  
 Besides diseases and trauma, there are several other factors which affect 
osteogenesis.  In cell culture experiments, dexamethasone, ascorbic acid, β-
glycerophosphate, 1,25-Dihydroxyvitamin D3 are supplements to formulate an 
osteogenic media to facilitate osteogenic differentiation of MSCs.  For instance, 
dexamethasone stimulates proliferation and aid in the osteogenic lineage differentiation, 
ascorbic acid and 1,25-Dihydroxyvitamin D3 can be used for osteogenic induction,  
promotion of the deposition of matrix, increasing ALP activity and osteocalcin 
production [48].  Ascorbic acid plays a role in the conversion of proline residues in 
collagen to hydroxyproline.  β-glycerophosphate acts as a form of phosphate supply and 
plays a role in mineralization and osteoblastic processes.   Free phosphates can induce the 
expression of osteoblastic markers such as osteopontin [49]. Other functions of 
phosphates include the production and nuclear export of an important osteogenic 
regulatory gene called core-binding factor α-1 (Cbfa-1) [50]. Osteogenic supplements 
such as dexamethasone are often added in culture medium to direct osteogenic 
differentiation of either MSCs, progenitor cells or osteoblasts.  Dexamethasone are bound 
to regulatory proteins and modulating the transcription of osteogenic genes [51,52].  
Encapsulated human MSCs (hMSCs) exhibited an osteogenic effect when 
dexamethasone was released in a sustained manner over a month in a poly(ethylene 
glycol) (PEG) hydrogel due to the hydrolysis of the lactide ester bonds, where ALP and 
Cbfa-1 were enhanced  [53].  Table 2.3 shows an overview of the effects of various 
culture media supplements for osteogenesis in vitro [54,55].  Some of the benefits of 
using differentiation medium are expansion of cell numbers, and cellular maturity, yet 
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there may be an increased risk of cell contamination during culture, cell aging, time loss 
in terms of direct application of cells into patient etc.  
 
Table 2.3: Effects of Culture Media Supplements on Osteogenic Markers In Vitro 
(Reprinted from [56], Copyright 2009, with permission from John Wiley & Sons Inc) 
 





1. Dexamethasone enhanced ALP activity 
but not BMP-2 
2. Dexamethasone caused the 
downregulation of Type I collagen 
3. Osteocalcin synthesis was dependent on 
Vitamin D. Dexamethasone or BMP-2 
alone had no effects on the basal 
osteocalcin levels but in the presence of 
Vitamin D and BMP-2 increased 
osteocalcin synthesis, whilst 
dexamethasone suppressed the 
production of osteocalcin 
4. Parathyroid hormone-induced cyclic 
adenosine mono phosphate (cAMP) 
production was significantly increased 
with the treatment of dexamethasone 
5. Mineralization was enhanced in cultures 
containing BMP-2 and dexamethasone 
elicited mineralization to a lesser degree    
6. Dexamethasone significantly increased 
cell proliferation  
[54] 
Rat bone marrow 
stromal cells and 
osteoblastic 
MC3T3-E1 cells 
Bone marrow stromal cells  
1. Vitamin C was essential for doubling 
cell viability  
2. Dexamethasone and β-glycerophosphate 
reduced the cell proliferation rate.  On 
the other hand, BMP, TGF-β, vitamin D 
sustained the growth rate given by 
Vitamin C.  
3. Vitamin C in Dulbecco’s modified 
Eagle (DME) medium was vital for the 
rapid proliferation 
MC3T3-E1 cells 
1. The incorporation of Vitamin C, 
Vitamin D, TGF-β and BMP did not 
give rise to a significant increase in 
cell proliferation 
[57] 
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2. Dexamethasone  with Vitamin C and 
β-glycerophosphate increased the cell 
proliferation 
3. There was no increase of cells in the 
samples treated with Vitamin C in 




1. ALP activity was induced by 1 α, 25-
dihydroxyvitamin D3 in a dose-
dependent manner and enhanced in the 
presence of dexamethasone  
2. Dexamethasone when used alone did 
not caused any detectable ALP 
expression 
3. Osteocalcin and osteopontin were 
produced in the presence of 1 α, 25-
dihydroxyvitamin D3 and 
dexamethasone 
4. In the presence of β-glycerophosphate 
and L-ascorbic acid plus 1 α, 25-
dihydroxyvitamin D3 and 
dexamethasone, extensive 
mineralization was observed 
5. The expression of type I core binding 
factor alpha-1 (Cbfa-1) was not 
significant in samples treated with 1 α, 
25-dihydroxyvitamin D3 and 
dexamethasone at 3, 10 and 20 days as 
compared to the controls  No expression 
of type II or III Cbfa was seen 




1. Vitamin D3, β-glycerophosphate and 
ascorbic acid were required for 
mineralization 
2. Type I collagen secretion was 
upregulated by ascorbic acid and β-
glycerophosphate 
3. Vitamin D3 induced osteonectin, 
osteopontin and osteocalcin expression 
4. Vitamin D3, β-glycerophosphate and 
ascorbic acid had a synergistic effect on 
sustained osteoblastic transcriptional 
gene expression such as RUNX-2 and 
transcriptional co-activator with PDZ-
binding motif (TAZ). TAZ is a Runx2 
transcriptional coactivator for 
osteocalcin expression. 
[55] 
  Chapter 2 
________________________________________________________________________ 
  30 
BMPs are members of the TGF-β family that are potent stimulators of bone 
regeneration.  For instance, BMP-2, BMP-7 etc. have been evaluated and it has been 
shown that they have the capability to heal bone defects in vitro and in vivo.   One 
particular study demonstrated that by using recombinant adenoviruses expressing BMPs, 
besides BMP-2, BMP-6 and BMP-9 showed the highest osteogenic activity (to a lesser 
degree, BMP-4 and BMP-7) in both in vitro and in vivo settings.  The osteogenic BMPs 
regulated a set of downstream target genes such as Ids, Dlx, and CTGF during the early 
stages of osteogenic differentiation [59].  Specifically, BMP-2 and BMP-7 are some of 
the predominant BMPs used and are able to induce osteogenic differentiation and bone 
healing.  In a study involving 450 patients with acute, diaphyseal, open tibial fractures, 
the risk of secondary intervention was greatly decreased in the recombinant human BMP-
2 (rhBMP-2) group as compared to the control group (standard of care for long bone 
repair) [60].  rhBMP-2 seeded on resorbable collagen sponge can be used in spinal fusion 
and open fractures in patients as it is FDA-approved.  rhBMP-7 and bovine collagen or 
OP-1 are also FDA-approved and can be utilized as an alternative option to autografts in 
long bone non-unions and lumbar spinal fusion.   
 
Despite the use of BMPs being potent inductors of osteogenic differentiation, the 
amounts of BMPs needed vary in humans and in animal studies.  In humans, greater 
levels of BMPs are required for osteogenesis as compared to animals.  It is evident that 
BMPs elicit a favorable response when added in culture medium or in material substrates.  
Yet there is variability in terms of patient response to BMP treatment and minute 
amounts of BMPs in the nanogram range are sufficient to trigger bone formation in vivo 
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[61-63]. Contrary, at least a magnitude of six orders was reported to result in osteogenesis 
in human with a matrix substrate [64].  A controlled delivery system of biomolecules or 
therapeutic agents can be achieved using tissue engineered biomaterials.  Besides BMPs, 
other growth factors such as IGF-1, FGF-2 and vascular endothelial growth factor 
(VEGF) are also important for bone formation.  Table 2.4 shows the types of growth 
factors used in polymeric substrates for bone repair [65,66].    
 
Table 2.4: Types of Growth Factors Used in Various Materials for Bone Regeneration 
(Reprinted from [56], Copyright 2009, with permission from John Wiley & Sons Inc) 
 
Materials Form Growth Factors Animal Model References 
Collagen Sponge BMP-2 Goat, rat, rabbit [67,68] 
Gelatin Hydrogel BMP-2 Rabbit [69] 
  TGF-β1+IGF-1 Rat [70] 
Alginate Hydrogel TGF-β3+BMP-2 Mouse [71] 
PLGA Scaffold VEGF Rat [66] 
  VEGF+BMP-4 Mouse [65] 
PLLA Scaffold TGF-β3 Sheep [72] 
HA/TCP Porous 
implant 
TGF-β2 Dog [73] 
 
Smad, Smurf and Tob proteins are also part of the intricate network of the 
osteogenic pathway [74].  The administration of such growth factors can be utilized in 
tissue-engineered constructs to induce bony formation.   Certain secreting proteins such 
as Wnts are known to be involved in cellular differentiation such as osteogenesis [75].  
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Notch signaling had been said to have a non-promotive role in osteogenic differentiation 
of progenitor cells and ALP activity, osteocalcin, type I collagen and in vitro calcification 
were suppressive [76].   
 
 
 Heparan sulfate (HS) was assessed as a potential osteogenic agent in a rat model 
[77].  5 µg of HS was incorporated in the fibrin glue scaffolds and the release kinetics 
were analyzed.  Over 50% of HS was released with an initial burst phase in the first 4 
hours, followed by a sustained release over 4 days at which 100% of HS was released.  
The released HS led to improved wound healing over a 3 month period and increased 
ALP, RUNX-2 and osteopontin gene expression.  In contrast, minimal healing was seen 
in the absence of HS after 1 and 3 months of implantation [77].  Growth factors such as 
FGF-2 and BMP-2 were susceptible to proteolytic degradation [78].  As such, HS comes 
in handy as it binds to several soluble proteins such as heparin-binding growth factors, 
providing a protective shield from extracellular proteases and aiding specific binding to 
their respective cell surface receptors [79].  
 
2.2 Types of materials for bone applications  
 There are a range of treatment options for bone regeneration.  Autografts are often 
preferred as they are harvested from the patient’s own body.  In some instances where 
harvesting of autografts are not possible (e.g. inadequate supply of autografts, poor bone 
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2.2.1 Autografts and allografts 
 
 The gold standard for bone grafts is autologous bone grafts, also known as 
autografts, whereby healthy bone tissue is harvested from the patient and implanted in the 
diseased site.  Some of the major advantages of autografts are that there is no 
immunological response due to host compatibility, the presence of osteoprogenitor cells 
and BMPs that are needed for bone regeneration.  The main drawbacks are donor site 
immobility and risk of infection at the site of harvest.  Allografts are grafts which are 
derived from another donor of the same species, often from cadavers that are freeze-dried. 
Some benefits of allografts include eliminating donor site morbidity caused by bone 
harvesting from the patient and a second operative procedure.  One of the disadvantages 
of allografts is the possible immunological response in the patient as allografts are 
harvested from another donor.  As such, there is a risk of disease transmission.  
Furthermore, donor shortage may also be an issue.  
 
 Demineralized bone matrix (DBM) is a processed product of allograft containing 
growth factors, collagen and proteins and it comes in various forms such as putty, 
injectable gel, granules or powder.  Since DBM is further processed, the risk of disease 
transmission is reduced but it does not provide a strong framework for bone healing.  
Some researchers had attempted to combine autogenous bone grafts and DBM to treat 
tibial and femoral non-unions [80-82] whereby out of thirty femoral non-unions cases, 
twenty-four were healed within six months after surgical intervention. Four patients 
needed a second plate before healing took place and the remaining two cases were lost to 
follow-up.  Others had shown that demineralized bone matrix gel could be used as a 
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supplement material to compensate the lack of autograft volume without compromising 
the fusion rates as of those who used autografts alone [83]. Different manufacturers have 
their own procurement, demineralization and sterilization procedures.  Moreover, 
individual DBMs are often coupled with different carrier materials such as calcium 
sulfate, hyaluronic acid and glycerol.   Donor variability is another concern in 
determining the osteoinductivity of the DBM material.  It had been demonstrated that 
various commercially available DBMs exhibited different biological properties for the 
induction of spinal fusion in an athymic rat model [84].  As such, there is a medical need 
to address these pertinent issues by developing a new class of tissue-engineered bone 
grafts for orthopedic applications. 
   
 
2.2.1.1 Drawbacks of current commercialized naturally-derived bone grafts 
 
 Table 2.5 lists the benefits and drawbacks of various naturally-derived bone graft 
materials. 
 
Table 2.5:  Properties of naturally-derived bone graft materials. (Reprinted from [85], 






  Advantages  Disadvantages 
 Structural 
strength 
Osteoconduction Osteoinduction Osteogenesis  
Autograft     Donor site 
morbidity 
 Cancellous No +++ +++ +++  
Cortical +++ ++ ++ ++  
Allograft     Risk of disease 
transmission 
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 Cancellous No ++ + No  
 Cortical      
 Frozen +++ + No  No  




No No, depending 
on physical form 







No No  +++ +++ Amount that can 
be extracted is 
limited. Cannot 
usually be used 
alone 







2.2.2 Synthetic bone grafts 
 
 To circumvent some of the deficiencies associated with autografts and allografts, 
scientists have come up with bone graft substitutes, which consist of systems based on 
DBM, bioceramics, BMPs, coral and composites.  Although bioceramics such as 
tricalcium phosphate (TCP) and HA do not carry the risk of disease transmission, due to 
the lack of bioactive molecules, bone regeneration may be impeded or the repair may 
occur at a slower rate.      
 
 
 Calcium phosphate materials have been used as bone substitutes because they 
possess excellent biocompatibility and osteoconduction characteristics.  Materials such as 
Bioglass®, TCP and HA are some bioactive ceramics used in orthopedic applications. 
Bioglasses consist of mainly silicon dioxide (mainly silicate), sodium oxide, calcium and 
phosphorus.  Bioglasses exhibit both osteoconductive and osteointegrative properties [86]. 
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Bioglass possesses bone bonding behavior, i.e. it can spontaneously bond to bone by 
forming a bone-like apatite layer on the surfaces. These materials are known to be 
bioactive ceramics. The formation of the apatite layer on the material/implant/bone 
surface is induced by functional groups such as Si-OH, Ti-OH, Zr-OH, -COOH and 
PO4H2 [87].  Calcium phosphates are usually used in bone defect filling in dental and 
orthopaedic applications.  There are several calcium phosphates such as HA, TCP, 
octacalcium phosphate (OCP), dicalcium phosphate dehydrate (DCPD) and their 
properties depending on their Ca:P ratios, acidity and solubility. For example, the lower 
the Ca:P ratio, the higher are the acidity and solubility of the material. The acidity and 
solubility of the calcium phosphates reduce when the Ca:P ratios are closer to 1.67:1.  
The most commonly used and studied calcium phosphate is HA, as it resembles the 
mineral component of bone. HA can be used as coatings of joint prostheses to improve 
bonding properties.  Other calcium phosphate materials include cements that can be 
resorbed and injected into the site of interest [42]. Table 2.6 summarizes the range of 
commercially available calcium-based bone graft materials.  Some issues pertaining to 
these materials are inadequacies in bulk properties, lack of mechanical strength especially 
in load-bearing sites, problems in filling up large bony defects etc.  Consequently, there is 
a medical need for a biomimetic material, which can be able to solve the above 
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Table 2.6: Various types of commercially available calcium-based bone graft substitutes.  




Some researchers had successfully fabricated ceramic nanofibers such as HA and 
fluoro-hydroxyapatite (FHA) using an electrospinning technology [88].  The HA and 
FHA precursors were employed in sol-gel solutions and the solutions were subjected to 
aging and gelation processes.  Subsequently, the sol-gel solutions were mixed with 
polyvinyl butyral (PVB) and used for electrospinning.  By manipulating the sol 
concentration, the diameter of the fiber ranged from micrometers to nanometers in size 
(1.55 µm to 240 nm).  Other processing factors which affected the fiber diameter to a 
lesser extent were the injection rate and field strength of the electrospinning parameters. 
Apatite polycrystallines (approximately 30 to 40 nm) were observed.  The FHA 
nanofibers exhibited greater chemical stability than HA nanofibers [88] and the release of 
fluorine ions was said to be beneficial in dental restoration applications because fluorine 
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helped to prevent the dental caries formation and enhanced mineralization and bone 
formation [89,90].    
  
 Biphasic calcium phosphate scaffolds comprising of β-TCP matrix reinforced 
with HA nanofibers were produced by using a gel casting and polymer sponge techniques 
to improve material properties [91].  HA nanofibers were first synthesized via a 
biomimetic chemical precipitation method and incorporated with the β-TCP powder to 
make ceramic slurries.  After polymerization of the monomers, a polyurethane foam with 
the desired shapes and sizes was then immersed into the ceramic slurries and subjected to 
sintering processes for the production of the nanocomposite scaffolds.  The compressive 
strength and modulus increased as the HA nanofiber concentration increased.  The HA 
nanofibers owing to their high surface energy could be easily diffused in the grain 
boundaries of the matrix during sintering.  Scaffolds with 5wt% HA nanofibers had a 
compressive strength of 9.8 ± 0.3 MPa, comparable to the high end of the compressive 
strength of cancellous bone (2 – 10 MPa) [92].  
 
 In a separate study, bioactive glass nanofibers were electrospun with average 
diameters ranging from 85 to 400 nm [93].  The presence of polyvinyl pyrrolidone (PVP) 
and surfactant pluronic P123 (EO20-PO70-EO20) resulted in the formation of smooth 
nanofibers and a reduction in diameter respectively.  The nanofibers were subjected to 
simulated body fluid (SBF) whereby its ionic concentration was similar to human blood 
plasma and calcium phosphate nanoparticles were deposited on the nanofiber surfaces 
after six hours of SBF immersion.  With increasing immersion periods, more apatite was 
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seen and after twenty-four hours of immersion, the bioglass nanofibers were entirely 
covered with apatite layers.  Unlike conventional bioglass fibers, the induction of apatite 
was accelerated on the bioglass nanofibers and this could be explained by virtue of the 




2.2.3 Tissue-engineered bone grafts 
 
The principle of tissue engineering is to regenerate diseased/damaged tissue or 
organ by the use of biodegradable materials with or without biological factors. Through 
the extensive understanding of the structure and chemical composition of natural bone, 
bone grafts can be designed to mimic the native bone to achieve optimal performance.   
 
The hype of fabricating nano-scale materials or the-like is due to the current 
advancement in nanotechnology, in areas such as electronics, filtration, catalysts, textiles, 
drug delivery etc.  In particular, tissue engineering is making waves in the research and 
development arena because of the breakthrough discoveries of enhanced absorption of 
biomolecules such as vitronectin on the scaffold due to a high surface area-to-volume 
ratio [12], which can be useful for wound healing.  Biodegradable materials are popular 
options for this new class of bone grafts.  These materials can be either synthetic or 
natural polymers.  Ultimately, researchers aim to develop bone grafts which surpass the 
status quo of existing bone grafts.  A cocktail of growth factors and cells are usually 
integrated within the material as it is believed that the synergistic interactions between 
the material, cells and growth factors will improve the effectiveness of such regenerative 
therapies in bone repair as depicted in Fig. 2.5.   
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Fig. 2.5: A typical tissue-engineered material construct, with the addition of cells and 
growth factors (Reprinted from [56], Copyright 2009, with permission from John Wiley 
& Sons Inc) 
 
 
 It is of paramount importance that material selection should not be overlooked as 
the type of material plays a pivotal consideration of the success of bone tissue 
engineering as illustrated in this section of the chapter.   
 
2.2.3.1 Types of polymers used for tissue-engineered bone grafts 
 
2.2.3.1.1 Natural Polymers 
Natural polymers such as collagen [23,94,95], gelatin [96], chitosan [97,98], 
alginate [96], hyaluronan [99], fibrin [100] and silk [101,102] are frequently used in bone 
tissue engineering. For instance, electrospun silk fibroin fibers were subjected to an 
alternate soaking method for nucleation and growth of apatite [102].  The fibers were first 
immersed in a calcium solution, followed by immersion in phosphate solution.  
Mineralization was achieved as apatite preferentially grew along the longitudinal 
direction of the fibers.  The silk fibroin and acidic peptides allowed the controlled 
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hyaluronan-based materials coated with fibronectin that were implanted in osteochondral 
defects in rabbits exhibited improved bone repair as compared to those without the 
implantation of the hyaluronan-based materials [99].  One of the drawbacks of natural 
polymers is the lack of mechanical properties and therefore, extensive investigations have 
been carried out in fine-tuning the material selection and design.  
 
2.2.3.1.2  Synthetic Polymers 
Synthetic materials are gaining popularity as alternative options because production 
scale-up is not an issue and they are mechanically better than natural materials.  The 
commonly used synthetic polymers encompass poly(lactic-co-glycolic) acid (PLGA) 
[103,104], poly-l-lactide acid (PLLA) [105] and polycaprolactone (PCL) [106,107].  
Polyglycolic acid (PGA) is often used in medical applications (such as sutures) because 
its degradable product, glycolic acid, is a natural metabolite.  Glycolic acid can also be 
excreted out of the body as urine.   Polylactic acid (PLA) is also used and it is generally 
more hydrophobic than PGA.  PLA has three isomeric forms, namely d(-), l(+) and 
racemic (d, l). Poly(l)LA and poly(d)LA are semi-crystalline solids and have similar 
degradation rates as PGA.  In general, the (l) isomer of lactic acid (LA) is preferred 
because it can be metabolized in the body.  The degradation rate of PCL is slower than 
that of PLA and is a suitable material for long-term, drug delivery systems.  One of the 
disadvantages of biodegradable synthetic polymers is the release of acidic by-productions 
during degradation [108].  Typically, a combination of ceramic-based materials is 
incorporated into the synthetic materials to aid in bone integration of the graft material to 
the native host tissue.  n-HA/Col/ PLLA system was developed and it was shown that the 
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construct could support cell adhesion, proliferation and migration. Evidence of new bone 
formation and integration of the segmental defect in a rabbit model was also 
demonstrated [109].  
 
2.2.3.2 Types of n-HA/Collagen-based composites used for tissue-engineered bone 
grafts 
Calcium phosphate (CaP) coatings are commonly deposited on orthopedic implants 
to improve on the biological properties, especially at the bone-implant interface.  Plasma 
spraying, laser deposition and ion beam deposition are some of the methods used to coat 
CaP on implants [110].  Studies had shown that nanoscale topography of materials 
favored cellular response.   As such, the fabrication of nanophase HA has been evident in 
recent years.  Electrostatic spray deposition, or electrospraying of n-HA is one such 
method, whereby n-HA particles were first synthesized via a precipitation reaction using 
calcium hydroxide (Ca(OH)2) and orthophosphoric acid (H3PO4) with a Ca/P ratio of 
1.67, similar to natural bone and subsequently, the n-HA particles were suspended in 
ethanol to form a ceramic slurry for electrospraying [111].   
 
As natural bone is a nanocomposite, investigators explore the possibilities of 
fabricating nanocomposite materials to combine the properties of at least two individual 
materials.  For instance, a composite was fabricated to act as a guided tissue regeneration 
(GTR) membrane for periodontal therapy [112].   This three-layered graded membrane 
consisted of one face of the material that was made of 8% nano-carbonated 
HA/Col/polylactic-co-glycolic acid (nCHAC/PLGA) porous membrane, the non-porous 
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opposite face that was made of pure PLGA and the middle layer that was made of 4% 
nCHAC/PLGA.  The porous membrane allowed cellular penetration and the non-porous 
side of the membrane inhibited cellular adhesion.  The composite was fabricated via a 
layer-by-layer casting method.  As all three layers consisted of PLGA, the composite 
exhibited sufficient flexibility and mechanical strength.  The nCHAC had the same 
constituent and had a nanocrystal size which was similar to that of natural bone [112].  
As such, it could act as a template for mineralization to take place and attracting bone 
cells to the bone graft site during bone remodeling.  PLGA is the choice polymer because 
it is biodegradable in vivo, and bone cells can deposit the osteoblastic components within 
the porous, degradable polymer over time, allowing it to be a suitable bone tissue 
engineered material, improving bone-biomaterial interface.   Composites which do not 
contain collagen can be produced via a hot temperature method such as hot pressing. 
Recently, a biomimetic self-assembly method which has been developed is said to be 
suitable for fabricating collagen-containing composites because collagen degrades rapidly 
in environments higher than the body temperature of 37ºC [85].  In this method, 
illustrated in Fig. 2 [85], type I collagen was first dissolved in acetic acid.  Aqueous 
solutions of Ca2+ and PO4- were added into the mixture for the initial nucleation of apatite.  
To adjust the pH of the solution, drops of sodium hydroxide were carefully added until 
the pH was approximately 8.  At this time, calcium phosphates began to co-precipitate 
with the collagen.  The precipitates were aged for 2 hours.  n-HA could be retrieved via 
centrifugation [113,114].   
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The n-HA/Col nanocomposite had nano-sized bone like apatite, embedded in the 
collagen matrix.  The three hierarchical levels namely the calcified collagen fibrils, 
collagen molecules and fibers showcased an example of a self-assembly biomimetic 
material, where the c-axes of the n-HA crystals were intimately aligned with the 
longitudinal axes of the collagen fibrils [113].  The n-HA and collagen molecules co-
precipitated into mineralized collagen fibrils were approximately 6 nm in diameter and 
300 nm in length as shown in Fig. 2.6  [113].    
 
The presence of this bone-like mineral is one of the prerequisites of good 
interfacial bonding with the orthopedic implants with the host’s bone (i.e. 
osteoconductivity) and may trigger osteogenic differentiation of progenitor or bone cells 
(i.e. osteoinductivity).   Table 2.7  summarizes the various types of nanocomposites and 




Fig. 2.6: Transmission electron micrograph of a biomimetic self-assembly n-HA/collagen 
composite (Reprinted from [113], Copyright 2004, with permission from Wiley 
InterScience) 
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Table 2.7: Biomimetic n-HA/collagen-based composite for bone tissue engineering 
(Reprinted from [56], Copyright 2009, with permission from John Wiley & Sons Inc) 
 
Nanocomposite Cell/Growth factors Tissue Reactions References  
n-HA/Collagen Osteogenic cells (In 
vitro and In vivo) 
In a marrow cavity 
or bone fragment co-
culture, interfacial 
bone formation at 2 
weeks 
[116-118] 





and form new bone 
in the surrounding 
area at 12 weeks 
[119-121] 
n-HA/Collagen Chondroitin sulfate No [122-124] 
n-HA/Collagen/PLA Osteoblasts (In vitro) In-growth 400μm 
depth of the porous 
scaffold 
[125] 
n-HA/Collagen/PLA rhBMP-2 (In vivo) 
 
8 weeks complete 



















The cell culture results were promising where osteoblasts adhered to the 
biomimetic PLA/Col/n-HA scaffolds within two days of culture and proliferated within 
the pores of the materials.  Within a week, full confluence was achieved.  The material 
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was then tested in an in vivo setting to evaluate its efficiency as a potential bone graft 
material [113].  A 15 mm segmental defect was made in the radius of twenty-four rabbits 
and the graft material was inserted into the defect with the incorporation of 0.5 mg of 
rhBMP-2.  Observations were made at 4, 8, 12 and 16 weeks, with six samples at each 
time point.  Histological observation also indicated that within 12 weeks post-
implantation, complete healing occurred and double cortical bone was connected to the 
defect. Spherical cells adhered to the pores of the scaffold and appeared at the composite- 
new bone interface after 8 weeks.  Trabeculae and bone marrow filled up the gaps left 
behind by the resorbed material.  Furthermore, there was more trabeculae bone replacing 
the implant at 12 weeks than at 8 weeks.  The n-HA/Col/PLA composite did not give rise 
to any acidic by-products unlike pure PLA materials as the pH value of the culture media 
did not change, enabling cellular processes to take place.  Liao et al postulated that the 
mineralized collagen could play a role in neutralizing the acidic PLA products [113].   
The porous nature of the scaffold provided a conducive environment for the deposition of 
bone matrix and mineralized collagen and could act as anchors for osteoblast adhesion.  
Further bone regeneration could be aided by the bone-cells in the scaffold [103,127,128].  
Nutrient and waste transport were made possible via these pores as well.  One study had 
reported that spinal fusion was achieved when rhBMP-2 in a collagen carrier was more 
homogeneous and underwent greater remodeling than when rhBMP-2 was in an autograft 
regardless of the presence of a collagen carrier.  In addition, the incorporation of rhBMP-
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2.2.4 Potential of electrospun nanofiber scaffolds (NFS) as tissue-engineered bone 
grafts 
The fibers or scaffolds being in nanometer scale (in diameter) are said to mimic 
the natural ECM, creating a more favorable environment for cellular interaction.  For 
instance, electrospun  NFS were fabricated from a mixture of PCL, type I Col and HA 
nanoparticles with an average fiber diameter of 180 ± 50 nm, was characteristic of the 
collagen fiber bundle diameter in native bone [130].  The presence of collagen in the 
nanofibers further improved the stiffness of the scaffold.  In addition, the apatite particles 
were uniformly distributed on the fibers [130].   Electrospinning technology was also 
employed in producing hybrid membranes made of PLLA and HA [131].  The presence 
of HA particles enhanced the tensile strength of the hybrid membranes and the increased 
elastic modulus and lower strain at failure were indicative of the fact that HA 
nanoparticles had made the nanofiber matrix stiffer and less plastic in deformation [131].   
Table 2.8 shows some examples of various types of nanofibrous composites that have 
been successfully fabricated using electrospinning [20,132,133].   
 
Table 2.8: Electrospun Nanofibrous Composites with Calcium Salts (Reprinted from [56], 
Copyright 2009, with permission from John Wiley & Sons Inc) 
 




β-calcium phosphate Polylactic acid [134] 
Hydroxyapatite Polycaprolactone [135] 
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Hydroxyapatite Silk Fibroin [133] 
Calcium carbonate Polycaprolactone [20] 
 
 
 One of the advantages of NFS was that biomineralization was significantly 
enhanced on NFS than on solid-walled scaffolds [13].  Nanofibrous PLLA scaffolds with 
interconnected pores were made using a phase separation method.   Osteoblasts were 
seeded on the scaffolds and higher alkaline phosphatase activity and an earlier and 
enhanced expression of Runx-2 protein and bone sialoprotein were observed on the NFS 
than on solid-walled scaffolds.  In addition, the NFS seemed to promote the adsorption of 
proteins such as fibronectin and vitronectin as integrins associated with fibronectin 
(αvβ3), vitronectin (αvβ3) and collagen-binding (α2β1) were present at higher amounts 
than those grown on solid-walled scaffolds.  These observations seemed to have an 
impact on osteoblastic phenotype and cellular signaling, suggesting that nanofibrous 
materials were superior to solid-walled materials [13].  Improved mechanical properties 
and wettability were demonstrated on electrospun gelatin/PCL fibrous membranes as 
compared with pure gelatin or PCL membranes [136].   Not only bone marrow stromal 
cells were favorably attached on the gelatin/PCL, the cells migrated into the scaffolds up 
to 114 µm after 1 week of culture [136].  
 
 
2.2.4.1 Techniques of fabricating NFS 
 
Since the native ECM are of a nanofibrous structure, several methods have been 
developed to make nanofibers or NFS such as drawing, template synthesis, phase 
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separation, self-assembly and electrospinning.  Table 2.9 shows the advantages and 
disadvantages of each technique. Briefly, drawing involves a micropipette that is 
submersed in a droplet of solution and withdrawn to draw a fiber.  In template synthesis, 
the polymer is extruded through a porous membrane into a solidification solution for 
nanofiber formation.  Phase separation is one method whereby separation of at least two 
different phases takes place, by the incorporation of polymer into a particular solvent; 
subsequently the freezing and freeze-drying processes give rise to a gel-like structure.  
For self-assembly method, smaller molecules act as building blocks to self-assemble 
fibers using specific bonds.   Lastly, electrospinning uses a high voltage electric field to 
draw fibers out of a needle tip where the syringe is loaded with polymer solution as seen 
in Fig. 2.7 [137-140].   
 
Table 2.9: Comparison of various fabrication methods of nanofibers (Reprinted from 
[141], Copyright 2007, with permission from Bentham Science Publishers Ltd.) 
 
Method Process Comments 
Drawing A micropipette is submersed 
into a droplet of solution and 
withdrawn at a certain speed 
(e.g. 1 x 10-4 ms-1) to draw a 
fiber  
Advantages 
1. Simple setup 
2. Repeatability  
Disadvantages 
1. Micro-sized fibers 
2. Cumbersome 
3. Not scalable 
Template 
Synthesis 
Extrusion of polymer 
through a membrane with 
nanosize pores into the 
solidification solution to 
form nanofibers 
Advantages 
1. Control of fiber diameter 
is possible 
2. Ease of fabrication 
Disadvantages 
1. Not scalable 
2. Technically difficult to 
set up 
Phase separation Phase separation consists of 
the separation of at least two 
different phases by the 
Advantages 
1. Repeatability  
2. Ease of fabrication 
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addition of polymer into a 
solvent, followed by freezing 
and freeze-drying to obtain a 
polymeric gel-like structure  
3. Simple setup 
Disadvantages 
1. Not suitable for certain 
polymeric materials 
2. Scaling up may be 
difficult 
Self-assembly Smaller molecules are used 
as building blocks for the 
self-assembly of fibers via 
specific bonds   
 
Advantage 
1. Smaller diameter 
nanofibers can be 
produced 
Disadvantages 
1. Sophisticated process 
2. Scaling up may be 
difficult 
Electrospinning This is a process which uses 
an electric field to draw 
fibers from the tip of a 
needle of a syringe which is 
loaded with a polymer 
solution to a collector plate 
Advantages 
1. Inexpensive equipment, 
therefore process is cost-
effective in a lab setting 
2. Long, continuous fibers 
with control of fiber 
diameter 
Disadvantages 
1. Toxicity of solvent due 
to solvent evaporation 
2. Instability of polymer jet 
causes collection of 
fibers difficult 
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Fig. 2.7: Electrospinning set-up to fabricate nanofibrous mesh . (Reprinted from [141], 





 Besides fabricating nanofibrous mesh, 3D nanofibrous conformation can be 
achieved using a modified electrospinning set-up as seen in Fig. 2.8 [142]. The aim of 
fabricating 3D scaffolds is to mimic the hierarchical structure of native tissues.   The 
modified electrospinning set-up employs a liquid system where fibers are deposited 
directly onto the water surface and then subsequently drawn down the vortex into the 
collector (water tank) or a mandrel (Fig. 2.8).  Liquid properties such as surface tension, 
viscosity and hydrodynamic interactions can be manipulated to achieve the desired 
nanofibers and various hierarchical organized nanofibrous assemblies can be obtained 
[143].  Bundles of aligned nanofibers and nanotexturing such as surface ridges and pores 
may be produced using this method of electrospinning [143].    
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Fig. 2.8: Electrospinning set-up to fabricate 3D nanofibrous yarns or scaffolds. Bundles 
of fibers can either be collected on a mandrel or deposited directly into the water tank. 
(Reprinted from [142], Copyright 2007, with permission from Elsevier Limited) 
 
 
 The hierarchical assembly of a 3D scaffold aids to stimulate specific biological 
response such as cell attachment, proliferation, differentiation and maturation as it 
recreates the complex cellular microenvironment in the body. As such, there is a need for 
reproducible scaffolds to have specific and desired characteristics in order to modulate 
cell behavior.   The surface topography and physical properties (or micro-architecture) 
such as the porosity, pore geometry and interconnectivity of the scaffold can affect 
cellular functions [144], thereby influencing tissue regeneration.  Moreover, the 3D 
spatial organization affects the development and function of the tissues [145,146].  
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2.2.5 Peptide-based materials  
 
In order to “coax” the native cells to adhere to the biomaterials, so that the cells 
would not view the material as a “foreign” object, peptides design and development have 
been gaining much attention, because these peptides contain adhesion domains of the 
ECM, thereby may have an impact on cell attachment, proliferation etc. and even 
inducing tissue formation.   
  
Specifically, amphiphilic peptides with a carbon alkyl tail and other functional 
peptide motifs can be synthesized to form nanofibers via the self-assembly process 
[147,148].   Hosseinkhani et. al. demonstrated that the incorporation of the MSCs (that 
were isolated from the femurs of rats) into collagen sponge self-assembled peptide–
amphiphile (PA) nanofiber hybrid scaffold in a bioreactor perfusion culture system had 
an impact on in vitro and in vivo osteogenic differentiation of the MSCs [149].  The 
hybrid material consisted of a hydrogel (PA) and a sponge (collagen sponge reinforced 
with polyglycolic acid (PGA) fiber). When the construct was subjected in a perfusion 
culture or static culture, bone formation was induced throughout the constructs, with 
those samples in the perfusion culture system exhibiting a greater and homogenous 
distribution of bone formation in a rat model.  This was indicative that the flow velocity 
of the perfusion culture system accelerated the osteogenic differentiation of the MSCs 
[149].   
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 A pivotal cell-binding domain of human Type I Col located in the α-1 (I) chain 
sequence (P-15) had been studied [150,151].  The P-15 peptide was said to facilitate bone 
formation, therefore this peptide had been used as a coating to mimic bone matrix 
components [152].  For instance, P-15 peptides were coated on anorganic bone mineral 
(ABM) particles and suspended in injectable hydrogels (such as hyaluronate (Hy), 
sodium alginate, carboxymethylcellulose) promoted cellular adhesion, osteoblastic 
activity and mineral deposition.  Preferential adhesion of the osteoblast-like cells was 
observed on the hydrogels with P-15 peptide, with more cell coverage and scattering, 
suggestive that P-15 peptide had also reinforced cellular migration.   In the presence of P-
15 peptide on ABM (with or without hydrogel), more actin and stress fibers were seen as 
compared to ABM surfaces which had little cell spreading and stress fibers, indicative of 
the adhesive properties of P-15 peptide.  The upregulation of gene expression (such as 
ALP, BMP-2 and BMP-7) was seen after ten days of culture and mineralized matrix 
deposition was more prominent after two weeks of culture in ABM/P-15/Hy than those in 
ABM/Hy [152].    
 
 
From the above-mentioned observations, P-15 peptides seemed to stimulate bone 
repair and showed a synergistic effect on osteogenic inductors such as BMPs.  Studies 
have shown that BMPs and TGF-β interact with collagen to promote osteoblastic 
processes [16,153].  Instead of using reconstituted collagen, some advantages of P-15 
peptide include minimal batch variations, large scale production, ease of handling, greater 
stability etc [154,155].  One of the advantages of hydrogels is that they can be used in 
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any bony defect, regardless of size and shape, although one must be cautious about cell 
viability, and the possibility of hampering cell migration may occur.    
 
 
 To improve the osteoinductive properties of bioceramics, grafting of RGD-
containing (Arg-Gly-Asp) peptides on HA by silanization, cross-linking and thiol 
bonding were done to mediate cell attachment [156] via the ligand-receptor interactions 
with ECM proteins such as collagen, fibronectin, vitronectin and laminin [157,158] .  The 
advantage of using smaller peptides was that these peptides were more resistance to 
proteolysis and possessed greater affinities to integrin receptors [156].  Biomolecules 
such as peptides, proteins and other functional groups can be grafted onto the 
biomaterial’s surface using plasma treatment without altering the construct’s structural 
integrity and bulk properties, while improving the hydrophilicity of the material.  Some 
groups had tried plasma-treatment as a form of surface modification on porous PLLA 
scaffolds to improve cell affinity [157].  A synthetic peptide derived from BMP-2 
conjugated to a covalently cross-linked alginate gel was reported to show prolonged 
ectopic calcification, up to seven weeks in a rat model and inducing many osteoblast-like 
cells.  Surprisingly, rhBMP-2 impregnated collagen gel showed maximum ectopic 
calcification after three weeks of implantation and the calcified products disappeared 
after five weeks.  In addition, histological results showed that it induced many osteoclasts.  
Dense calcification was restricted in a particular region in the rhBMP-2 impregnated 
collagen gel, whereas the uniform calcification occurred in the BMP-2 peptide 
conjugated alginate gel.  The results suggested that the peptide conjugated alginate gel 
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had greater stability than the rhBMP-2 impregnated collagen gel [159].    It was 
postulated that MSCs from the muscle tissue (implant site in the rat model) could have 
migrated into the alginate gel and osteoblastic differentiation occurred after the 
stimulation of the BMP-2 derived synthetic peptide. Subsequently, the osteoblasts then 
released phosphorus ions and the carboxyl functional groups of the alginate gel 
stimulated apatite nucleation, with the HA crystals being deposited on the gel [160].  
Other synthetic peptides such as B2A2 which promoted rhBMP-2 bioactivity or B2A2-K-
NS (an analog of B2A2) was said to improve osseous phenotypes in an osteoinductive 
environment [161,162].    
 
 
2.2.6 Gene-based materials  
 Gene-based factor delivery systems can be designed in such a way that a gene 
encoding a target protein can be delivered.  In this way, the upregulation and 
downregulation of a desired protein can be achieved.  In bone repair, the upregulation of 
BMPs is generally favored.   
 
 Some of the drawbacks of delivering osteoinductive growth factors from the 
material constructs are that growth factors are easily degradable and the material 
processing may destroy them.  Until now, there is no gold standard in terms of the 
optimal dose levels of growth factors to be added.  By and large, the using of gene 
therapies in bone applications renders much attention as this facet of study provides an 
alternative option to bone repair.  In essence, vectors are viral (e.g. retroviruses, 
  Chapter 2 
________________________________________________________________________ 
  57 
adenoviruses etc.) or non-viral (e.g. cationic lipid (CL) formulations etc.) tools that can 
be used for the delivery of recombinant proteins via the transfection, i.e. transfer of DNA 
to the cell nucleus, that are applicable in either an in vitro or in vivo setting.  For instance, 
the delivery of a gene encoding for an osteoinductive factor to target the cell-of-interest 
can galvanize the cells to produce the necessary factors at the location of bone pathology.   
The in vivo approach of gene therapy is to inject the genetically-modified vector or 
plasmid into the patient, although there might be interferences such as the possibility of 
not being able to transfect the desired cell type or recombination with a wild-type vector.  
Alternatively, the patient’s cells can be harvested and expanded in vitro prior to 
transfection before implantation.   Nevertheless, this process is more cumbersome and 
time-consuming.  
 
  Bone marrow stromal cells that were isolated from rats were transfected with an 
adenovirus encoding cDNA for rhBMP-2 and seeded on PLGA/HA microspheres.  In co-
culture experiments (primary human MSCs and transfected cells), BMP-2 produced by 
the transfected cells promoted osteogenic differentiation and mineralization, with a 
significant increase in proliferation, ALP and calcium deposits than those MSCs which 
were co-cultured with non-transfected cells [163].    
 
 
 In another case, retrovirus encoding the CDNA for BMP-2 was used to transfect a 
murine stromal cell line and the transfected cells were cultured on the PLGA/HA material 
for a week [164].  The results showed that the transfected cells were attached onto the 
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material and proliferation was seen.  BMP-2 was also continually expressed by the 
transfected cells.  The material specimens were then implanted into the quadriceps 
muscle porch of severe combined immunodeficient (SCID) mice, with three sample 
groups namely PLGA/HA with 3 µg of rhBMP-2 (positive control), PLGA/HA with 
BMP-2 producing W-20 cells and PLGA/HA with non-transfected W-20 cells.  No bone 
formation was observed in the PLGA/HA with non-transfected W-20 cells, unlike for the 
PLGA/HA with the BMP-2 producing cells and PLGA/HA with rhBMP-2 groups. This 
was indicative of the potential application of retroviral gene transfer in concert with an 
appropriate material for bone regeneration [164]. 
 
 Non-collagenous molecules in bone such as dentin matrix protein 1 (DMP1) have 
been reported to be involved in apatite nucleation [165,166].   Using genetically-
engineered silk DMPI, combined with SBF treatment, calcium-deficient carbonated HA 
was formed.  It was found that the carboxyl terminal domain of DMP1 induced HA 
nucleation.  HA was absent in samples with no carboxyl terminal domains of the DMP1.  
Such studies had shown that other macromolecules besides collagen, were involved in 
HA nucleation and deposition [165].   
 
 
 Recombinant collagen technology has also been investigated extensively.  It has 
been shown that recombinant human-like collagen synthesized from Escherichia coli 
(E.coli) underwent mineralization when the collagen was subjected to a series of 
chemical treatments involving CaCl2 and NaH2PO4 solutions [167].  n-HA crystals were 
deposited on the recombinant collagen fibrils, forming mineralized collagen fibers and 
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the crystallographic c-axis alignment of the n-HA crystals was parallel to the longitudinal 





2.3 Types of cells used in bone tissue engineering for osteogenic differentiation  
 
 Work in the last decade includes evidence that stem cells possess self-renewal, 
multi-lineage differentiation and in vivo functional capabilities. The stem cells of interest 
include mainly embryonic stem cells (ESCs) and MSCs, although hematopoietic stem 
cells (HSCs) are extensively studied as well.  ESCs are derived from the inner cell mass 
(ICM) of blastocyst-stage five-day embryo [168]. They possess high proliferative 
capability [169,170], are able to form three embryonic germ layers (endoderm, mesoderm 
and ectoderm) [168], produce germline chimaeras [171], exhibit differentiation in 
teratomas [168] and express specific ESC markers [168]. Human ESC (hESC) was 
isolated in 1994 [172]. Coincidentally, the generation of hESC lines [168] and human 
embryonic germ cell lines from aborted fetus [173] were established.  ESCs are capable 
of becoming any specialized cells and can be useful for drug screening assays.  However, 
the safety and efficacy of hESC lines may be a concern. These include technical issues 
such as potential of hESC rejection and the risk of tumorigenicity. There are also ethical 
and religious issues involving the harvesting of donor oocytes and destruction of the 
blastocyst. A recent study shows that the bone nodules that are formed by osteoblasts and 
MSCs exhibit the hallmarks of native bone, whereas those are formed by ESCs differ in 
terms of composition, stiffness and nano-architecture [174].  As such, MSCs provide an 
attractive alternative to ESCs and these cells can be readily obtained with less 
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controversy from bone marrow [175], umbilical cord blood [176] and adipose tissue 
[177].  More importantly, MSC has a versatile differentiation profile.  Autologous MSCs 
surmount immune rejection and carcinogenesis is minimized.  Several reports stated that 
MSCs facilitate bone repair [27,178,179] .  In the light of the fact that the number of 
MSCs in bone marrow is low, the expansion of MSCs is often necessary prior to 
implantation.  The number of MSCs in marrow was said to be approximately 1 in 
100,000 cells [180].  Usually, about 100 to 500 attached bone marrow-derived MSCs are 
obtained from 50 to 100 million cells that are introduced into culture [181].  The minute 
number of MSCs (especially as donor age increases), tissue regeneration capability 
through self-renewal and proliferation are also limited.  As such, to improve the 
proliferative and differentiation capabilities of MSCs, more attention has been devoted 




2.3.1 Potential of mesenchymal stem cells (MSCs) for bone healing 
MSCs are non-hematopoietic stem cells which have the ability to become many 
tissues such as bone, adipose, cartilage, skin, muscle and tendon etc.  MSCs can be 
derived from several sources and comprehensive studies have been done in hope of 
determining the ideal source of MSCs for bone applications as discussed in the 
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2.3.2 Potential of bone marrow derived mesenchymal stem cells (BM-MSCs) 
 
Pittenger et. al. indicated that by using stem cells from bone marrow aspirates from 
humans,  the undifferentiated cells had the potential to differentiate into several lineages 
namely osteogenic, chondrogenic, adipocytic [175].  When expanded to colonies, the 
multi-linage potential of the cells were maintained.  In one study by Xin et. al., they had 
showed that osteogenic and chondrogenic differentiation of human BM-MSCs (hMSCs) 
were observed when the cells were seeded on electrospun PLGA nanofiber scaffolds 
[104]. Note that these cells were treated with chondrogenic and osteogenic supplements.   
 
 
hMSC from the vertebral bodies that were cultured in serum-free conditions 
seemed to have preferential response to treatment with certain BMPs, with regards to 
osteoinduction [182].  Amongst BMP-2, 4, 6 and 7, BMP-6 appeared to be a potent 
stimulus of osteoblastic differentiation and its gene expression was detected prior hMSC 
osteoblastic differentiation.  The incorporation of BMP-6 to hMSC promoted the 
expression of osteoblastic genes such as type I Col, osteocalcin and bone sialoprotein.  
Furthermore, it stimulated key osteoblastic transcription factors such as core-binding 
factor α-1/runt-related transcription factor-2 (cbfa-1/Runx-2) and osterix.  The synergistic 
effects led to an enhanced mineralization of ECM and HA deposition.  It was found that 
the osteogenic growth factors such as IGF-1, FGF-β and vascular endothelial growth 
factor (VEGF) did not have direct osteoinductive effects on hMSC under serum-free 
media conditions.  It was also suggested that the above-mentioned growth factors though 
essential in the function of osteoblasts or pre-osteoblasts and skeletal development, may 
not be sufficient in osteoblastic hMSC differentiation [182] .   In a separate study, Boden 
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et al. showed that BMP-6 stimulated induced differentiation readily in rat calvarial cells, 
without glucocorticoid potentiation [183].  Similarly, the upregulation of BMP-6 
production in rat calvarial cells in the presence of glucocorticoid was observed [182,184].  
Conversely, the lack of sensitivity to BMP-2 and BMP-4 could be due to the expression 
of several families of secreted BMP antagonists, of which these antagonists could have a 
high affinity to BMP-2 and BMP-4, hindering their signaling, unlike BMP-6 and BMP-7 
that had a lower affinity to the antagonists [182].  Another explanation as to the lack of 
responsiveness of MSCs to certain BMPs could be due to a dose-dependent issue, at 
which higher doses were essential for the induction of differentiation [185].   
 
Surface chemistry was said to influence the MSC behavior on silane-modified 
surfaces in both basal and stimulated conditions [186], highlighting the importance of 
studying the minute details of material science such as surface area, porosity, local 
acidification, degradation properties etc.  This phenomenon also pertains to other cell 
types as well. 
 
 Although for bone applications, bone marrow aspirates seem to be a “more” 
suitable choice for the extraction of stromal cells, the harvesting procedure for bone 
marrow is invasive and the number of stem cells from bone marrow varies from patient to 
patient, depending on the medical condition and age.  Bone marrow stromal cells can be 
as little as 1 in 107 to 108 cells [51]. The numbers of osteogenic progenitor cells that are 
found in bone marrow decrease from 66.2 ± 9.6 cells for every 106 cells in patients who 
are under 40 years of age.  The numbers of these cells further decrease to 14.7 ±  2.6 cells 
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per 106 cells in older patients [187].  In addition, the amount of bone marrow drawn from 
the patient is limited. 
 
 
2.3.3 Potential of adipose-derived stem cells 
  To counter these issues associated with BM-MSCs, adipose tissue has been used 
as a source for stem cells as an enormous quantity of fatty tissue can be harvested.  There 
are about 300 colonies per 100-mm dish for bone marrow samples and out of which, 1 
MSC per 33,000 nucleated cells is present [188].  In other studies, typically there is 1 
MSC in every 50,000 or 1 MSC in every 100,000 nucleated cells, which constitute to 
about a few hundred MSCs for every milliliter of bone marrow [187,189].  The number 
of adherent BM-MSCs is about 1 in 105 nucleated cells [190].  The confluency of the 
BM-MSCs took about five to seven days when the cells were plated between 20,000 to 
400,000 cells/cm2 [191,192].  Confluence was achieved within the same time period 
using the initial plating of 3,500 adipose derived stromal cells/cm2 [193].  
 
 Immortal adipose stromal cell lines (ATSCs) was developed by transducing non-
human primate-derived ATSCs with a retrovirus expressing TERT (catalytic protein 
subunit of the telomerase complex) [194].  The expression of TERT could be utilized for 
creating cell lines that could expand indefinitely while maintaining the multi-linage 
potential.  The ATSC-TERT cells exhibited an increase level of telomerase activity and 
mean telomere length.  These ATSC-TERT cells showed multi-lineage potential, at a 
lesser extent in untransduced cells in vitro.   The duration of which calcium was produced 
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by ATSC-TERT cells was greatly shortened (one week of culture). However, calcium 
production occurred when native ATSCs was subjected to three to four weeks of culture 
in an osteogenic media.  Enhanced expression of osteoblastic markers such as osteoblast-
specific factor 2 and chondroitin sulfate proteoglycan was associated with ATSC-TERT 
cells.  These observations suggested that telomerase expression could open new avenues 
for bone repair [194].   The use of T-box (Tbx) factors, in particular Tbx-3, was studied 
in human adipose-derived tissue stromal cells (hADSCs) by using a lentivirus si-RNA 
vector and it was proven that Tbx-3 played a role in proliferation and osteogenic 
differentiation of the stem cells [195].   
 
 
2.3.4 MSCs derived from other sources 
Umbilical cord blood (UCB), periosteum, synovium and muscle tissues are some of 
the alternate sources whereby MSCs can be derived [196-199].  Kern et al delved the 
characteristics of three different tissues (UCB, bone marrow and adipose tissue) as a 
human source of MSCs [196].  There were no significant differences in terms of 
morphology (fibroblastoid) and immune phenotype of the MSCs. All these sources 
portrayed a multi-potential differentiation ability with the capability of formation of 
colony-forming unit-fibroblast (CFU-F) and expression of a set of surface proteins (e.g. 
CD44, CD73, CD29, CD90, HLA-1).  The success rate of isolating MSCs was 100% for 
both the bone marrow and the adipose tissue samples.  Conversely, the isolation rate for 
umbilical cord blood was 63% [149]. This observation could be attributed to the fact that 
the MSCs could be circulating in the prenatal organism and residing in tissues of the 
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adult [153].  UCB showed the lowest colony frequency, whereas adipose tissue showed 
the highest colony frequency [196].  MSCs from UCB showed the longest culture period 
and the highest proliferation ability, but MSCs from bone marrow had the shortest culture 
period and lowest proliferation ability.  Another noteworthy point to be elaborated was 
that MSCs from UCB did not show adipogenic differentiation capacity unlike those 
MSCs from bone marrow and adipose tissue which showed osteogenic, chondrogenic and 
adipogenic differentiation [196].  With regards to this, it was debated that a hierarchical 
or restricted differentiation capability of MSCs could be possible [175,200].   The 
proliferation rates of bone marrow, adipose and periosteum were similar after four, seven 
and eleven days of culture in a separate study [197].  Osteogenic and chondrogenic 
differentiation were achieved in all the MSCs.  Using a rabbit model, it was demonstrated 
that bone-marrow and periosteum-derived MSCs had superior physeal arrest over 
adipose-derived MSCs [197].   
 
 For the comparative studies between bone marrow, adipose tissue, synovium, 
periosteum and skeletal muscle, bone marrow samples generated the greatest extent of 
calcification, followed by synovium, periosteum, adipose and muscle samples.  For bone 
marrow samples, the colony number for every 103 nucleated cells was lower and cell 
number per colony was greater as compared to other tissue sources.  The number of 
nucleated cells (x103) per volume or weight of tissue obtained was as follows: bone 
marrow (2,045±920), adipose tissue (22±21), synovium (3±4), periosteum (3±6) and 
muscle (2±1).   Similarity in epitope profiles were found regardless of the tissue source 
[199].  One group had also evaluated on the immunological properties of bone marrow 
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stromal cells and adipose tissue derived MSCs and it was concluded that their properties 
were maintained during in vitro pre- and post-osteogenic induction and the results 
seemed to be similar in both tissues [201].   
 
 
2.4 Cell-material constructs as bone grafts 
After material selection, factors such as the type of pre-treatment of the substrate, 
choice of cells to be seeded and culture environment (dynamic/static conditions, 
cyclic/static loading) have to be considered. To create a more favorable environment for 
in vivo osteogenesis, many have attempted to pre-seed osteoblasts or MSCs on the bone 
graft materials.   Essentially, bone is made up of two main cell types, namely osteoblasts 
and osteoclasts.  These bone cells which are connected by gap junctions allow cellular 
communications between the bone surface and the mineral matrix.  Osteoblasts are 
involved in the production of Type I Col and mineralization.  The secretion of 
prostaglandin E2 and interleukin-6 by osteoblasts stimulates osteoclasts, leading to bone 
resorption. MSCs seem to be an attractive cell source because they are capable of 
differentiating into an osteoblastic lineage when induced in the appropriate conditions.   
The ECM secreted by MSCs can involved in several cellular processes such as the 
recruitment, proliferation, differentiation and maturation of progenitor cells.   
Physiologically, MSCs differentiate into mature matrix-secreting osteoblasts, which 
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2.4.1 Mesenchymal stem cells (MSCs)-material constructs 
For instance, coral which has a natural architecture that resembles spongy bone is 
said to be suitable as a bone graft material owing to its porosity (with an average pore 
size of 150 µm) because the blood vessels, ECM deposition and other cellular 
constituents can be intertwined within the graft, giving rise to an enhancement of material 
properties and stability.   In a particular study, it was illustrated that the use of low level 
laser irradiation applied to a MSC/coral construct stimulated the proliferation and 
differentiation of MSC into an osteoblastic phenotype during the initial culture period and 
significantly induced in vitro osteogenesis over time [202].  Higher levels of calcium 
deposition was seen in irradiated-treated samples at early (days 3 and 6) and late culture 
periods (days 21 and 28).  On the other hand, phosphate deposition was enhanced in 
those samples which were laser-treated in later culture periods (days 14, 21 and 28).    In 
addition, ALP activity was observed.  Laser-treated coral materials showed a significant 
level of ALP activity on day 2 of culture but at later culture stages (days 21 and 28), ALP 
activity was significantly reduced as compared to the control samples.  These results 
implied that low level laser irradiation quickened the differentiation of MSC into an 
osteoblastic phenotype during bone formation processes in early culture periods, whilst at 
later stages, cellular response and bone maintenance by osteocytes were predominant 
[202].   Mygind and co-workers studied the effect of different pore sizes of the coralline 
HA scaffolds and found out that scaffolds with an average pore size of 200 µm showed a 
greater rate of osteogenic differentiation based on increased alkaline ALP and enhanced 
expression of osteogenic markers such as osteocalcin, BMP-2, BSP-I (bone sialoprotein-
I) etc. than a 500 µm pore-sized scaffold [203] .  They had also showed that slightly 
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fewer but more differentiated cells were found in the 200 µm pore sized scaffold.  These 
scaffolds reached full confluency quicker than bigger pore-sized scaffolds owing to a 
higher degree of cell-to-cell communication, resulting in a higher rate of osteoblastic 
differentiation. Contrary, a significant number of less differentiated cells, i.e. higher 
proliferation, was associated with the bigger pore-sized scaffolds, possibly due to its 
higher surface area-to-volume ratio, which could have facilitated cellular adhesion on day 
1 of culture.  Other probable reasons were that more cells were needed to fill up the voids 
in the bigger pore-sized scaffolds for 3D confluency and the stimulated fluid flow aided 
in the proliferation process.  By subjecting the constructs in a dynamic spinner flask as 
compared to a static cultivation, superior proliferation and differentiation of the cells 
within the scaffolds were demonstrated.  Osteoblast matrix production was more 
prominent in constructs that underwent dynamic cultivation [203].    
 
 Chastain et al. showed that MSCs isolated from adult bone marrow in 3D 
poly(lactide-co-glycolide) acid (PLGA) scaffolds expressed and maintained greater 
osteocalcin gene expression than in PCL over a period of 5 weeks [204].  They 
hypothesized that the differential adsorption of certain ECM proteins in the serum-
containing culture media and integrin-mediated attachment could be the reason of this 
difference.    Type I Col seemed to favor MSC adhesion to PLGA.  However, vitronectin 
enhanced the attachment of MSC to PCL.  Greater ALP activity was observed for the 
PLGA group after two weeks, suggesting osteogenesis was more predominant in the type 
I Col-mediated attachment of MSC to PLGA (more osteoconductive) than in vitronectin-
mediated MSC attachment to PCL.  It was acknowledged that the conformation and 
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specific integrin-binding motifs in the ECM proteins and not just the identity of the ECM 
protein were some factors which modulated osteogenesis [204].   Other reasons for the 
preferential adsorption of the ECM proteins could be the wettability of the polymer, 




The MSC’s fate to an osteogenic lineage was said to be dependent on certain cues 
such as cell shape which could be regulated by for example Rho A modulation [209].  
hMSCs which were allowed to adhere and spread underwent osteogenesis.  Local cues in 
the microenvironment and plating density were crucial for lineage-specific differentiation 




2.4.2 Non-mesenchymal stem cells (Non-MSCs)-material constructs 
 
Osteoblasts were seeded on hybrid membranes made of PLLA and HA [131].  It 
was evident that the number of viable cells on PLLA/HA hybrid membranes was greater 
than that of those on pure PLLA membranes. This was indicative that HA provided an 
osteoconductive environment for cell adhesion.  SaOS-2 osteoblast-like cells underwent 
biomineralization when cultured in the presence of multi-phasic calcium phosphates 
which were synthesized via a self-propagating high temperature combustion synthesis 
(SHS) process, despite that culture conditions favored cell quiescence [210].  Membrane 
vesicles with calcium phosphate and porous plate-like calcium phosphate structures were 
found to be adjacent to the cells.  Pseudopodia and a flattened morphology of the cells 
were observed, suggesting that the cells had a normal metabolism and anchored to the 
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heterogeneous calcium phosphates (mainly TCP and HA).  The heterogeneous calcium 
phosphates had distinct crystalline regions as well as amorphous regions and the bulk 
porosity was spherical in nature.  This heterogeneity and the hydrolysis of the amorphous 
phase resulted in the availability of calcium and phosphate, and resulting in enhanced 
biomineralization [210].   
 
 Nano-crystalline silicon-substituted HA (SiHA) coatings on titanium (Ti) 
substrates were produced by magnetron co-sputtering and increased Si content resulted in 
decreased crystallite size [211].  There was a significant increase in osteoblast cell growth 
density on coated SiHA Ti surfaces compared to uncoated Ti surfaces.  Thian et al 
observed that flattened cells were attached on the coated surfaces with enhanced ECM 
synthesis.  Moreover, a distinct and well-defined cytoskeleton with actin stress fibers was 
present on coated surfaces, whereas on uncoated Ti surfaces, the actin filaments were not 
present in the cytoskeleton structure.  Rapid bone mineralization was seen in those 
coatings with a high Si content (4.9 wt% Si) by day 16 of culture.  The drawback of high 
Si content was that rapid dissolution of the coating was apparent because of the small HA 
crystal size, thus the attachment of cells at very early stages may not be ideal.  As such, it 




2.5 Regulating osteogenic differentiation via nanotopographical characteristics 
 
 Regulating stem cell fate can be achieved through various means, such as 
chemical, topographical, mechanical and electrical or electromagnetic cues. This study 
focused on the topographical features and substrate characteristics for osteogenic 
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differentiation.  For instance, lateral spacing geometry of TiO2 nanotubes of 30-50 nm 
was reported to be the critical threshold for cell fate [212].  Diameter (<15 nm) and 
spacing (<30 nm) were considered to be the effective length scale for improving integrin 
clustering and focal contact formation.  Good evidence showed that smaller diameter 
nanotubes (15 nm) were associated with greater focal contact formation, stress fiber 
(contractile actomyosin bundles or actin filaments) assembly, cell spreading and 
osteocalcin differentiation compared to larger diameter nanotubes (100 nm). On the other 
hand, larger diameter nanotubes (>50nm) resulted in the reduction in cellular activity, 
fewer focal contact and stress fibers and even programmed cell death [212].  In a separate 
study, it was shown that larger diameter nanotubes enhanced cell spreading compared to 
smaller diameter and flat substrates [213]. Increased MSC adhesion on smaller diameter 
nanotubes was said to be due to the increased protein aggregates such as fibronectin and 
albumin.  Conversely, larger diameter nanotubes increased osteogenic differentiation as 
the cells were forced to elongate and stretch in search of protein aggregates, and such 
guidance and stressed-induced elongation resulted in osteogenic differentiation.  Lower 
cell numbers were seen on larger diameter nanotubes within one day, but after seven days, 
the cell numbers for the different sized nanotubes were comparable, suggesting that the 




 A landmark paper highlighted the importance of matrix stiffness and its influence 
in directing MSC commitment towards a specific lineage [214].  Briefly, soft matrices 
were associated with neurogenic differentiation, stiffer matrices were corresponded to 
myogenic differentiation and lastly rigid matrices were related with osteogenic 
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differentiation [214]. In a separate study, the stiffness of substrates (PEG-based 
materials) affected differentiation of pre-osteoblastic cells via mitogen-activated protein 
kinase (MAPK) activation [215].  It was reported that such ECM rigidity regulated 
osteogenic differentiation involving MAPK activation downstream of the RhoA-ROCK 
signaling cascade [216].  Early osteogenic differentiation markers, such as RUNX-2 and 
ALP expression were associated with stiffer materials [215,216]. The elasticity of the 
substrates also impinged upon cell proliferation, where stiffer substrates resulted up to 
ten-fold increase in cell numbers compared to lower stiffness substrates [217].  
Interestingly, osteogenic differentiation of MSC was significantly increased on type I 
Col-coated substrates with the highest modulus [217], suggesting that substrate elasticity 
alone did not direct stem cell fate, but rather a network of factors such as the presence of 
integrins and integrin-receptor interactions was also likely at work.  This highlights the 
importance of designing materials that are more closely related to the microenvironments 
found in native tissues.  
 
 
 Besides cell-substrate interactions, the presence of protein secretion by the cells 
would alter the chemistry of the material surface, thereby influencing osteogenic 
differentiation.  The de novo synthesis and deposition of ECM proteins by the MSCs was 
said to modify the chemical characteristics of PLGA substrates, in turn affecting the 
MAPK and phosphatidyl inositol-3-kinase (PI3K) pathways which influenced osteogenic 
differentiation [218].  In addition, the attenuation in MAPK and PI3K pathways greatly 
inhibited MSC osteogenic differentiation [218].  Several studies have shown that the 
dimensionality of the substrate (2D vs. 3D) has an impact on cell fate and signaling 
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cascade.   3D scaffolds provide more precise, reproducible nano-topographical features 
and such nano-texturing is usually absent in 2D substrates.  Certain stress mediators such 
as p38 and c-Jun N-terminal kinase (JNK) were significantly activated in 3D calcium 
phosphate scaffolds, thereby indicating that cells responsed to environmental signals, 
triggering certain signaling pathways such as MAPK cascade.  This phenomenon was 





 In summary, although there are several bone graft materials in the market, there 
are huge differences in terms of graft performance and patient outcomes.  Moreover, 
most of the calcium-based graft materials are blended systems and they do not mimic the 
composition and structure of native bone.  Current research focuses mainly on developing 
bone graft materials that most likely constitute several strategies such as the use of 
biodegradable materials, functional cellular components and attempting to mimic the 
structure and properties of analogous ECM as described in this chapter.   In this thesis, a 
biomimetic NFS was designed and developed by combining the functionality of 
electrospinning, biomineralization and physiologic activity of precursor cells such as 
BM-MSCs and osteoblasts.   Here, biodegradable PLLA was the base material for 
electrospinning with the option of co-blending with type I Col.  Biomimetic n-HA 
deposition was considered on both PLLA and PLLA/Col nanofibers for inducing 
osteogenic differentiation of osteoblasts and BM-MSCs. The efficiency of the resultant 
nanofiber/cell composite as bone grafts was further evaluated in a rabbit model.  This 
strategy aimed to provide advanced bone graft materials that would by-pass the tedious 
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and time-consuming process of cell expansion to facilitate bone regeneration in the 
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In bone tissue engineering, biomimetic mineralized collagen material, also known 
as n-HA/Col composite, can be prepared by various methods [116,121,220].  In an earlier 
study, n-HA/Col (nHAC)-based composite was prepared through a self-assembled co-
precipitation method and its structure was similar to that of natural bone [121,220].  After 
mixing nHAC with PLLA solution via a phase separation technique, the nHAC/PLLA 
scaffold was prepared as a three-dimensional porous structure [113]. Osteoblasts were 
able to adhere and migrate into the inner part of the three-dimensional scaffold 
(nHAC/PLLA) [109].  When implanted in rabbits, these materials underwent remodeling 
with new bone formation [28,113,118].  Bone-like apatite was formed when the polymer 
substrates such as PLLA were subjected to SBFs [221].   In a separate study, nano-sized 
single crystalline HA fibers were synthesized using SBF as a solvent [222].  Co-
precipitation methods were employed to fabricate a carbonate-substituted HA/chitosan-
silk fibroin composite with improved compressive strength as compared to precipitated 
HA in the absence of any organic material due to the enhanced adhesion between HA and 
the organic matrix, whilst facilitating the distribution of stress transfer [223].  As such, a 
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combination of a polymeric material and bioceramic such as HA is often explored for 
future bone substitute materials.   
 
The aim of this study was to develop a novel nanofibrous composite that would 
mimic the main components and nanofibrous characteristic of natural bone by combining 
the advantages of electrospinning and mineralization methods.  Two types of polymers, 
namely PLLA and type I Col were chosen to be electrospun into nanofibrous scaffolds.  
Human bone derived osteoblasts were cultured on mineralized nanofibrous scaffolds over 
various time points to investigate cell affinity behavior.  We hypothesized that there 
would be a preferential n-HA deposition on PLLA/Col nanofibers and improved early 
osteoblast attachment on mineralized nanofibers.   
 
3.2 Materials and Methods 
3.2.1 Processing of nanofibrous scaffolds by electrospinning 
Type I Col (Koken Co. Tokyo, Japan) and a biodegradable polymer, PLLA 
(300,000 Da, Aldrich Chemical Company, Inc.) were used to prepare the scaffold. 3% of 
pure PLLA and a blend of PLLA/Col (50:50 w/w) solutions for electrospinning were 
prepared by dissolving the polymers in 1,1,1,3,3-hexafluoro-2-propanol (HFP, Aldrich 
Chemical Company, Inc.).  Although the starting ratio for the preparation of the polymer 
solution was 50:50 w/w for PLLA/Col, the actual final ratio of the constituents was not 
determined in this study. For the preparation of 6.66% of pure electrospun collagen 
nanofibers, type I Col was dissolved in HFP solvent.  Part of the electrospinning setup 
involved the connection of the syringe loaded with the polymer solution to a DC high 
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voltage power supply from Gamma High Voltage Research.  A voltage was applied to the 
spinneret with a specified working distance, i.e. the distance from the tip of the spinneret 
to the surface of the collector plate. The voltage used for the preparation of the nanofibers 
was 15 kV (for PLLA and PLLA/Col nanofibers) or 12 kV (for collagen nanofibers).  
The working distance for the production of PLLA or PLLA/Col nanofibers and collagen 
nanofibers was 15 cm and 12 cm respectively.  The spinneret used in our case was a BD 
27G ½ needle which was ground to give a flat tip in order to produce smooth, continuous 
fibers. A KD Scientific syringe pump was used to provide a constant feed rate of 1 
mL/hour. The entire electrospinning process was conducted under the controlled 
conditions; that is, at the room temperature of 25±1 ºC and at the relative humidity of 
65%.  The electrospun nanofibrous scaffolds were then vacuum dried overnight and 
sterilized with 70% ethanol for 10 minutes before mineralization was carried out. 
 
3.2.2 Mineralization of electrospun nanofibrous scaffolds 
PLLA and PLLA/Col nanofibrous scaffolds were mineralized using the modified 
alternate soaking method (Ca-P soaking) [224].  PLLA and PLLA/Col scaffolds were 
first immersed in 0.5 M of CaCl2 (Aldrich Chemical Company, Inc.) for ten minutes.  
After rinsing with de-ionized (DI) water for a minute, the scaffolds were subsequently 
immersed in 0.3M of Na2HPO4 (Merck, USA) for 10 minutes.   This denotes 1 cycle of 
Ca-P treatment.  The DI water was then collected and centrifuged to collect the HA 
residues.  After centrifugation, the HA was subsequently freeze-dried overnight before 
XRD analyzes. For PLLA scaffold, the material was subjected to five cycles of Ca-P 
treatment. For PLLA/Col scaffold, mineralization was achieved after three cycles of 
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alternate soaking.  The mineralized scaffolds were subsequently freeze-dried for twenty-
four hours.  
 
3.2.3 Material characterization 
The surface morphology of the electrospun scaffolds and the mineralized 
scaffolds were examined by using a field-emission scanning electron microscopy 
(FESEM) (Quanta 200F, FEI) with an accelerating voltage of 20 kV. The average fiber 
diameter of the scaffolds was determined from the FESEM micrographs using an image 
analysis software (Image J, National Institutes of Health, USA).   The chemical 
functional groups of the (both Ca-P treated and non-treated) scaffolds were recognized by 
a spectroscopic method using a Fourier transform infrared (FTIR) spectrophotometer 
(Varian 3100 Excalibur Series).  The crystallographic phase analyzes were carried out by 
powder X-ray diffraction (XRD) method using a Shimadzu XRD 6000 (Japan) 
diffractometer.  The measurement was performed with the use of Ni filtered Cu Kα1 
radiation at the wavelength of 1.5406 Å, at a scan rate of 2˚ min-1, at a sampling interval 
of 0.02˚ and in the 2θ range of 10˚ ~80˚. The data was analyzed using a XRD-6000 V2.5 
software. Wettabilities of the nanofibers before and after mineralization were measured 
by sessile drop contact angle measurement using a VCA Optima Surface Analysis 
System (AST products, Billerica, MA).  To quantify amount of HA on the fibers, 
thermogravimetry analysis (TGA) using TA Instruments TGA 2050 Thergravimetric 
Analyzer (Japan) was employed.  The specimens (n=5) were heated up to 1000ºC, with a 
heating rate of 10ºC/min in air.   
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3.2.4 In vitro culture of osteoblasts 
Scaffolds were imbedded in 70% ethanol twice for a period of 20 minutes at each 
time under UV light for sterilization purposes. The scaffolds were then washed with 
phosphate buffered saline (PBS) thrice to remove any residual ethanol.  Human fetal 
osteoblast cells, hFOB 1.19 (ATCC, US), cultured until passage five, were seeded on the 
PLLA and PLLA/Col scaffolds , mineralized PLLA and PLLA/Col scaffolds, at a cell 
concentration of 104 cells/sample.  For each material group, the sample size was three and 
tissue culture plastic (TCP) controls were used for all cell-related studies.  
 
The constituents of the culture medium used include 1:1 mixture of Ham's F12 
medium and Dulbecco's modified Eagle's medium (DMEM) without phenol red with 2.5 
mM L-glutamine (Invitrogen, US), 0.3 mg/mL G418 (Sigma, US) and 10% fetal bovine 
serum (Invitrogen, US).  The medium was changed every two days.   
 
3.2.5  Cell attachment study 
1 mL of the solution containing 10,000 osteoblasts was added to each of the wells 
containing the samples. The cells were incubated with the different test samples at room 
temperature for 10, 20, 30, and 60 minutes.  At the end of the incubation period, the 
solutions containing the unattached cells were discarded and each well containing the test 
samples was washed thrice with 1 mL of PBS.  For the purpose of cell counting, the 
nuclei of the attached cells were stained with DAPI (4’, 6-diamidino-2-phenylindole, 
dilactate) (InvitrogenTM) using the following protocol.  Pre-chilled methanol was added to 
the wells containing the attached cells and allowed for fixation at room temperature for 
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10 minutes.  Next, the nuclei of the attached cells were stained with 0.25 mL/well of 1 
µg/mL DAPI for 30 minutes at room temperature.  Each test sample was photographed 
using a fluorescence microscope (Leica DM IRB) at 100 times magnification.  For each 
test sample, the number of cells in 5 predetermined rectangular areas (top, centre, bottom, 
left and right portions of the culture well) was counted based on the nuclei count.  This 
cell count method was also used to calculate the cell number at the day 1, day 4 and day 7 
of culture for cell proliferation quantifications. 
 
 
3.2.6 Total protein assay 
Osteoblasts (10,000 cells/sample) were seeded on non-mineralized and 
mineralized PLLA and PLLA/Col composite scaffold samples in three 24-well plates and 
cultured in osteoblast cell culture medium under standard cell culture conditions for 1, 4, 
and 7 days respectively. At the end of the prescribed times, the culture medium was 
removed from the culture wells and washed thrice with PBS. Samples were stained with 
bicinchoninic acid (BCA) protein assay working reagent (BCA Kit No.23225, PIERCE) 
at 37ºC for 30 minutes.  Once room temperature was reached, the protein content was 
determined at 590nm using a FLUO Star Optima microplate reader (BMG Labtech 
GmbH).  The total intracellular protein (expressed in mg) synthesized by the osteoblast 
cells cultured in the medium was determined from a standard curve of absorbance versus 





Phase I: Fabrication of 2D NFS                                      Chapter 3 
Objectives (a) & (b) 
________________________________________________________________________ 
  81 
3.2.7 Alkaline phosphatase (ALP) activity assay 
The prescribed cells were cultured on the materials and the alkaline phosphatase 
(ALP) activity was measured at day 1, 4, and 7 respectively. 400µL of p-Nitrophenyl 
Phosphate, Disodium Salt (PNPP) solution (Phosphatase Substrate Kit, No. 37620, 
PIERCE) was added to the 24-well culture plate and incubated at room temperature for 1 
hour. The reaction of p-nitrophenol conversion to p-nitrophenylate ceased by the addition 
of 200µL of 2M of NaOH.  Light absorbance of these samples was measured at 405nm 
on a FLUO Star Optima microplate reader.  
 
 
3.2.8 SEM of cell morphology 
Scaffolds with cells which were cultured for 1 day, 4 days and 7 days were fixed 
in 4% paraformaldehyde solution for 30 minutes at room temperature. Scaffolds were 
dehydrated in 50%, 70%, 95%, 100% (twice) (5 cycles with increasing concentrations of 
ethanol) for 10 minutes respectively.  Samples were subsequently air-dried overnight and 
observed by SEM.  
 
3.2.9 Mechanical Testing 
After osteoblasts were cultured on the nanofibrous scaffolds for a period of time 
(1 day, 4 days and 7 days), the nanofiber/cell contracts were freeze-dried overnight at -
60˚C.  The nanofibrous scaffolds with or without cells were separated from the 
aluminium foil, using a paper frame with double-sided tape.  The frame was designed to 
provide extra strength and support to the sample ends for proper fixation in the tensile 
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tester clamps and to ensure constant sizes of the samples being tested (10 mm width, 20 
mm length).  A micrometer (Mitutoyo) was used to measure the thickness of the 
membrane at three different positions and the average thickness was taken to calculate 
the cross sectional area of the specimen.  Using a Tensile Tester (Instron Micro Tensile 
Tester 5848, USA) each sample (n=5 specimens) was subjected to a load of 2.5 Newton.  
Load deformation data was recorded at a deforming speed of 5 mm/min and a sampling 
rate of 100Hz. The E-modulus was calculated for low strain at the linear regime using 












E: E-modulus (Pa), σ: stress (Pa), ε: strain 
 
3.2.10 Statistical analysis 
Data was gathered at least in triplicate and expressed as mean ± standard 
deviation (SD). Statistical analyzes were carried out using one-way analysis of variance 
(ANOVA) testing by SPSS for Windows (SPSS Inc., Copyright1989-2002) version 
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3.3 Results  
3.3.1 Nanofibrous and mineralized nanofibrous scaffolds 
Uniform nanofibers of PLLA (Fig. 3.1a) and PLLA/Col (Fig. 3.1b) with average 
diameters of 287nm and 364nm respectively were fabricated by electrospinning.  There 
were various definitions of “nanomaterials”.  It was widely accepted that nanomaterials 
refer to those materials with a nano-size topography or encompass of nano-size building 
blocks. The scale length/size/diameter of nanostructured materials, nanocrystals, 
nanocoatings, nanoparticles and nanofibers were typically in the range of 1-100 nm [110]. 
However, fibers that were above 100 nm but below 1000 nm were also described as 
“nanofibers” in several publications which had been cited in this document and in the 
public domain.  After mineralization, the morphologies of both types of nanofibers were 
contrastive.  The n-HA on PLLA nanofibers (Fig. 3.1c) was not formed in a continuous 
manner where there was a tendency for n-HA to be deposited at the cross points of at 
least two fibers, unlike those formed on PLLA/Col nanofibers (Fig. 3.1d) where the fibers 
were substantially covered with n-HA and no superior or enhanced mineralization at the 
cross points was seen.  
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                                   (c)                                                          (d) 




From the XRD patterns, the formed minerals on PLLA and PLLA/Col were n-HA, 
with no impurities present.  The n-HA obtained was similar to that of natural HA in 
human tooth (Fig. 3.2).  All the diffraction peaks of PLLA+n-HA and PLLA/Col+n-HA 
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Fig. 3.2:  XRD results of  (a) mineralized PLLA nanofiber; (b) mineralized PLLA/Col 
and control (c) natural tooth of human, which identified that minerals on PLLA and 
PLLA/Col nanofibers are n-HA with same pattern as natural HA in human tooth. Note: 
Intensity in arbitrary (Arb) units. 
 
 
Fig. 3.3 shows the FTIR results of the nanofibers. The spectrum of PLLA and 
PLLA/Col nanofibers (Figs. 3.3b and c) after mineralization exhibited typical absorption 
bands characteristic of carbonated hydroxyapatite, which was not seen in the spectrum of 
pure PLLA nanofibers (Fig. 3.3a).  Peaks at 1755 cm-1 and 1086 cm-1 referred to carbonyl 
and C-O stretch in PLLA.  Peaks at 1086 (ν3), 1033 cm-1 (ν3) and 558 cm-1 (ν4) referred 
to the phosphate group, and peaks at 1637 cm-1 (ν3), 866 cm-1 (ν2) referred to the 
carbonate group.  For mineralized PLLA/Col nanofibers, amide I (1661 cm-1) and amide 
II (1544cm-1) were attributed to collagen although they were slightly overlapped by the 
carbonate group. Comparing the peak for carbonate group (866 cm-1) in Figs. 3.3b and c, 
the n-HA on PLLA/Col nanofibers encompassed more carbonated component than that of 
PLLA nanofibers.  
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Fig. 3.3:  FTIR spectra of (a) PLLA nanofibers; (b) mineralized PLLA nanofibers and (c) 
mineralized PLLA/Col nanofibers. Peaks at 1755 cm-1 and 1086 cm-1 referred to carbonyl 
and C-O stretch in (a) PLLA. Peaks at 1086, 1033 and 558 cm-1 in (b) and (c) referred to 
phosphate groups from nano HA. Although the absorption band (1086 cm-1) from (a) 
PLLA overlapped with the vibration bands of the phosphate groups, the relative 
intensities of the phosphate groups were greater in (b) and (c).  Peaks at 1637 and 866 
cm-1 referred to carbonate groups from n-HA. Peaks at 1661 and 1544 cm-1 referred to 
amide I and II groups from collagen 
 
 
As shown in Fig. 3.4, collagen improved the wettability of the nanofibers, from 
115.5˚ (PLLA) to 41.5˚ (PLLA/Col).  n-HA deposition on PLLA (PLLA/n-HA) (110.7˚± 
5.2˚) did not significantly improve the wettability as compared to PLLA nanofibers 
(115.5˚±9.4˚).  Conversely, the hydrophilicity property of PLLA/Col was significantly 
improved by the deposition of n-HA (16.4˚ ±4.2˚) compared to PLLA/Col (41.5˚±6.5˚) 
and the controls (pure collagen nanofibers, 53.8˚±7.1˚).    The quantities of HA were 
established using TGA where PLLA and PLLA/Col contained 37.8 wt% and 30.2 wt% of 
HA.   
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Fig. 3.4:  Water contact angles of PLLA, mineralized PLLA, PLLA/Col, mineralized 
PLLA/Col and Collagen nanofibers (control). Significant difference between different 
groups were denoted as * (p<0.05) 
 
 
3.3.2 Enhanced cell capture on mineralized nanofibrous scaffolds 
Mineralization further enhanced the cell capture efficiency as shown in Fig. 3.5.  
The initial cell number for the cell capture study on each sample is 10,000.  From 10 
minutes to 60 minutes, approximately 10% of the cells were attached on TCP controls, 
which was lower than all the nanofibers.  For PLLA and PLLA/Col nanofibers, 
mineralization significantly enhanced the cell capture efficiency, especially within 30 
minutes.  The prominent cell capture at 10 minutes was on PLLA+n-HA (35% ± 9%) and 
PLLA/Col+n-HA (37% ± 9%). The most desirable cell capture results at 20 minutes were 
on PLLA/Col+n-HA (61% ± 5%).  At 30 minutes, there was no significant difference of 
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Fig. 3.5:  Cell attachment on PLLA, PLLA+n-HA, PLLA/Col, PLLA/Col+n-HA and 
TCP (control) from 10 minutes to 60 minutes at room temperature. Significant difference 
between different groups were denoted as * (p<0.05) 
 
 
3.3.3 Cell behavior on nanofibrous scaffolds 
Cell proliferation, total protein assay and ALP expression were assessed on day 1, 
4 and 7 of culture.  Interestingly, the cell proliferation results were not in cognate with the 
results of the cell capture study as previously mentioned.  Cell proliferation was greatest 
in the TCP control group as seen in Fig. 3.6.  The increasing trend of cell proliferation 
was evident on non-mineralized nanofibers analogous to that on TCP.  However, on 
mineralized nanofibers, there was no significant increase in cell proliferation.  From day 
1 to day 7, the number of attached cells on PLLA+n-HA and PLLA/Col+n-HA were 
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Fig. 3.6:  Cell proliferation on PLLA, PLLA+n-HA, PLLA/Col, PLLA/Col+n-HA and 
TCP (control) from day 1 to day 7. Significant difference between different groups were 
denoted as * (p<0.05) 
 
 
Fig. 3.7 shows the cell morphology and the observations are as follows: 
PLLA/Col+n-HA (Fig. 3.7d) was conducive for cell expansion than PLLA+n-HA (Fig. 
3.7a) after day 1 of culture.  In addition, there was a substantial increase in cell size on 
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Fig. 3.7: SEM images of cells growing on mineralized nanofibers (a) PLLA+ n-HA  for 1 
day; (b) PLLA+ n-HA  for 4 days;  (c) PLLA+ n-HA  for 7 days;  (d) PLLA/Col+ n-HA  
for 1 day; (e) PLLA/Col+ n-HA  for 7 days 
 
 
The final protein concentrations synthesized by the cells depicted in Fig. 3.8 were 
obtained by dividing the initial results by the cell numbers (in Fig. 3.6).  Here, the values 
of each expanded cell on the mineralized scaffolds performed at a higher level of function 
than each cell on non-mineralized scaffolds and TCP controls.  Cells on mineralized 
nanofibers had higher protein amounts than non-mineralized nanofibers at day 1 and day 
4 of culture.  The ALP activity (Fig. 3.9) was comparable for all the material groups.   
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Fig. 3.8: Total protein assay of cells on PLLA, PLLA+n-HA, PLLA/Col, PLLA/Col+n-
HA and TCP (control) from day 1 to day 7. Significant difference between different 



























Fig. 3.9: Alkaline phosphatase (ALP) expression of cells on PLLA, PLLA+n-HA, 
PLLA/Col, PLLA/Col+n-HA and TCP (control) from day 1 to day 7.   Results shown 
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Tensile testing was done on all the scaffolds (with or without cells).   Fig. 3.10 
shows the E-modulus of the scaffolds after day 1 and 4 of culture.  No results were 
obtained for those cultured for 7 days because the samples were damaged during the 
separation of the fibers from the support material (aluminum foil) as the nanofibers were 
extremely “sticky”.  The increased tackiness could be due to the increased expression of 
ECM proteins secreted from the osteoblasts at day 7.  Although there was no 
improvement in osteoblast proliferation on mineralized fibers after a week, the E-
modulus of PLLA+n-HA with cells at day 1 and day 4 were significantly enhanced 
compared to PLLA+n-HA without cells (Fig. 3.10).  On the other hand, the E-modulus of 
the PLLA/Col+n-HA nanofibers with cells at day 1 and day 4 was significantly decreased 










Fig. 3.10: E-modulus for PLLA, PLLA+n-HA, PLLA/Col+n-HA nanofibrous scaffold 
and various scaffold with cells after 1 day and 4 days of culture.  Significant difference 
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3.4 Discussion 
The main objective of this study was to develop a novel nanofibrous composite 
using electrospinning and the alternate soaking methods. Various coating methods such 
as alternate dipping or SBF treatments [225-227] have been employed for apatite 
deposition on polymeric substrates for tissue engineering applications. The SBF strategy 
is to increase the concentration of Ca and P ions in the fluid by regularly replacing the 
solution with fresh SBF fluid.   Studies have shown that the initial apatite nucleation by 
chemical means such as alkaline treatments to introduce functional groups such as 
carboxylate groups prior to SBF immersion is pivotal for the acceleration of apatite 
deposition.  Apatite deposition was seen on PCL materials which were first treated with 
O2 plasma followed by alternate dipping in calcium and phosphate solutions, 
subsequently subjected to SBF solutions for 24 hours [228].  PLLA scaffolds which were 
alkali-treated showed apatite deposition after 4 days in SBF [225].  However, the 
complete deposition of HA on the nanofibers occurred after 2 weeks of SBF soaking 
[225].  One of the advantages of our study was that the samples did not have to undergo 
any pre-treatment and successful apatite deposition occurred after a few rounds of 
alternate Ca-P dipping.  From the results, n-HA deposition on pure PLLA nanofibers 
occurred at the cross points of at least two fibers. One possible reason was that the 
surface tension at these cross points was high and residual amounts of reactants of the 
Ca-P solutions during dipping could adhere to these sites, facilitating the initial 
nucleation process.  Consequently, the higher supersaturation of Ca2+ ions at the cross 
points than the area of single nanofiber would in turn accelerate the induction of n-HA.  
This phenomenon had been reported during the mineralization of bioglass nanofibers [93].  
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As for the blended PLLA/Col nanofibers, n-HA was deposited more uniformly on the 
fibers and there was no preferential deposition at the cross points of the nanofibers.  This 
was indicative that collagen was a good template for deposition, giving rise to uniform 
and accelerated mineralization of n-HA.  About 11% of amino acid residues of collagen 
have carboxyl groups (-COOH).  Those carboxyl groups ionized to –COO-, which 
favored Ca2+ ion chelation [220,229].  The alternate soaking method for mineralization 
appeared to be effective and rapid n-HA formation on nanofibers was achieved by 
increasing concentrations of Ca and P ions that corresponded to the Ca/P ratio of 1.66 
(equivalent to the ratio of natural bone).   
 
Using our mineralization method of n-HA deposition, the n-HA on the nanofibers 
paralleled to that of natural HA in human tooth delineated in our XRD results.   Moreover, 
the extensive broadening and overlap peaks were due to the extremely fine grain size of 
the crystal which was even lower than that of human teeth.  Similarly to pure collagen 
molecules as templates for mineralization in vivo, nanofibers of PLLA and PLLA/Col 
could serve as templates for mineralization in vitro.   It is commonly known that the HA 
phase which is present in natural bone, dentin and enamel contains approximately 7.4, 5.6, 
3.5 wt% of carbonate respectively [230] and it is said that carbonated HA materials have 
excellent biocompatibility and properties, which can be favorably compared with those of 
hard tissue.  In our study, phosphate and carbonate groups were present on our treated 
nanofibers.  The carbonate content in the n-HA on the PLLA/Col nanofibers was more 
evident compared to PLLA nanofibers.  The broad peaks could suggest the low 
crystalline apatite phase, which could be a mixture of amorphous calcium phosphate and 
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crystalline HA [231]. This could be beneficial as the major bone mineral was amorphous 
calcium phosphate (Young bone: 65%; Adult bone: 35%), which acted as a precursor to 
crystalline HA [232].  
 
PLLA/Col nanofibers experienced lower contact angle results, suggesting that 
blending the polymer with collagen was an effective way to improve the hydrophilic 
property of synthetic polymer nanofibers [233].  The presence of n-HA on PLLA 
nanofibers did not significantly increase the hydrophilicity as compared to untreated 
PLLA nanofibers.  Contrary to this observation, n-HA deposition significantly enhanced 
the wettability of blended PLLA/Col nanofibers than on PLLA nanofibers and the control 
(pure collagen nanofibers).  In the light of these observations, one plausible explanation 
could be due to the distribution of n-HA on PLLA nanofibers than on collagen-blended 
PLLA nanofibers, leading to an increase in hydrophilicity in PLLA/Col+n-HA substrates. 
The TGA results showed that despite an increase in the number of treatment cycles in 
PLLA (five cycles) than in PLLA/Col (three cycles), the HA contents in both types of 
fibers were comparable, indicating that the presence of collagen favored HA deposition.   
 
The objective of conducting a short-term cell attachment (named as cell capture, 
to emphasize this unique cell attachment on the nanofibers) study at room temperature 
was to explore the possibility of an attractive therapeutic approach in which scaffold with 
an enriched population of target cells could be achieved, i.e. direct cell seeding could be 
attained in-situ at the operating theatre.   In this study, mineralization on the nanofibers 
improved the cell capture efficiency, especially at earlier time points.  Principally, the n-
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HA deposition on nanofibers could increase the surface roughness of the scaffold, thus 
mineralized nanofibers could provide more binding sites for cell attachment than pure 
nanofibers.  Based on previous in vivo models, high osteoblast affinity was associated 
with n-HA based materials [28,113,118].   In one study, there was a significant increase 
in cell attachment on composite co-precipitated chitosan/n-HA microsphere-based 
scaffolds than on pure chitosan scaffolds after 30 minutes [234].  However after one and 
two hours, the number of cells that were attached to both scaffolds was comparable.  
Here, we attempted to provide a reasonable explanation and elucidate this point: n-HA 
may be able to attract the osteoblasts by enhancing the cell capture efficiency. 
 
Cell proliferation and cell expansion were enhanced on collagen blended PLLA 
nanofibers.  These results were consistent with other studies such that the introduction of 
collagen blending or coating aided endothelial cells proliferation on electrospun PLLA-
CL nanofibers [233,235].  There was a significant enlargement in cell size on mineralized 
PLLA nanofibers.  Taken together, osteoblast proliferation was significantly greater on n-
HA than on conventional HA after 3 and 5 days as reported by Thomas J. Webster [228].  
Greater cell proliferation measured by the total amount of dsDNA was observed on the 
chitosan/HA scaffolds than pure chitosan scaffolds after 5 and 7 days [234].  It is well-
known that nanophase calcium phosphate is capable of enhancing osteoblastic 
proliferation and differentiation. However, other studies showed that while osteoblastic 
proliferation performed well on both chitosan and chitosan/powdered β-tricalcium 
phosphate scaffolds, no improvement was found when calcium phosphate was added 
[236].   In this case, the n-HA deposition actually prohibited the cell proliferation and 
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there was enhanced cell expansion if the substrate materials were PLLA or PLLA/Col 
nanofibers.   Some studies reflected similar observations: cell proliferation was not 
significantly different after one and three weeks on pure freeze-dried chitosan and 
chitosan scaffolds mineralized with HA nanocrystals using a double-diffusion method 
[237].  They indicated that after one week, ALP activity was similar for both non-
mineralized and mineralized scaffolds but after three weeks, the ALP production 
increased although similar cell proliferation was seen at the same time point [237].  As 
our cell culture work was only up to a week, it may not be facile to make any conclusive 
or concrete judgments.  In our case, even though n-HA inhibited proliferation and similar 
rates were in cognate with both mineralized PLLA and PLLA/Col nanofibers, the ALP 
activity for all the material groups including the controls were comparable.  Such studies 
highlighted the fact that although a material surface may favor certain cellular 
characteristics, some phenotypic expressions such as ALP activity and bone matrix 
formation may also be modified [238].  To expound on the above-mentioned 
phenomenon, PCL and PCL/HA scaffolds fabricated by fused deposition modeling 
(FDM) were treated with SBF [239].  HA deposition induced by SBF treatment failed to 
increase the osteoconductivity, i.e. cell attachment, proliferation, growth and 
mineralization were impaired.   ALP activity peaked immediately upon seeding on day 1, 
but fell after 3 to 7 days of culture for all samples.  From day 10 onwards, PCL and 
PCL/HA scaffolds exhibited an increasing trend in ALP production, peaking at day 17.  
Throughout the cell culture study, the ALP activity of SBF-treated samples was 
consistently lower than that of PCL and PCL/HA samples, where the difference increased 
substantially on day 10 onwards and a significant difference was observed on day 17 and 
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20.  One probable explanation could be due to the increasing number of non-viable cells 
as the integrity of apatite layer was not optimal since flaking of the apatite was seen on 
the SBF-treated PCL scaffolds.  Likewise, an increase in osteocalcin expression occurred 
on PCL and PCL/HA scaffolds after 10 days of culture but not for SBF-treated PCL 
scaffolds.  Again, this could be due to the inability of the osteoblasts to attach properly on 
apatite-coated PCL samples, hence not able to produce ECM proteins [239].  
Consequently, these findings allowed us to understand the importance of precise 
controllable deposition of n-HA, and the key function for n-HA was not to improve cell 
proliferation but to direct osteoblastic behavior at a single cell level. In contrast to tissue-
engineered materials, osteoblastic attachment was reduced on titanium (Ti) surfaces with 
micro-rough rugosities compared to TCP or smooth Ti surfaces [240].  Cells that did 
attach showed reduced proliferation as well.   Lohmann et. al. demonstrated that 
increased production of osteocalcin, transforming growth factor β-1 (TGF-β1), 
prostaglandin E2 (PGE2) was seen on surfaces with increasing roughness was caused by 
the greater synthesis per cell, i.e. lesser number of cells was synthesizing more proteins 
or cytokines [240].     In a separate study, ALP and enzymatic activities were also 
reduced on rougher Ti surfaces [241].    
 
The presence of n-HA on the scaffolds had a greater influence on the functionality 
of the cells at early time points of the culture, i.e. day 1 and day 4 as there was an 
increase in intracellular protein produced by the cells.  These results were in concordance 
with some studies which showed that the total protein content of mineralized scaffolds 
were significantly higher than non-mineralized specimens after 3 days of culture [242].  
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Enhanced protein adsorption was evident on n-HA/polymer composites fabricated via a 
thermally induced phase separation (TIPS) method [243].  Similarly, in our case, 
mineralization on both PLLA and PLLA/Col nanofibers increased the protein 
concentration, suggestive that n-HA was favorable in cellular conditions, where the 
quantification of HA on the nanofibers were analogous.  The increased protein 
concentration could be due to a greater surface-to-volume ratio compared to non-
mineralized nanofibers.  This is important because the initial interactions of the cells and 
the material would affect the overall performance of the material in the host body.   Our 
total protein concentration and ALP findings had been normalized by the cell numbers. 
The protein concentration results illustrated that HA improved the protein concentrations 
at early time points and the ALP results were comparable for all groups, even though our 
cell proliferation results decreased in the mineralized groups.  This implied that the 
activity of the cells was not hampered even though there was less cell proliferation.   
 
Good evidence showed that n-HA significantly enhanced the compressive 
modulus of n-HA/polymer composites [243].  Contrary to the above-mentioned study 
[243], n-HA surface deposition did not improve the E-modulus property of our materials.  
In addition, HA in electrospun PLLA/HA hybrid membranes contributed to higher tensile 
strength due to better integration of HA with the PLLA matrix [131].  Yet in a study done 
by Venugopal et. al., there was no improvement in mechanical properties (tensile 
strength and E-modulus) for electrospun blended PCL/HA nanofibers as compared to 
PCL nanofibers [244].  Tensile strength values were 3.37 and 1.07 MPa for PCL and 
PCL/HA nanofibers respectively.  On the other hand, the E-modulus values were 10.82 
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and 3.52 MPa for PCL and PCL/HA nanofibers respectively.  We suspected that the 
distribution of HA, be it surface coated or homogenously integrated in a bulk material 
could impinge upon on the type of mechanical property which may serve as a possible 
explanation in our case.  Mechanical testing was done on unseeded control scaffolds and 
those explanted after 14 weeks in vivo, where the mean stiffness of PCL, PCL/HA and 
apatite-coated PCL was similar but the stiffness of the apatite-coated PCL samples after 
fourteen weeks of implantation was less than the control samples, possibly due to the 
poor attachment of cells on the weak apatite layer [239].  Contrary, after explantation, 
there was an increase in stiffness for PCL and PCL/HA scaffolds due to tissue in-growth 
and ECM formation.  A different phenomenon was observed when osteoblasts were 
present on the nanofibers.  The E-modulus of PLLA+n-HA seeded with cells was 
significantly higher than that of those without cells.  One possible explanation that we 
postulated for this observation was that the cell expansion and secretion of ECM proteins 
were considered to be a major contributing factor for this improvement of mechanical 
strength.  On the other hand, there was a significant reduction in E-modulus of 
mineralized PLLA/Col nanofibers with osteoblasts compared to those nanofibers without 
cells. This could be due to water absorption and the rapid biodegradation of collagen in 
nanofibers, thus despite the fact that ECM proteins were secreted by the cells, it was 
insufficient to compensate the strength provided by the blended collagen in the 
nanofibers.  The influence of degradation was not explored in this short term study, but 
rendered future considerations in order to assess the duration of which the damaged bone 
tissue would need to repair itself and the appropriate mechanical stability provided by the 
scaffold.   Although some published findings on the mechanical properties of tissue-
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engineered constructs may appear more “promising” than others, the status quo may 
never be attained because the modulus of cortical bone ranges from 12.8-17.7 GPa and 
cancellous bone has a modulus of 0.4 GPa [245].   NFS had a variable pore-size 
distribution and the pore diameters could range up to 100nm [110]. Although the pore 
sizes of the NFS were small [36,37], the NFS substrates provided an excellent scaffolding 
structure for cells to adhere, proliferate, migrate and differentiate.  The cells were able 
push the surrounding fibers aside as they migrated through the matrix. This was because 




Rapid n-HA deposition was observed using the alternate dipping method. 
Blending collagen in PLLA polymer was an effective way to enhance the mineralization 
of nanofibers. n-HA significantly improved the hydrophilicity of PLLA/Col nanofibers.  
Moreover, n-HA deposition enhanced the cell capture efficacy within 30 minutes for 
PLLA and PLLA/Col nanofibers.  Although there was no improvement of osteoblast 
proliferation by n-HA deposition in a week culture, the E-modulus of PLLA+n-HA with 
cells at day 1 and day 4 were significantly increased compared to PLLA+n-HA without 
cells due to the enhanced cell expansion and extracellular matrix secretion. Our findings, 
in correspondence to other published results demonstrated the possibility of 
misinterpreting the overall functionality of the material with regards to surface 
topography and chemistry on cellular response if we look at only certain characteristics 
whilst neglecting other important physiological parameters.  As such, one must closely 
examine and strike a balance between optimizing material properties whilst improving 
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cellular response.  In conclusion, mineralization of the nanofibrous scaffolds may provide 
a promising biomimetic method to exploit the advantages of early osteoblast capture 
although in-depth approaches can be further investigated and harnessed in future work.  
The final PLLA/Col ratio of the electrospun NFS can also be determined for future 
research.  
 
(Note: The results have been published in Tissue Engineering and they are reprinted in 
this chapter from: Michelle Ngiam, Susan Liao, Avinash J. Patil, Ziyuan Cheng, Fengyi 
Yang, Miguel J. Gubler, S. Ramakrishna, and Casey K. Chan, Tissue Engineering, Vol 
15(3), Fabrication of mineralized polymeric nanofibrous composites for bone graft 
materials, 535-546, 2009. Copyright 2009, with permission from Mary Ann Liebert Inc.) 
Phase I: Fabrication of 2D NFS  Chapter 4 
Objective (c) 
________________________________________________________________________ 




Osteogenic Differentiation of Bone-Marrow derived Mesenchymal Stem 






MSCs are particularly popular because of its versatile differentiation profile and 
may be derived from several tissue sources such as bone marrow, adipose tissue, muscle 
and umbilical cord blood etc [175,246].  In addition, the use of autologous MSCs seems 
promising because chances of immune rejection and carcinogenesis are minimized. 
 
 Although MSCs are thought to be potential cell sources for autologous bone tissue 
engineering as it is said to facilitate bone repair in various bone defects [247],  some 
drawbacks include the minute numbers of MSCs (especially as donor age increases), self-
renewal and proliferative abilities are limited [247,248].  Since the relative frequency of 
MSCs in the marrow is approximately 1 in 100,000 cells, only a small population of these 
cells can differentiate into an osteogenic lineage [246-248].  As such, several attempts 
have been done to improve the proliferation and differentiation capabilities of the MSCs, 
either through material selection and modification and/or culture supplements and 
techniques.  
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Several reports have shown that cells are sensitive to the intrinsic properties of the 
materials such as composition, structure and elasticity they are exposed to.  Nanofeatures 
(nanopits) of different symmetries and varying degrees of disorders on 
polymethylmethacrylate (PMMA) had showed to have an effect on osteogenic 
differentiation of MSCs, where nanoscale disorder stimulated MSC osteogenic 
differentiation bypassing the application of chemical means [31].  Moreover, rigid 
matrices were associated with osteogenic differentiation whilst soft and stiffer matrices 
were associated with neurogenic and myogenic differentiation respectively [214].  
Furthermore, the geometry of the substrates influenced cell behavior. Larger diameter 
nanotubes (100 nm) coincided with more well-spread, cell elongation, lamellipodia and 
mobility compared to smaller diameter nanotubes [213].  In this study, we hypothesized 
that the nanotextured topography of n-HA on nanofibers would have a positive influence 
on osteogenic differentiation of MSCs without chemical treatment.  
 
 
4.2 Materials and Methods 
 
4.2.1 Fabrication of electrospun nanofibers and mineralization  
Electrospinning was employed to fabricate our PLLA and PLLA/Col nanofibers as 
previously mentioned in Chapter 3.  Similarly, n-HA mineralization on the PLLA and 
PLLA/Col nanofibers was done by employing a series of chemical treatments according 
to the same parameters as described in Chapter 3.  
 
4.2.2 BM-MSC culture on nanofibers 
Human MSCs were purchased (P2, Lonza, MD, U.S., Product No. PT-2501).  
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According to the technical sheet provided by Lonza, the MSCs were obtained from 21 
year-old male African-Americans. The MSCs (P3) were cultured on PLLA, PLLA/Col, 
PLLA+n-HA and PLLA/Col+n-HA (10,000 cells/well/sample for all experiments) at 
various time points from 1 and 28 days in normal and osteogenic media and incubated at 
37ºC in 95% humidified atmosphere and 5% CO2.  The normal media consisted of low-
glucose Dulbecco's modified Eagle's medium (DMEM) (Aldrich Chemical Company, 
Inc., St. Louis, MO, U.S.), 10% fetal bovine serum (FBS) (Invitrogen, CA, U.S.) and 1% 
penicillin-streptomycin (PS) (Invitrogen, CA, U.S). The osteogenic media had the same 
constituents as the normal media, with the additions of 10 nM dexamethasone (DEX) 
(Aldrich Chemical Company, Inc., St. Louis, MO, U.S.), 0.05 mM ascorbic acid (Aldrich 
Chemical Company, Inc., St. Louis, MO, U.S.) and 10 mM β-glycerophosphate (Aldrich 
Chemical Company, Inc., St. Louis, MO, U.S.).  The media was changed every 2 to 3 
days to ensure a constant supply of nutrients.  The cell morphology was observed using 
the fluorescence microscope (Leica DM IRB, Leica Microsystems GmbH, Wetzlar, 
Germany) at 100 times magnification. 
 
4.2.3 Material characterization 
 The morphologies of the mineralized nanofibers were analyzed using the Atomic 
Force Microscope (AFM) in tapping mode (Dimension 3100 AFM, Veeco Instruments 
Inc., CA, U.S.) using a silicon tip (Pointprobe-Plus® silicon-SPM sensor, Nanosensors™, 
Switzerland) under ambient conditions with scanned areas of 800×800 nm. The images 
were recorded at a scan rate between 0.5 and 1 Hz. The cantilever tips had a tip radius of 
between 5 and 7 nm, with a resonance frequency of 315–369 kHz. The images were 
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scanned at five predetermined areas for each material (n=3).  The specific surface area of 
each substrate (n=3-5) was determined using the Brunauer-Emmett- Teller (BET) 
Analyzer (NOVA-3000 Ver 6.07, Quantachrome Instruments, Florida, U.S.).  The fibers 
were degassed at room temperature for a day before measurements were taken.  After the 
predetermined time point of culture, the scaffolds with cells were fixed in fixed in 4% 
paraformaldehyde (Lancaster, England) solution for 30 minutes at RT.  Subsequently, the 
cell/material constructs underwent a series of dehydration process in ascending 
concentrations of ethanol, i.e. 10 minutes in each solution at 50%, 70%, 95%, 100% 
(twice) respectively.  The samples were then air-dried overnight prior to scanning 
electron microscopy (SEM) imaging.  The topographies of the substrates were assessed 
using a field-emission scanning electron microscopy (FESEM) (Quanta 200F, FEI, 
Oregon, U.S.) at an accelerating voltage of 20 kV.  The Ca-P ratios of the mineralized 
PLLA and PLLA/Col fibers and the bone minerals (n=10 measurements) secreted by the 
MSCs were measured using SEM-EDX (Energy Dispersive X-ray Spectroscopy, (JSM-
5600LV, JEOL, Japan/Oxford EDX, INCA).  
 
4.2.4 Cell proliferation 
 All samples were inoculated with MSCs (10,000 cells/sample) for a culture period 
of 1 day to 28 days. At the end of the stipulated time period, the medium was removed 
from each well and the wells were washed with PBS thrice. Next, 300 µL of pure DMEM 
and 30 µL of CCK-8 reagent (Scientific Resources) were added and the samples were 
incubated for 1.5 hours at 37ºC.  After thorough mixing, the light absorbance was 
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measured at 490 nm using a FLUO Star Optima microplate reader (BMG Labtech GmbH, 
Offenburg, Germany) to arbitrate the number of cells. 
 
4.2.5 Alkaline phosphatase (ALP) expression 
ALP expression was measured at day 1 and 7, where the activity was normalized 
by cell number at the respectively culture time point.  Using a Phosphatase Substrate Kit 
(No.37620, Pierce Biotechnology, IL, U.S.), 400 µL of p-Nitrophenyl Phosphate, 
Disodium Salt (PNPP) solution was added in each well and incubated for an hour at room 
temperature.  Next, 200 µL of 2M NaOH was incorporated to terminate the reaction of p-
nitrophenol conversion to p-nitrophenylate.  Using a FLUO Star Optima microplate 
reader (BMG Labtech GmbH, Offenburg, Germany), the light absorbance was measured 
at 405nm.  
 
4.2.6 Protein assay 
 At the end of each incubation period, the medium was removed and phosphate 
buffered saline (PBS) solution was used to wash the well thrice.  The samples were 
treated with a bicinchoninic acid (BCA) protein assay working reagent (BCA Kit 
No.23225, Pierce Biotechnology, IL, U.S.) and incubated for 30 minutes at 37ºC.  The 
protein content was quantified using a FLUO Star Optima microplate reader (BMG 
Labtech GmbH, Offenburg, Germany), set a wavelength of 590nm at RT. The total 
intracellular protein (expressed in milligrams) results were normalized by the respective 
cell numbers.  
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4.2.7 Immunostaining 
4.2.7.1 CD29 staining of BM-MSCs 
 After 14 days of culture, CD 29, a human MSC marker, was incubated with the 
substrates and incubated with the secondary antibody goat anti-mouse antibody-
fluorescein isothiocyanate (FITC) according to the protocol in 4.2.7.1.  Confocal imaging 
(FV 1000, Olympus Corporation, Japan) was then carried out to ascertain that the cells 
used were MSCs.   
 
4.2.7.2 Osteocalcin (OC) expression 
After day 21 of culture, OC expression was assessed. The media was first 
removed and 4% formaldehyde with 1% sucrose was added and incubated at 37ºC for 15 
minutes to fix the cells.  After removal of the fixative solution, the wells were washed 
with PBS, followed by the addition of permeabilizing buffer (10.3g sucrose, 0.292g NaCl, 
0.06g MgCl2, 0.476g HEPES buffer, 0.5mL Triton X in 100ml water, pH 7.2) and then 
incubated for 5 minutes at 4ºC.  After which, the permeabilizing buffer was removed and 
1% bovine serum albumin (Sigma Aldrich Chemical Company Inc., St Louis, 
U.S.)/phosphate buffered saline (BSA/PBS) is added and the samples were incubated at 
37ºC for 5 minutes. For OC staining, mouse monoclonal anti-osteocalcin (Invitrogen, CA, 
U.S.) was diluted 1:100 in 2%BSA/PBS and incubated at 37°C for 1 hour.  After washing 
3 times with PBS to remove the primary antibody, the samples were incubated at 37°C 
for 1 hour with goat anti-mouse antibody-fluorescein isothiocyanate (FITC) (Sigma 
Aldrich Chemical Company Inc., St Louis, U.S.)  that was diluted in 1:100 BSA/PBS.  
Next, the wells were washed with PBS thrice and 300 µL of DAPI (Invitrogen, CA, U.S.) 
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(1:5000 diluted in PBS) was added and the culture plates were incubated at RT for 30 
minutes. Samples were then observed using a confocal microscope (FV 1000, Olympus 
Corporation, Japan). Using an image analysis software (Image J, National Institutes of 
Health, Bethesda, U.S.), the intensities of the green fluorescence signals of the confocal 
images (n=10 to 19) were calculated for semi-quantifications.  
 
4.2.8 Alizarin red staining (ARS) 
 ARS was carried out after day 14 and day 28 of culture.  Briefly, chilled 70% 
ethanol was used to fix the cells and the samples were incubated at 4ºC for an hour.  After 
which, DI water rinsing (twice) was done prior to the addition of 40 mM of ARS staining 
reagent (Sigma Aldrich Chemical Company Inc., St Louis, U.S.) and the samples were 
incubated for 30 minutes at RT. The staining reagent was then removed and the samples 
were again washed with DI water. Next, 10% cethyl pyridinium (CPC) (Sigma Aldrich 
Chemical Company Inc., St Louis, U.S.) was prepared by dissolving the CPC in sodium 
phosphate (Sigma Aldrich Chemical Company Inc., St Louis, U.S.) solution. 1 mL of 
10% CPC was added in each well and left at RT for 1 hour.  Subsequently, 100 µL of the 
CPC from each well was removed and diluted to 900 µL of pure CPC solution.  The 
absorbance was then measured at 570 nm using a UV/VIS spectrophotometer (Unicam 
UV 300, Thermo Spectronic, WI, U.S.).  ARS staining was also carried out on samples 
without cells to normalize absorbance readings of the mineralized substrates with cells.  
 
4.2.9 Von kossa (VK) staining 
 After 28 days of culture, VK staining was conducted to assess the extent of 
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mineralization.  According to conventional VK protocols, after cell fixation with 4% 
paraformaldehyde at RT for 1 hour, the samples were incubated with 5% silver nitrate 
(Sigma Aldrich Inc.) at RT for 1 hour with ultraviolet (UV) exposure.  The samples were 
then rinsed with DI water and 5% sodium thiosulfate (Sigma Aldrich Inc.) was added. 
After a couple of minutes, DI rinsing was employed prior to the incorporation of nuclear 
fast red (Sigma-Aldrich Inc.) to stain the cell nuclei.  After 5 minutes, the samples were 
rinsed with DI water before imaging.  VK staining was also employed on the mineralized 
samples without cells to differentiate cell mineralization from n-HA of the scaffolds.  
 
4.2.10 Statistical analysis 
The data obtained (at least in triplicate) was expressed as mean ± standard 
deviation (SD).  The Student’s T-test (T-test) and two-way ANOVA were used and 





4.3.1 Material characteristics of 3D nanoyarns 
 
         Fig. 4.1 shows the nanotextured surface of mineralized PLLA (Figs. 4.1b and c) and 
PLLA/Col (Figs. 4.1e and f). Our previous work showed that n-HA were attached along 
PLLA nanofibers and homogeneously dispersed on PLLA/Col nanofibers [19]. The Ca/P 
ratios for the mineralized PLLA and PLLA/Col fibers were 1.8 ± 0.12 and 1.7 ± 0.14 
respectively, which was similar to hydroxyapatite (~1.67) [249] in native bone.  The 
presence of n-HA on PLLA (22.7 ± 7.3 m2/g) and PLLA/Col (25.2 ± 9.7 m2/g) 
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significantly improved the specific surface area compared to pure PLLA (8.9 ± 3.5 m2/g) 





















Fig. 4.1: SEM images of mineralized (a) PLLA and (d) PLLA/Col fibers. AFM images 
depicting the nanotexturing of mineralized fibers (b) PLLA+n-HA, (c) 3D surface 
topography of (b) PLLA+n-HA, (e) PLLA/Col+n-HA and (f) 3D surface topography of 
(e) PLLA/Col+n-HA. (Arrows represent n-HA on the fibers) 
 
 
4.3.2 Cell morphology in normal and osteogenic media 
  
 From our results, MSCs cultured in the osteogenic media differentiated (Figs. 
4.2b and d) to a greater extent (more elongated morphology) than those in normal media 
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  (a)                                                (b) 
    
      (c)                                              (d) 
 
Fig. 4.2: Cell morphology of BM-MSC on tissue culture plastic (TCP) in either normal 
media or osteogenic media. (a) after 1 day in normal media, (b)  after 1 day in osteogenic 
media, (c) after 4 days in normal media, (d) after 4 days in osteogenic media 
 
 
4.3.3 Cell proliferation of BM-MSCs  
Fig. 4.3 shows the cell proliferation on the NFS.  In general, the cell proliferation 
levels in all the nanofiber groups were lower than the TCP controls.   There was a 
reduction in the cell proliferation levels in the presence of n-HA, especially for 
mineralized PLLA/Col compared to their non-mineralized counterparts. 
Normal Osteogenic 
100 µm 100 µm 
100 µm 100 µm 
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Day 1 (Normal media)
Day 1 (Osteogenic media)
Day 7 (Normal media)
Day 7 (Osteogenic media)
Day 14 (Normal media)
Day 14 (Osteogenic media)
Day 21 (Normal media)
Day 21 (Osteogenic media)
Day 28 (Normal media)
Day 28 (Osteogenic media)
 
Fig. 4.3: Cell proliferation on various nanofiber substrates after 1 to 28 days of culture in 
normal and osteogenic media. Significant difference between different groups were 
denoted as * (p<0.05) 
 
 
4.3.4 Protein concentrations of BM-MSCs on various NFS 
Fig. 4.4 shows the protein concentrations after cell normalization.  The protein 
concentrations for both mineralized PLLA and PLLA/Col substrates were significantly 
meliorated compared to their non-mineralized counterparts on both days except those 
cultured in osteogenic media on day 1.  In general, all the nanofiber groups fared better 
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Fig. 4.4: Protein concentration of various nanofiber substrates after 1 and 7 days of 
culture in normal and osteogenic media. Significant difference between different groups 
were denoted as * (p<0.05) 
 
 
4.3.5 Immunostaining of MSC marker on various NFS  
 CD29, a MSC marker was used to ascertain the presence of MSCs used on our 
nanofibers. Fig. 4.5 shows that all the material groups in different media conditions 
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(g)  (h) 
 
(i)  (j) 
Fig. 4.5: CD29 staining of various substrates after 14 days of culture. Blue denotes 
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4.3.6 Osteogenic differentiation of BM-MSCs on various NFS 
Fig. 4.6 illustrates the ALP (an early osteogenic differentiation marker) activities 
after cell normalization.  There was a significant increase in ALP expression in 
mineralized PLLA substrates compared to non-mineralized PLLA substrates.  The ALP 
level was raised in mineralized PLLA/Col compared to PLLA/Col in normal media after 
day 1, but the presence of n-HA and collagen did not significantly improve the ALP 
























Fig. 4.6: Alkaline phosphatase (ALP) expression on various nanofiber substrates after 1 
and 7 days of culture in normal and osteogenic media. Significant difference between 
different groups were denoted as * (p<0.05) 
 
 
 Osteocalcin, a middle-stage osteogenic marker, was used to determine the level of 
osteogenic expression.  From the images (Fig. 4.7), osteogenic supplements enhanced 
* 
* 
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osteocalcin expression in PLLA and PLLA+n-HA nanofibers.  It was noteworthy to 
highlight that OCN expression levels were comparable in both media conditions for 
mineralized PLLA and blended PLLA/Col nanofibers (Fig. 4.8), suggesting that n-HA or 
collagen alone was a potent inducer of osteogenic differentiation in the absence of 
osteogenic supplements. More importantly, the combination of n-HA and collagen 
significantly elevated OCN expression in normal media conditions compared to those in 
osteogenic media, which also implied that the n-HA aided in osteogenic differentiation.    
In general, the OCN levels of the nanofiber groups fared better than TCP controls 
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Fig. 4.7: Osteocalcin staining of various substrates after 21 days of culture.  Blue denotes 
DAPI-stained cell nucleus and green denotes osteocalcin expression. Scale bars for x10 
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Fig. 4.8: Osteocalcin intensities of various substrates after 21 days of culture.  Significant 
difference between different groups were denoted as * (p<0.05) 
 
 
 Fig. 4.9 shows the cell morphologies after 14 days of culture in normal media. 
Minerals secreted by the MSCs were observed on all the nanofiber groups except PLLA. 
More minerals were seen on mineralized PLLA and PLLA/Col. As mineralization is 
considered a late-stage osteogenic marker (usually seen after 28 days of culture and often 
aided with osteogenic supplements), our results are considered a breakthrough as 
minerals secreted by the cells were obtained just after 14 days without any osteogenic 
supplements.  The extent of mineralization was more evident on both PLLA+n-HA and 
PLLA/Col+n-HA than on blended PLLA/Col.  This implied that the nanotextured surface 
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Fig. 4.9: MSC morphologies on mineralized and non-mineralized substrates after 14 days 
of culture in normal media at various magnifications. (a) to (d) PLLA, (e) to (h) 





 After 14 days in osteogenic media, minerals were seen on the cells in all the 
nanofiber groups (Fig. 4.10). A greater extent of minerals secreted by cells was noted on 
mineralized PLLA and PLLA/Col substrates compared to their non-mineralized 
counterparts, suggesting the benefits of the use of osteogenic supplements.   The Ca/P 
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spectra for mineralized PLLA are presented in Table 4.1 and Fig. 4.11 respectively.  With 
the exception of PLLA group in osteogenic conditions, the Ca/P ratios hovered between 

































Fig. 4.10: MSC morphologies on mineralized and non-mineralized substrates after 14 
days of culture in osteogenic media. (a) to (d) PLLA, (e) to (h) PLLA+n-HA, (i) to (l) 
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Table 4.1: Ca/P ratios of bone minerals secreted by MSCs after 14 days of culture in 
normal and osteogenic media. NA: Not applicable. 
 
 PLLA PLLA+n-HA PLLA/Col PLLA/Col+n-HA 
Normal  NA 1.7 ± 0.14 1.5 ± 0.31 1.83 ± 0.39 









 By day 21, the cells on pure PLLA began to secrete limited minerals without 
osteogenic media (Figs. 4.12a-d). Mineralized nodules by the cells on PLLA/Col (Figs. 
4.12i-l), PLLA+n-HA (Figs. 4.12e-h) and PLLA/Col+n-HA (Figs. 4.12m-p) continued to 
increase and again, more minerals were evident on cells on mineralized substrates, 
proving our hypothesis that the nanotextured surface of n-HA on nanofibers was capable 
of driving MSCs towards a osteogenic lineage without any chemical and mechanical 
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Fig. 4.12: MSC morphologies on mineralized and non-mineralized substrates after 21 
days of culture in normal media. (a) to (d) PLLA, (e) to (h) PLLA+n-HA, (i) to (l) 
PLLA/Col and (m) to (p) PLLA/Col+n-HA  
 
 
  Further mineral enlargement was demonstrated in those cultured in osteogenic 
media (Fig. 4.13), again with a greater extent of bone nodules by cells on mineralized 
PLLA (Figs. 4.13e-h) and PLLA/Col (Figs. 4.13m-p) compared to non-mineralized 






























Phase I: Fabrication of 2D NFS  Chapter 4 
Objective (c) 
________________________________________________________________________ 
































Fig. 4.13: MSC morphologies on mineralized and non-mineralized substrates after 21 
days of culture in osteogenic media. (a) to (d) PLLA, (e) to (h) PLLA+n-HA, (i) to (l) 
PLLA/Col and (m) to (p) PLLA/Col+n-HA  
 
 
 The ARS absorbance levels were normalized with those without cells.  Despite 
the reduction of cell numbers on the nanofibers compared to TCP at early time points, the 
ARS level was higher in all the nanofiber groups compared to TCP controls as shown in 
Fig. 4.14.  The absorbance levels were negligible for PLLA/Col (normal media: day 14) 
and TCP controls (normal and osteogenic media: day 14). Osteogenic supplements aided 
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the ARS absorbance levels were comparable at each time point regardless of media 
conditions.  Besides, increased ARS level was seen in PLLA+n-HA than PLLA in normal 
media after 28 days. The synergistic effects of collagen and n-HA was evident as the 
ARS levels were significantly higher on PLLA/Col+n-HA than PLLA+n-HA at both time 
points.  Interestingly, the presence of n-HA significantly expedited the ARS levels on 
PLLA/Col compared to pure PLLA/Col.  In fact, n-HA on PLLA/Col ameliorated ARS 
levels without the assistance of osteogenic supplements on day 28. These results showed 





















Day 14 (Normal media)
Day 14 (Osteogenic media)
Day 28 (Normal media)
Day 28 (Osteogenic media)
 
Fig. 4.14: Absorbance level of alizarin red stains of various substrates after 14 and 28 
days of culture in normal and osteogenic media. * denotes significant difference between 









Phase I: Fabrication of 2D NFS  Chapter 4 
Objective (c) 
________________________________________________________________________ 
  126 
 Figs. 4.15 and 4.16 showed the ARS stained substrates after 14 and 28 days of 
culture respectively.  In both figures, osteogenic supplements hastened the ARS levels on 
PLLA, PLLA/Col nanofibers and TCP controls. The intensity was the strongest on 
mineralized PLLA/Col nanofibers at both time points compared to the other material 
groups. Not surprisingly, osteogenic differentiation was enhanced further after 28 days of 
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Fig. 4.15: Alizarin red staining of various substrates after 14 days of culture in normal 



































Phase I: Fabrication of 2D NFS  Chapter 4 
Objective (c) 
________________________________________________________________________ 







Fig. 4.16: Alizarin red staining of various substrates after 28 days of culture in normal 
and osteogenic media. Scalebar: 100 µm 
 
 
 Fig. 4.17 shows the von kossa staining of the nanofibers after 28 days of culture. 
Black deposits were seen on all the nanofibers. Osteogenic media enhanced the mineral 
deposition on PLLA and PLLA/Col compared to those cultured in normal media. The 
presence of collagen and n-HA promoted mineral deposition compared to mineralized 
PLLA nanofibers regardless of media conditions.  Again, this shows that n-HA alone or 
the combination of n-HA and collagen is able to drive osteogenic differentiation of MSCs 
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Fig. 4.17: Von kossa images of various substrates after 28 days of culture in normal and 
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4.4  Discussion 
Studies have shown that BM-MSCs are able to differentiate into an osteoblastic 
lineage [11,24,25,250,251].  From our results, it was shown that the n-HA present on our 
nanofibers had a positive impact on cellular activity, as shown by the increase in ALP 
and protein expression, despite lower cell proliferation levels.  Our results were in 
concordance with this study, where BM-MSCs cultured on mineralized Type I collagen 
membrane, had lower proliferation rates and increased in ALP activity [25].  The ALP 
expression of BM-MSC was promoted on calcium phosphate-based materials without the 
presence of osteogenic differentiation additives [252].  It was postulated that calcium 
phosphate surfaces enhanced osteogenic differentiation, in response to lower number and 
smaller focal adhesions, but with an increase mobility of focal adhesions [252].  An 
intracellular signal transduction was likely to be involved and induced by changes in the 
cell-ECM interaction.  Firstly, the chemical properties of the material may induce 
selective adsorption of matrix proteins [253].   In addition, non-collagenous matrix 
protein such as osteocalcin and bone sialoprotein exhibit calcium and HA binding 
characteristics which are likely to preferentially be adsorbed onto a calcium phosphate-
based material.  Likewise, type I collagen, vitronectin and laminin were also able to 
support increase osteogenesis from MSCs [254,255].   The matrix protein composition 
serves as a substrate for cells for binding and activation of specific integrins.  For 
instance, the binding of integrin β1α5 is vital for osteoblastic differentiation and 
mineralization [256].  Not only do the material properties affect selective adsorption of 
proteins, the material characteristics also influence the structural organization of the 
matrix proteins, where alternations in integrin binding domains may occur. For example, 
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when the structure of the adsorbed fibronectin was modified by surface chemistry, the 
integrin biding activity was affected, in turn modulating osteoblastic differentiation [206].   
Moreover, higher surface area was associated with mineralized substrates and this could 
in turn attribute to enhance the adsorption of soluble factors onto the substrate surfaces. 
 
Nanofiberous scaffolds being in nanometer scale (in diameter) are said to 
resemble the ECM proteins, and such microenvironment is conducive for cellular 
interaction.  Nanotexture is said to influence cell activity.  Cells are subjected to 
topographical features such as protein folding, collagen bending within a niche in vivo. 
Nanoscale disorder has shown to stimulate osteogenic stem cell differentiation without 
chemical treatments [31].  Such geometric cues have demonstrated a dominant effect on 
adhesion, spreading, growth and differentiation of MSCs.  Increase cell growth, cell 
numbers and osteogenic differentiation was also more evident 3D scaffolds with 
nanotextured surfaces compared to smooth 3D scaffolds [257], implying the importance 
of nanotopographical features in modulating cellular activities.   In our study, the 
biophysical cues which aided in the osteogenic differentiation include the 
nanotopography of the fibers and the n-HA particles on the fibers. This is the first time 
that osteoinductivity is demonstrated on nanofibrous scaffolds without any osteogenic 
supplements. Bone nodule formation by the cells occurred at very early time point 
without osteogenic reagents, especially on mineralized substrates. The cells first undergo 
attachment, proliferation, ECM formation and lastly mineralization in an osteoblastic 
lineage [258]. Typically, mineralization usually occurs after 28 days.  In osteogenic 
conditions, BM-MSCs and osteoblasts reached confluence at day 14, but bone nodules 
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were formed after 21 days [258].  Here, good evidence showed that the synergistic 
combination of collagen and n-HA greatly induced osteogenic differentiation as 
osteocalcin expression and ARS levels were meliorated in normal media but not in 
osteogenic media.   Furthermore, the higher ARS levels were cognate with mineralized 
PLLA/Col compared to mineralized PLLA/Col regardless of media conditions.  
 
 When MSCs were cultured on HA surfaces, osteo-specific genes were up-
regulated [24,25].  It was speculated that when the cells interacted with HA, potent 
inductive substances were released.  Using this conditioned media after the initial culture, 
uncommitted MSCs were then cultured without the presence of HA and upregulation of 
osteo-specific genes were observed [24].  During bone remodeling, the mineral phase in 
bone undergoes a degree of bioresorption and cells such as MSCs and osteoblasts are 
recruited to the site of interest for the ossification process.  As the n-HA on our fibers 
resemble the morphology and composition of natural n-HA in bone, we cannot rule out 
the possibility of a local release of Ca and P ions from the fibers in the media, which 
could in turn induce the cells towards an osteogenic lineage.  Although some reports 
stated that HA induced osteogenic differentiation of MSCs and other cell types, there 
were also conflicting reports which saw an attenuation in osteogenic differentiation when 
cells were cultured on HA surfaces [259,260].  This could be due to the physical and 
chemical characteristics of the HA material such as crystallinity and particle size etc 
[260].    
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In vivo osteoinductivity in a rat model was attenuated when the MSCs were 
subjected to longer culture periods (16 days) compared to shorter culture period (4 days) 
in osteogenic media for expansion prior to seeding on titanium fiber meshes [261].  The 
meshes seeded with MSCs that were expanded in normal media for 6 days (as the control 
group) fared better than those cultured in osteogenic media for 16 days, but less bone 
formation was observed in the control group compared to those pre-cultured for 4 days in 
osteogenic stimulants. These observations implied that cell aging caused by prolonged 
osteogenic factors had a negative effect on osteoinductivity and high cell proliferative 
capability (control group) alone was not sufficient in elevating osteoinductivity, but 
rather the stimulated cells needed to be at the earlier differentiation phase in order to 
enhance the recruitment of new osteoprogenitor cells for optimal in vivo bone formation 
[261].  From these observations, the state of differentiation level and the type of MSC 




 Our results delineated the importance of nanotopography and nanotexturing in 
stimulating stem cell osteogenic differentiation, without compromising cell functions and 
material properties.  By minimizing cell aging from extensive long culture periods, 
optimal cell functionality and regenerative process may be achieved. As our 
biomineralized nanofibrous composites are biomimetic and also scalable into 3D 
scaffolds, this further translates into potential clinical applications for bone regeneration.  
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3D nanofibrous scaffold enriched with bone marrow stem cells for bone 




 Large segmental bone defects are difficult to treat in clinical settings, because of 
the extensive loss of bone and in many cases, the periosteum is damaged [32]. In many 
clinical situations, compromised bone is often inevitable and thus, the bone’s load-
bearing capacity is greatly hindered.  Despite the plethora of bone graft materials 
commercially available, there are concerted efforts to develop tissue-engineered 
substrates for bone graft applications to address problems associated with autografts such 
as donor site morbidity and limited supply.  Allografts on the other hand, posed the risk 
of graft rejection and disease transmission.   Although synthetic bone grafts provide a 
solution to address the shortage of autografts and allografts, the main disadvantages of 
these calcium-based systems are that they are brittle and have slow resorption especially 
HA.    
 
 Multiple reports have examined several 3D material fabrication techniques such 
as phase separation [262,263], solvent casting and particular leaching [264], and various 
rapid prototyping methods [265,266].  Although rapid prototyping produce scaffolds with 
controlled micro-architectures such as defined porosity and structural dimensions, precise 
micro and nanotexturing of the surface are often not present.   Such surface features are 
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important and they serve as contact guidance, influencing cell adhesion behavior and cell 
growth.  Cell attachment, proliferation, migration and differentiation are also strongly 
dependent on the chemical characteristics of the substrates. Several studies have shown 
that nanopatterns and topographical features affect cell fate [31,257].  Our previous work 
showed that the n-HA on nanofibers could modulate cell behavior [19,21].  It was 
demonstrated that nanofibers were effective in early cell capture.  Since cells are 
subjected to different nanotextures within a 3D ECM niche in vivo, it was hypothesized 
that 3D nano-scaffold could be an effective carrier for rapid cell capture, which could 
provide an in-situ therapeutic bone graft option for bone regeneration.  
 
 
5.2 Materials and Methods 
 
 
5.2.1 Fabrication of 3D PLLA/Col nanoyarns 
 
 PLLA (300,000 Da, Aldrich Chemical Company, Inc.) and Type I collagen 
(Koken Co., Tokyo, Japan) were dissolved (w/w 50:50) in 1,1,1,3,3-hexafluoro-2-
propanol (HFP, Aldrich Chemical Company, Inc., St. Louis, MO).  The fabrication of 3D 
nanoyarns was described in our previous work [267]. Briefly, a dynamic liquid system 
was employed to create a vortex through a 5mm diameter hole at the centre of the 
collector basin as the water was pumped into the basin at room temperature (25±1ºC) and 
relative humidity of 65%.  The syringe loaded with the polymer solution was connected 
to a direct current high-voltage power supply (Gamma High Voltage Research, Ormond 
Beach, Florida) and the applied voltage was 15 kV.  The spinneret used was a BD 27G ½ 
flat-tip needle and the feed rate was set at 1ml/hour (KD Scientific syringe pump, 
Holliston, MA).   The working distance was 15 cm.   The fibers which were collected on 
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the surface of the water of the basin were then drawn through the vortex and collected at 
the bottom of the water tank, which supplied the flow of water to the basin through a 
pump.  After an hour, the nanofibers were then collected and stored in DI water prior to 
n-HA mineralization. For non-mineralized scaffolds, the nanoyarns were immediately 





5.2.2 Mineralization of 3D nanoyarns 
 
 The 3D nanoyarns were chemically treated in calcium and phosphate (Ca-P) 
solutions. Using the same treatment conditions in our previous studies [19,21], the 
nanoyarns were first subjected in 0.5M of CaCl2 (pH 7.2) (Aldrich Chemical Company, 
Inc., St. Louis, U.S.) for 10 mins, following by deionized water (DI) rinsing for a couple 
of mins.  The nanoyarns were then immersed in 0.3M Na2HPO4 (pH of 8.96) (Merck & 
Co. Inc., N.J, U.S.) solution for 10 minutes and then rinsed with DI water.  This typified 
1 cycle of treatment and the PLLA/Col nanoyarns underwent 3 cycles of Ca-P treatment.  
After n-HA mineralization, the nanoyarns were fitted into a mold (6mm in diameter, 
17mm in length) and then subsequently freeze-dried overnight.  
 
 
5.2.3 Material characterization of 3D nanoyarns 
 
 The morphologies of the nanoyarns and a commercial product (mineralized 
collagen fibers) were observed using a field-emission scanning electron microscopy 
(FESEM) (Quanta 200F, FEI, Oregon, U.S.) at an accelerating voltage of 10 kV or 20 kV. 
From the FESEM micrographs, the average fiber diameter of the nanoyarns (n=10 fibers) 
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was determined using an image analysis software (Image J, National Institutes of Health, 
Bethesda, U.S.).  Scaffolds incubated with bone marrow were dehydrated by treating in 
increasing concentrations of ethanol (50%, 70%, 90%, 100% (twice)) for 10 minutes in 
each solution, followed by vacuum-drying for 2 days prior to SEM observation. 
Thermogravimetry analyzes (TGA) (TGA 2050 Thergravimetric Analyzer, TA 
instruments, Tokyo, Japan) were conducted to determine the amount of HA present on 
the mineralized nanoyarns.  The fibers (n=5) were heated up to 1000°C, at a heating rate 
of 10°C/min in air conditions. The specific area of the nanoyarns was tested using the 
Brunauer-Emmett-Teller (BET) Analyzer (Nova-3000 Version 6.07, Quantachrome 
Instruments, Florida, U.S.). The nanoyarns (n=3-4) were degassed at room temperature 
for a day before measurements were taken [113,268].  Porosity assessment of the 
scaffolds (n=3) was determined by the liquid displacement method.  Each scaffold was 
weighed prior to submersion in a known volume of water and a series of brief 
evacuation-repressurization cycles was performed to force the liquid into the pores of the 
scaffold.  The liquid-impregnated scaffold was then weighed and the porosity was 
calculated as a percentage.  The mineralized and non-mineralized nanoyarns (n=3-4), 
with a length of 6 mm and diameter of 6 mm were mechanically-tested under 
compressive conditions, at a strain rate of 3 mm/min, using an Instron 3345 single 
column test system (Instron, MA, U.S), with a load of 100N. Compressive results were 
analyzed by Instron Bluehill software (Version 2.16.635). The calcium and phosphate 
(Ca/P) ratios (n=10) were measured using the SEM-EDX (Energy Dispersive X-ray 
Spectroscopy, JSM-5600LV, JEOL, Japan/Oxford EDX, INCA).     
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5.2.4  Cell capture from rabbit bone marrow 
 
 Bone marrow was harvested in each of the tibia of the rabbit [269,270].  The bone 
marrow obtained from each tibia was mixed together and separated into two equal 
portions consisting of 5 mL, one portion for determining the cell number (control) and 
the other portion for cell capture.  For the first portion, 20 mL of Hank’s balanced salt 
solution (HBSS, Invitrogen, CA, U.S.) was added to the 5 mL of bone marrow to make 
up a total volume of 25 mL.  This mixture was then gently overlaid onto a separate tube 
containing 20 mL of Histopaque 10771 (Sigma-Aldrich, U.S.). After centrifugation at 
1800 RPM for 30 minutes at room temperature, the cell layers at the 20-25 mL mark of 
the tube was collected after removing the top layer of solution (from the 25 to 45mL 
mark of the tube).   The 5 mL of cell layer was then transferred to a tube containing 15 
mL of HBSS and then centrifuged at 1000 RPM for 10 minutes at room temperature.   
After which, the cell pellet was collected and then mixed with 15 mL of HBSS and 
centrifuged again, at 1000 RPM for 10 minutes at room temperature.  The supernatant 
was removed and the cell pellet was diluted with cell media consisting of α-MEM 
(Invitrogen, CA, U.S.), 10% fetal bovine serum, 1% penicillin-streptomycin and 10 nM 
of dexamethasone for cell counting using a hemocytometer.   The second portion of the 
fresh bone marrow was gently and slowly flushed through a 5 mL syringe containing the 
3D mineralized nanoyarn scaffold for a series of ten times (i.e. suction and plunging 
marrow through syringe equates one time).  Subsequently, the nanoyarn scaffold was 
incubated at room temperature for 20 minutes.  After which, the nanoyarn was 
immediately fixed with 4% paraformaldehyde for 30 minutes at 37ºC and the residual 
bone marrow was collected, diluted with HBSS and centrifuged according to the protocol 
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as previously mentioned.   The number of cells in the residual marrow (effluent) which 
was obtained after incubation with the scaffold was also determined using the 
hemocytometer.  After fixation, the nanoyarn scaffold was washed with phosphate 
buffered saline (PBS) thrice and then blocked with 2% bovine serum albumin (Sigma 
Aldrich, U.S.) diluted in PBS (BSA/PBS) for 40 minutes at 37ºC.  After rinsing with PBS 
thrice, the scaffold was incubated overnight at 4ºC with rabbit CD44 (SM 607 from Acris 
GMBH, Germany) that was diluted in 2%BSA/PBS (1:100).  Subsequently, the scaffolds 
were incubated at 37°C for 1 hour with goat anti-mouse antibody (FITC) (Invitrogen, CA, 
U.S.) that was diluted in 2% BSA/PBS (dilution of 1:100). DAPI diluted in PBS (1:5000) 
was then incorporated and this incubation was done at room temperature for 30 minutes.  
To test for non-specific antibody binding, some scaffolds were not incubated with 
primary antibody CD44 but incubated with FITC and DAPI. The nanoyarns were then 
observed using a confocal microscope (Olympus FV 500, Olympus Corporation, Tokyo, 
Japan).  The sample size for cell capture studies was five. The cell morphology on the 
nanoyarns was also observed using SEM.  As it was almost an gargantuan task to 
quantify the total number of nucleated cells and MSCs captured in the 3D scaffolds, we 
plated the cells from the control and effluent samples onto three wells of 24-well tissue 
culture plates and incubated for 1 hour at 37ºC prior to DAPI and CD44-FTIC staining. 
Confocal images (at least 20-30 images) were taken and the number of MSCs was 
calculated from these images to ascertain cell capture results based on hemocytometer. 
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5.2.5  Colony-forming unit (CFU) study 
 
 After cell counting of the control (without flushing through scaffold) and 
residual/effluent marrow (obtained after flushing through scaffold), each of these marrow 
samples (n=3) were plated onto the 6-well plate and cultured  in α-MEM (Invitrogen, CA, 
U.S.), 10% fetal bovine serum, 1% penicillin-streptomycin and 10 nM of dexamethasone.  
Media was changed on the 6th day. After 13 days of culture, the media was removed and 
rinsed with DI water.  2 mL of CFU staining reagent (120 mM Tris buffer (BioRad 
Laboratories, CA, U.S.), containing 0.9 mM Naphthol-AS-MX phosphate (Sigma-
Aldrich, U.S.), 1.8 mM Fast Red TR (Sigma-Aldrich, U.S.) in DI water) was added in 
each well and incubated for 30 min at 37% degrees in 5% CO2. The staining reagent was 
then removed and the culture plates were rinsed with DI water once before colony 
counting. The number of CFUs (eight or more cells in a cluster) that were expressing 
alkaline phosphatase activity was considered [271]. Images were taken using a 
fluorescent microscope (Leica DM IRB, Leica Microsystems GmbH, Wetzlar, Germany) 
at x100 magnification and a digital camera.  
 
 
5.2.6  Implantation of mineralized 3D PLLA/Col nanoyarns enriched with bone 
marrow in a rabbit model 
 The mineralized PLLA/Col nanoyarn (6mm in diameter, 17mm in length) treated 
with rabbit bone marrow was implanted in the midshaft of the rabbit ulna (n=3). The 
rabbit was anesthetized using ketamine 50mg/kg (i.m) + Xylazine 10mg/kg (i.p).  We 
also administered pre-op antibiotics and analgesic, Baytril @ 5mg/kg (i.m) + Rimadyl @ 
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2mg/kg (s.c).  Prior to implantation, 5 mL bone marrow (inclusive of 0.5 mL of heparin 
of 5000 IU/ml) was harvested from the proximal right tibia of the rabbit using a 13G 
aspiration needle and collected in a 10 mL syringe. The bone marrow was then placed in 
a kidney dish.  The mineralized PLLA/Col nanoyarn was placed in the interior of a 
separate 5 mL syringe and bone marrow was slowly flushed through the syringe 
containing the material for ten times (i.e. suction and plunging marrow through syringe 
equates one time).  The nanoyarn was then incubated with the marrow at room 
temperature for 20 minutes whilst the bony defect was created.   The effluent marrow was 
collected for cell counting.  The bony defect of 15 mm was created using an oscillating 
saw under continuous saline cooling. The entire bone block was removed with the 
periosteum and the bone ends were cleaned with a bone rongeur. The defect site was then 
copiously irrigated with saline to remove any bone debris.   Our mineralized PLLA/Col 
treated with bone marrow was then removed from the syringe and implanted into the 
defect. Post-surgery, the rabbit received Baytril @ 5mg/kg (i.m) - 5 days postop+ 





5.2.7 MicroCT analyzes 
 
 The explant was removed after three months of implantation.  The explant was 
immediately fixed in 10% neutral buffered formalin. The explant was scanned through 
360º with a rotation step of 3º/s, at a spatial resolution of 27 µm x 27 µm x27 µm using a 
microCT machine (SMX-100CT X-ray CT Sys, Shimadzu, Japan).   The parameters used 
were: X-ray voltage (47 kV), X-ray current (50 µA), detector size (9”) and scaling 
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coefficient (50). No filter was used during the scanning. The scan files were then 
reconstructed using a modified Feldkamp algorithm (Skyscan, Belgium), at a step size of 
27 µm. The microCT software (VGStudioMax, version 1.2, Volume Graphics GmbH, 
Germany) was used to construct the 3D image of the explant.  Bone volume values were 
determined by using the reconstructed 3D image where the gray value range for bone 
were set at 225-255 (CTAnalyser, version 1.9, Skyscan, Belgium).  
 
 
5.2.8 Statistical analyzes 
 
 Student’s T-test was employed to assess statistical differences between the 
material groups for TGA, compressive and cell capture tests. Difference was considered 







5.3.1 Morphology of 3D mineralized and non-mineralized nanoyarns 
 
 3D mineralized nanofibrous yarns (nanoyarns) were successfully fabricated which 
highly resemble the characteristics of native bone which has a nano to macro hierarchical 
assembly.  Depending on the defect size, the 3D nanoyarns can be molded in a cylindrical 
form (Fig. 5.1a), blocks, fibrils or granules for various applications. Using 
electrospinning technique, bundles of yarns encompassing continuous, smooth nanofibers 
were generated by direct freeze-drying of PLLA/Col (Fig. 5.1b).   
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Fig. 5.1: 3D pure PLLA/Col nanoyarn. (a) Gross image and (b) to (c) SEM micrographs 
of pure nanoyarn at different magnifications.  Arrowheads denote the bundles of yarns 
(collection of nanofibers). 
 
 
 PLLA/Col was used as the base material for n-HA deposition and interestingly, 
the individual fibers in each yarn bundle were uniformly mineralized with n-HA (Fig. 
5.2).  At higher magnifications (Figs 5.2d and 5.2e), the mineralized fiber morphology 
resembles to that of native bone (Fig. 5.2f from Fantner’s Nature’s paper [1]).  The 
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Fig. 5.2: 3D mineralized PLLA/Col nanoyarn. (a) Gross image, (b) to (e) SEM 
micrographs of mineralized nanoyarn at different magnifications and (f) SEM micrograph 
of native bone [1].   Note that n-HA is uniformly distributed on individual fibers.  The 
yarn structure is maintained after n-HA mineralization as represented by the arrowheads 
in (c) 
 
 From the SEM micrographs, the average diameters of the mineralized PLLA/Col 
and pure PLLA/Col nanoyarn were 563 ± 76 nm and 450 ± 34 nm respectively.  
Furthermore, the morphology of our mineralized fibers closely mimicked native bone 
fibers compared to a commercial product which was also mineralized fibers (Fig. 5.3).  
The Ca/P ratio for the commercial mineralized fibers was 4.94 ± 2.15, which was not 
similar to that of native bone.  
 
10 µm 5 µm 
500 nm 
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Fig. 5.3: Commercial product (mineralized collagen fibers). (a): Gross image and (b) to 
(g) are the SEM micrographs at different magnifications  
 
 
5.3.2 Porosities of 3D nanoyarns 
 The porosities of non-mineralized and mineralized 3D scaffolds were 82.0 ± 6.1% 
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hierarchical structure of the mineralized nanoyarn, where its specific surface area (30.67 
± 4.29 m2/g) was higher than that of non-mineralized nanoyarn (11.23 ± 3.39 m2/g). 
 
 
 Based on our previous work, the alternate dipping method was effective in 
depositing n-HA on PLLA [19] and poly(lactide-co-glycolide) acid (PLGA) [21] NFS. 
The 3D PLLA/Col fibrous structure (68.91 ± 0.94 wt%) significantly improved n-HA 
deposition compared to 2D PLLA/Col structures (30.2 ± 9.98 wt%).  Strikingly, the 
amount of n-HA on our 3D nanoyarns were comparable to that of native bone, where the 
mineral part of natural bone constituted approximately 67% of nanophase HA.  This 
could be attributed to the spatial 3D organization of our scaffolds, allowing n-HA 
deposition to occur throughout the fiber surfaces.   Pre-treatment of the substrates are 
often considered in order to incorporate functional groups for initial apatite nucleation.  
Some of the pre-treatment methods include alkaline treatment [225], and surface 
modification such as plasma surface treatment [226,272]. In this study, such pre-
treatment methods were not required.   Compared to using SBF where the induction of 
HA deposition occurs over a period of a few days [273], sufficient HA deposition is 
accomplished within an hour using our method. 
    
 
5.3.3 Mechanical properties of 3D nanoyarns 
 From a biomechanical standpoint, most tissue-engineered constructs possess 
mechanical properties several orders of magnitude lower than native bone.   Besides 
morphological and compositional similarities to bone, our mineralized nanoyarns had 
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compressive strength of 1.035 ± 0.22 MPa, which was the lower limit of the compressive 
strength of human cancellous bone (1 - 100 MPa) [274]. The presence of n-HA improved 
the mechanical property, where the compressive strength of non-mineralized nanoyarns 
was 0.58 ± 0.31 MPa. This improvement of 44% in compressive strength of the 
mineralized nanoyarns was possibly due to the interlocking of the fibers by the n-HA.   In 
a separate study, 3D PLGA scaffold reinforced with 20 wt% grated L-lactic acid 
oligomer HA nanoparticles showed the maximal compressive strength of 2.31 MPa [275], 
whereas those scaffolds reinforced with 5, 10 and 40 wt% of HA had compressive 
strength values of less than 1 MPa.  This suggests that increasing the HA content past its 
threshold can potentially compromise the compressive properties as it would make the 
material weaker. Besides, more micropores which were present in the pore walls were 
associated with scaffolds with higher HA content, coinciding with the decrease in 
compressive strength [275].   
 
5.3.4 Rapid cell capture from bone marrow on mineralized 3D nanoyarns 
 To demonstrate the effectiveness of our 3D mineralized nanoyarns for rapid cell 
capture, rabbit bone marrow was flushed through the scaffolds.  The average nucleated 
cell count in 5 mL of marrow prior to marrow flushing was 1,145,500 ± 300,710 cells.  
The average amount of effluent marrow left after flushing was 3.04 ± 0.36 mL.   In 
addition, the average number of nucleated cells in the effluent was 203,500 ± 92,679 cells.  
This was significantly lower than the number of nucleated cells of the bone marrow prior 
to flushing (control samples). 
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 This is the first report that shows that high cell capture from bone marrow is 
achievable in a 3D biomineralized nanofibrous construct in less than an hour.  The 
nucleated cell capture was 80.2 ± 10.9% (Fig. 5.4) after 20 minutes.    Fig. 5.5 shows the 

























Fig. 5.4: Percentage of cell capture in 3D mineralized nanoyarn scaffolds after 20 
minutes of incubation in rabbit bone marrow.  Note that cells were captured in scaffolds 
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Fig. 5.5: Nucleated cell count using the hemocytometer. (a) Control: 5 mL of marrow 
without flushing through the scaffold. (b) Effluent: Residual marrow left after flushing 
through the scaffold 
(a) 
(b) 
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 To assess the average number of MSCs captured by the scaffold, the nucleated 
cells in the bone marrow (before flushing, i.e. control samples) and the nucleated cells in 
the effluent were stained with an antibody, CD44 and counted using a predetermined 
number of confocal images. CD44 is one of the MSC markers [276]. The average 
proportion of the MSCs captured in the scaffold was 76.1 ± 15.2% (Table 5.1).  This 
proportion was similar to the total number of nucleated cells captured in the scaffolds.  
As such, we could infer that a large proportion of MSCs were captured in our nanoyarns.   
 
 
Table 5.1: Average of number of MSCs before flushing through the scaffold (control) and 
after flushing through the scaffold (effluent) 
 
 Sample 1 Sample 2 Sample 3 
Average number of MSCs (CD44-FITC 
positive) in control 
9.45 9.68 3.41 
Average number of MSCs (CD44-FITC 
positive) in effluent 
1 3.91 0.71 
% of MSC capture 89.42 59.56 79.27 
 
 
5.3.5 Colony-forming units (CFU) study 
 In order to determine the number of osteoblastic progenitor cells, colony-forming 
assays can be employed.  These assays can be used to determine the number of colonies 
formed after culture and these colonies include cells that can differentiate towards an 
osteogenic lineage or other types of lineages such as fat, muscle, cartilage etc.  Such 
tissue-derived cells can be broadly classified as connective tissue progenitor cells [277].  
ALP is an early osteoblastic differentiation marker.  Colony-forming units (CFUs) that 
express ALP activity denote the presence of the osteogenic progenitor cells.  Fig. 5.6 
shows the colony-forming units-alkaline phosphatase positive (CFU-ALP) of the marrow 
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obtained before flushing (control) and after flushing through scaffold (effluent). The 
number of CFU-ALP was significantly higher in our control samples (27 ± 21) than in 
the effluent samples (0 ± 1).  This was consistent with the nucleated cell capture results, 
where the total cell numbers in the marrow prior to flushing were greater the cell 
numbers in the effluent samples.  Table 5.2 shows the absolute number of CFU-ALP of 
















Fig. 5.6: Colony-forming units-alkaline phosphatase positive (CFU-AP) after 13 days of 
culture.  Gross images of (a) control (without flushing through the scaffold), (b) effluent 
(after flushing through the scaffold) and light micrographs of CFU-AP colonies in (c) 
control and (d) effluent samples 
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Table 5.2: Number of colony-forming unit-alkaline phosphatase positive (CFU-AP) in 
the control and effluent samples. Note that marrow used for the control and effluent 
samples was obtained from the same rabbit 
 
Sample ID No of CFU-AP in 
control 
No of CFU-AP in 
effluent 
Sample 1 124 0 
Sample 2 3 0 




5.3.6 Immunostaining of mineralized 3D nanoyarn enriched with cells 
 Confocal images showed that the nanoyarn captured a substantial number of cells, 
as indicated by the DAPI-stained (blue) nucleated cells (Figs. 5a, 5d, 5g). Interestingly, 
despite a short cell incubation period, cells were able to penetrate through the nanoyarn 
as seen in the cross-section of the construct (Fig. 5.7g-i).   Immunostaining of the primary 
rabbit antibody CD 44 (green fluorescent signal) showed the presence of CD44-positive 
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Fig. 5.7: Immunostaining of 3D mineralized nanoyarn scaffolds with primary antibody 
CD 44. (a) to (c) Surface of scaffold (x10), (d) to (f) Surface of scaffold (x60), and (g)-(i) 
Cross-section of scaffold (x60).  Note that there are more nucleated cells (blue DAPI-
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 It is important to ascertain if the primary antibody CD 44 is cell-specific or 
physically absorbed onto the scaffold.  As such, another scaffold was incubated with only 
the secondary antibody FITC and without CD44, as seen in Fig. 5.8.  Both Figs. 5.7 and 
5.8 showed that the scaffold surface was saturated with nucleated cells, with some 
nucleated cells being captured in the interior of the scaffold.  In addition, the green 
signals (in Fig. 5.8) were weaker. This corroborated that both nucleated cells and MSCs 





















Fig. 5.8: Immunostaining of 3D mineralized nanoyarn scaffolds without the primary 
antibody CD 44. (a) to (c) Surface of scaffold (x10) and (d) to (f) Cross-section of 
scaffold (x10). Green signals (b) and (e) are very much weaker compared to samples (Fig. 
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 Confocal z-stacking of 3D mineralized nanoyarn as seen in Fig.5.9 where the 
nucleated cells and MSCs were distributed in the multiple layers of the scaffolds.    
 
 
   




5.3.7 Cell morphology on 3D mineralized nanoyarns 
 The SEM images showed that the surface (Fig. 5.10a-j) and the cross-section (Fig. 
5.10 k-t) of the scaffolds were inoculated with cells.  In some cases, the cells underwent 
morphological changes as they began to stretch, which was evident on both the interior 
and the exterior of the scaffold.   
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                        (c)    
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Fig. 5.10: SEM micrographs of mineralized nanoyarns which were inoculated with bone 
marrow and then incubated for 20 minutes. (a) to (j) show the surface and (k) to (t) show 
the cross-section of scaffold.  Note that the fibers were inoculated with cells and cell 
morphological changes (e.g. cell stretching) was observed in both the surface and cross-
section regions of the scaffolds after 20 minutes of incubation. 
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5.3.8 Rapid cell capture from rabbit bone marrow in implanted 3D mineralized 
nanoyarns 
   The mineralized nanoyarns enriched with bone marrow cells were tested in a 
rabbit model.  Using the same bone marrow incubation conditions, the cell capture in the 
implanted scaffolds was 78.73 ± 6.95% (Fig. 5.11).  This was consistent with the in vitro 



































Fig. 5.11: Percentage of cell capture in 3D mineralized nanoyarn scaffolds after 20 
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5.3.9 MicroCT analyzes  
 The microCT results (Fig. 5.12) showed that bone formation was distributed 
uniformly at the defect site, suggesting that the enrichment of bone marrow cells in the 
mineralized scaffold could have an osteoinductive effect.  The amount of bone 
regeneration was 63.8 ± 20% based on micro-CT results. 
    
 
Fig. 5.12: Micro-CT images of segmental ulnar defect site of the rabbit where 3D 
mineralized nanoyarn enriched bone marrow cells was implanted. Bone formation was 




 Tissue-engineered scaffolds have been considered as potential bone graft 
materials.  In order to improve the performance of the graft material, bone marrow is 
often used with the graft material as the marrow contains osteoblastic progenitor cells, 
MSCs, HSCs and other potent inductive substances such as growth factors, which are 
necessary for bone healing.  It was reported that the intraoperative processing of bone 
marrow can be used to concentrate the bone marrow-derived cells in order to enhance the 
graft performance [278].  Furthermore, the percutaneous injections of bone marrow were 
successful in the treatment of eighteen of twenty tibial non-unions, with the combination 
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of either the use of a cast or fixation [279]. As such, enriched biomineralized NFS 
provide a means of a quick, easy, safe and cost-effective strategy of facilitating cell 
attachment, cell delivery and migration of the desired cell population at the injury site. 
The incubation period of twenty minutes was chosen in this study because the duration of 
marrow incubation with the graft was twenty minutes prior to cell counting or 
implantation in several studies [280,281].   
 
 
 Studies have shown that the efficiency of cell attachment from canine bone 
marrow in mineralized and demineralized cancellous bone chips were 49 ± 8% and 44 ± 
19% respectively [281].  In a separate study, demineralized canine cortical bone powder 
was used as a matrix for cell attachment, where the cell capture efficiency was 23 ± 8%.  
These studies show that the enrichment of bone marrow-derived cells in a material carrier 
enhances spinal fusion in a canine model [281,282]. Other material substrates used for 
cell capture from bone marrow include coralline HA and demineralized human 
cancellous bone [283,284].  It was reported that the percentages of nucleated cells from 
human bone marrow that were retained in coralline HA and demineralized human 
cancellous bone were 47% and 24% respectively [283,284].   By employing a 3D 
material matrix to act as a means of cell selection and enrichment from bone marrow, 
bone healing can be further promoted as a conducive and biological environment 
containing the appropriate cell populations and inductive stimuli is created.  In this way, 
the potential of proliferation and differentiation of the cells may be enhanced. Pre-
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existing cells in the graft may also induce further cell recruitment at the injury site 
necessary for bone healing and revascularization.  
 
 As the motivation was towards in situ application of bone marrow in this study, 
the 3D biomineralized NFS was considered as a substrate to facilitate the rapid cell 
attachment from bone marrow.  In this way, cell expansion can be avoided.  This strategy 
would improve on the efficiency in which osteoprogenitor cells, primary MSCs, or other 
bone marrow-derived cells can be seeded, expanded and differentiated on an implantable 
graft material.  
 
 
 Some cells are able to migrate through the scaffold as they are able to push the 
surrounding nanofibers aside as these fibers have very little resistance to the amoeboid 
movement of the cells [110]. The 3D nanofibrous conformation provides spatial and 
temporal hierarchical levels to mimic the ECM, thereby modulating cell behavior. 
Besides, such nanoscale materials are biologically preferred [228] . Moreover, nanoscale 
materials are said to have an increased number of atoms and crystal grains on their 
surfaces and have a higher surface area-to-volume ratio compared to microscale materials.  
These differences in surface topography can affect the surface energy for protein 
adsorption [110].  Protein interactions in the native tissues control the cell functions such 
as proliferation, migration and ECM production [285]. Consequently, the 
nanotopographical features and surface characteristics such as roughness, surface charge, 
surface chemistry, wettability etc. will in turn affect protein adsorption [286].  In addition, 
cumulative adsorption and bioactivity of adhesion proteins was reported to be 
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significantly higher on nanophase materials. For instance, enhanced adsorption, 
conformation and bioactivity of vitronectin on nanophase alumina were correlated with 
the increase of osteoblast adhesion on the substrates [208].  The 3D organization and 
nanotextured surfaces could have an effect on protein adsorption.  At this point, we could 
not completely rule out the possibility that there could be a synergistic effect on surface 
topographical and chemical cues on the initial cell adhesion and cell stretching.  One 
study suggested that surface chemical cues (caused by pre-adsorption of fibronectin) 
influenced initial cell-substrate contact, whereas surface topographical signals dictated 
cell morphology within one day [287].   Several studies have shown that surface 
nanotopography elicited different biological response. For example, nanoporous fibers 
significantly increased BM-MSCs proliferation and cell spreading compared to smooth 
nanofibers [288].  Furthermore, nanotopography had an effect on integrin-mediated focal 
adhesion and focal adhesion kinase expression [289].   
 
 To assess the efficacy of a material-cell construct as a bone graft, Quarto et al. 
[290] was the first to report the repair of large bone defects (4-7cm) in humans using a 
porous ceramic scaffold with in vitro expanded autologous MSCs.  However, it would be 
an attractive option to be able to circumvent the need for the expansion of MSCs prior to 
implantation.  It was reported that increased cell growth, cell numbers and osteogenic 
differentiation was associated with 3D scaffolds with nanotextured surfaces compared to 
smooth 3D scaffolds [257], highlighting the importance of nanotopographical signals in 
controlling cell functions.   
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5.5 Conclusion 
 A 3D NFS was developed in the form of bio-mineralized 3D nanoyarn with high 
resemblance to native bone, in terms of morphology, composition and compressive 
strength.  A dynamic liquid electrospinning system and nano-hydroxyapatite (n-HA) 
deposition technique was employed to fabricate the mineralized 3D scaffold.  The unique 
3D nanostructural facilitated early cell capture (in less than 30 minutes), where up to 80% 
of the cells were captured when rabbit bone marrow was flushed through the scaffold.  
The current work showed that human MSCs were able to secrete bone minerals at very 
early time point on mineralized PLLA and more evidently on PLLA/Col nanofibers in the 
absence of osteogenic media, suggesting that osteoinduction can be modulated by the 
material characteristics of our biomimetic nanocomposites. The mineralized nanoyarn 
enriched with bone marrow cells was implanted in a ulnar critical size defect in a rabbit 
model.  There was evidence of bone regeneration after three months. These observations 
provide good evidence that such tissue engineered nanofibrous scaffolds could be 
employed in today’s clinical settings.    In summary, these results delineated the 
importance of 3D organization and nanotopography for enriched cell capture.  At this 
stage, it would be inappropriate to claim that osteoinduction was solely controlled by the 
3D biomimetic nanocomposites alone or by the interplay between the enriched cell 
population and biophysical cues directing osteogenic differentiation in vivo.  The 
physiological and regenerative strategy needs to be further elucidated in order to achieve 
effective clinical outcomes.   
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Bone regeneration in a rabbit ulnar model using novel 3D mineralized 





  Calcium phosphates are often sintered at extremely high temperatures (> 1000ºC) 
and are highly crystalline.   Not only do they differ in structure and composition of native 
n-HA, the osteointegration rates vary according to their crystalline size and stoichiometry 
[291].  As such, tissue engineered scaffolds are touted to be the next generation of bone 
grafts [108]. 
 
 Besides improving on the osteoconductive properties of the graft material to 
support bone healing, osteoinductivity is also important as the active recruitment of host 
MSCs from the surrounding tissues to the graft site help to differentiate into bone-
forming osteoblasts.  BMPs are growth factors in the TGF-β group of proteins which are 
involved in several signaling pathways such as hedgehog pathway and the TGF-β 
signaling pathway [292].  These potent proteins are capable of stimulating and hastening 
bone growth.  Currently, rhBMP-2 and rhBMP-7 (or osteogenic protein 1 [OP-1]) are 
routinely used, with excellent clinical outcomes.  Typically, BMPs are loaded onto carrier 
materials (such as INFUSE, rhBMP-2 on type I collagen sponge [293] and OP-1, rhBMP-
7 also on type I collagen material [294]) for effective administration into the targeted 
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sites.   As such, tissue-engineered scaffolds are often impregnated with BMPs because of 
their highly osteoinductive prowess.   
 
 Current bone grafts only mimic native bone at a micro-level and are usually 
blended systems.  This gave us the motivation to develop biomimetic n-HA/polymeric 
nanofibrous scaffolds.  We have shown that the n-HA on our scaffolds mimic native bone 
which was similar in nanostructure and composition [19,21].  In this study, we attempted 
to examine the in vivo response of our 3D nanoyarn (collection of fibers in bundles) 
scaffolds with or without n-HA and also as a carrier for BMP-2 in a rabbit model.  
 
 
6.2 Materials and Methods 
 
6.2.1 Scaffold fabrication 
  
 Pure PLLA (300,000 Da, Aldrich Chemical Company, Inc.) and PLLA/Type I 
collagen (Koken Co., Tokyo, Japan) were dissolved (w/w 50:50) in 1,1,1,3,3-hexafluoro-
2-propanol (HFP, Aldrich Chemical Company, Inc., St. Louis, MO).  The fabrication of 
3D nanoyarns was described in our previous work [267]. Briefly, a dynamic liquid 
system was used to create a vortex through a 5mm diameter hole at the centre of the 
collector basin as the water was pumped into the basin at room temperature (25 ± 1ºC) 
and relative humidity of 65%.  The syringe loaded with the polymer solution was 
connected to a direct current high-voltage power supply (Gamma High Voltage Research, 
Ormond Beach, Florida) and the applied voltage was 15 kV.  The spinneret used was a 
BD 27G ½ flat-tip needle and the feed rate was set at 1ml/hour (KD Scientific syringe 
pump, Holliston, MA).   The working distance was 15 cm.   The fibers were gathered on 
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the surface of the water and then drawn through the vortex and collected at the bottom of 
the water tank, which supplied the flow of water to the basin through a pump.  After an 
hour, the nanoyarns were then collected. For non-mineralized scaffolds, the nanoyarns 
were immediately mounted into a mold (6mm in diameter, 17mm in length) and freeze-
dried overnight.  For mineralized scaffolds, the yarns were stored in DI water (no longer 
than 1 day) prior to n-HA mineralization. 
 
6.2.2 Mineralization of 3D nanoyarn scaffolds 
 
 The 3D nanoyarns were chemically treated in calcium and phosphate (Ca-P) 
solutions. Using the same treatment conditions in our previous studies [19,21], the 
nanoyarns were first subjected in 0.5M of CaCl2 (pH 7.2) (Aldrich Chemical Company, 
Inc., St. Louis, U.S.) for 10 mins, following by deionized water (DI) rinsing for a couple 
of mins.  The nanoyarns were then immersed in 0.3M Na2HPO4 (pH of 8.96) (Merck & 
Co. Inc., N.J, U.S.) solution for 10 minutes and then rinsed with DI water.  This typified 
1 cycle of treatment and the PLLA/Col nanoyarns underwent 3 cycles of Ca-P treatment.  
After n-HA mineralization, the nanoyarns were fitted into a mold (6mm in diameter, 
17mm in length) and then subsequently freeze-dried overnight.  
 
 
6.2.3 Material Characterization 
 
 The morphologies of the nanoyarns were studied using a using a field-emission 
scanning electron microscopy (FESEM) (Quanta 200F, FEI, Oregon, U.S.) at an 
accelerating voltage of 10 kV or 20 kV. 
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6.2.4 Loading BMP-2 onto mineralized scaffolds 
 
 Human recombinant bone morphogenetic protein-2 (rhBMP-2, from ProSpec-
Tany TechnoGene Ltd, Israel ) was diluted with sterile saline to obtain a concentration of 
0.4 mg/cm3 [295].  250 µL saline +BMP-2 solution (final concentration: 0.4 mg/cm3) was 
added and completely absorbed into the PLLA/Col+n-HA scaffold before implantation.  
0.4 mg/cm3 was chosen as the final concentration because this was the minimum 
concentration that was needed to show bone repair based on radiographical evidence 
[295].   
 
6.2.5 Operative procedures 
 
 Prior to implantation, all the scaffolds are sterilized in gamma irradiation 
conditions (Gamma Chamber 4000A, Co60 source, Isotope Group, Bhabha Atomic 
Research Centre/Trombay/India), at a total dose of 25 kGrays.  Each scaffold was 
implanted in the midshaft of the rabbit ulna (n=3/material group). The material groups 
were 1) pure PLLA/Col, 2) mineralized PLLA/Col+n-HA, 3) PLLA/Col+n-HA 
impregnated with BMP-2 and 4) Blank control (n = 1). The rabbit was anesthetized using 
ketamine 50mg/kg (i.m) + Xylazine 10mg/kg (i.p).  We also administered pre-op 
antibiotics and analgesic, Baytril @ 5mg/kg (i.m) + Rimadyl @ 2mg/kg (s.c).  The bony 
defect of 15 mm was created using an oscillating saw under continuous saline cooling. 
The entire bone block was removed with the periosteum and the bone ends were cleaned 
with a bony rongeur. The defect site was then copiously irrigated with saline to remove 
any bone debris.  Internal fixation was not considered because of the fibro-osseous 
syndesmosis between the ulna and radius.  Post-surgery, the rabbit received Baytril @ 
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5mg/kg (i.m) - 5 days postop+ Rimadyl at 2mg/kg (s.c) - 3 days postop. After three 
months implantation, the explant was removed.  The explant was then fixed in 10% 




 The ulna was assessed bi-weekly using X-ray radiography (Siemens Polymobil 
Plus, Siemens Medical, Singapore) to evaluate the extent of bone formation.  The settings 
used were 40 kV and 0.8 mAs.  
 
 
6.2.7 Microcomputed tomography (MicroCT) 
 
 The explant was scanned through 360º with a rotation step of 3º/s, at a spatial 
resolution of 27 µm x 27 µm x27 µm using a microCT machine (SMX-100CT X-ray CT 
Sys, Shimadzu, Japan).   The parameters used were: X-ray voltage (47 kV), X-ray current 
(50 µA), detector size (9”) and scaling coefficient (50). No filter was used during the 
scanning. The scan files were then reconstructed using a modified Feldkamp algorithm 
(Skyscan, Belgium), at a step size of 27 µm. The microCT software (VGStudioMax, 
version 1.2, Volume Graphics GmbH, Germany) was used to construct the 3D image of 
the explant.  Bone volume values were determined by using the reconstructed 3D image 
where the gray value range for bone were set at 225-255 (CTAnalyser, version 1.9, 
Skyscan, Belgium).  
 
 
6.2.8 Histological analyzes 
 
 The explant was thoroughly dehydrated prior to histological staining. Serial 5 µm 
paraffin sections were done using a microtome.  The sections were stained with 
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hematoxylin and eosin (H&E), Masson’s Trichrome and von Kossa stains, according to 
routine histology protocol.  Images of the stained sections were captured using an 
Olympus microscope (Leica Microsystems Ltd, DFC 295 (model), Germany), at 
magnifications of x4, x10, x20 and x63.    
 
 
6.2.9 Statistical analyzes 
 
 Student’s T-test and two-way ANOVA were employed to assess statistical 
differences between the material groups for microCT tests. Difference was considered to 





6.3.1  Morphology of 3D nanoyarns 
 
 The 3D scaffold as seen in Fig 6.1(a) was used for implantation.  Both PLLA/Col 
(Fig. 6.1b) and mineralized PLLA/Col scaffolds (Figs. 6.1d, e, f) maintained their yarn 
structures (collection of nanofibers in bundles).  The n-HA deposition was uniform on the 
fibers.  Furthermore, the morphology of the mineralized nanofibers highly resemble to 
that of native bone fibrils [1].  
 
 
(a)  (b) 
 
(c) 
100 µm 10 µm 
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Fig. 6.1: 3D nanoyarn scaffolds. (a) Gross image of 3D scaffold used for implantation. 
(b)-(c) SEM micrographs of pure PLLA/Col nanoyarn scaffold, (d) to (h) SEM 
micrograph of mineralized PLLA/Col nanoyarn scaffold and (i) native bone fibrils [1].  
Arrows denote bundles of fibers (collection of fibers in yarn formation). Note that yarn 





6.3.2   X-rays analyses  
 
 Fig. 6.2 shows the X-ray images of all the groups at various time points. 
Surprisingly, just two weeks after surgery, all the scaffold groups showed initial bone 
growth from the bony ends, with the BMP-2 group leading the rest. On the contrary, this 
observation was not evident in the blank control group.  By one month, denser callus 
formation was noted in the BMP-2 group, with a notable bony bridging at the proximal 
end of the radius.  More bone growth was seen in PLLA/Col group compared to the 
mineralized PLLA/Col group.  After one month, the blank control group showed 
evidence of bone formation.  After six weeks, callus bridging was more prominent in the 
200 µm 100 µm 
5 µm 500 nm 
500 µm 
10 µm 
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mineralized PLLA/Col group, whereas further bone growth was not radiographically 
evident in the PLLA/Col, BMP-2 and blank control groups.  By two months, partial bone 
bridging was present in all the scaffold groups except the blank control group. 
Interestingly, callus formation increased in the PLLA/Col and mineralized PLLA/Col 
groups over time, but for the BMP-2 group, the amount of bone growth did not fluctuate 
as seen in the X-ray images.  After three months, the scaffold groups showed more bone 
formation compared to the blank control group, where mineralized PLLA/Col group 
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Fig. 6.2: Representative ulnar radiographs.  Sequential radiographs depict bone formation 
immediately after implantation (Week 0), 2 weeks, 1 month, 6 weeks, 2 months and 3 
months after implantation. (a)-(f) PLLA/Col, (g)-(l) PLLA/Col+n-HA, (m)-(r) 




6.3.4  MicroCT analyzes  
 
 The 3D representative microCT images in Fig. 6.3 depict the amount of bone 
formation after three months of implantation.  Interestingly, the blank control group did 
not show bone specks within the defect site.  Interestingly, the mineralized PLLA/Col 
group exhibited bone specks uniformly within the defect site, without the presence of 
BMP-2.  This could suggest that the presence of n-HA alone could elicit an 
osteoinductive bone formation process.  Furthermore, the bone formation in the 
PLLA/Col group did not display such uniform bone specks in the defect site, but rather 
the growth proceeded from the bony ends of the midshaft.  
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(a) PLLA/Col (RSL 11) 
 
  
 (b) PLLA/Col+n-HA (RSL 6) 
  
(c) PLLA/Col+n-HA+BMP-2 (RSL 15) 
 
   
(d) Blank control (RSL 10) 
 
Fig. 6.3: 3D Micro-CT images after three months of implantation 
  
  
 Based on the microCT results, the amount of bone volume was calculated from all 
the groups.  In Fig. 6.4, the percentage of bone formation in all the nanoyarn groups was 
higher than the blank control.  The mineralized PLLA/Col group showed the highest bone 
volume, followed by the PLLA/Col group.  The mineralized PLLA/Col scaffold 
impregnated with BMP-2 did not perform as well as expected and we suspected this 
could be due to the low concentration of BMP-2.  
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6.3.5 Histological analyzes  
 
  Histology results revealed all the scaffold groups were well-tolerated and 
osteoconductive. There was no evidence of infection or chronic foreign body response. 
Fig. 6.5 shows the histology images of our material groups.  New bone formation was 
evident in all the groups, and confirmed by Masson Trichrome’s staining, where collagen 
was stained blue.  Even though the explants were decalcified, some minerals still 
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Fig. 6.5: Histology images after three months of implantation. (a) to (c) PLLA/Col, (d) to 
(f) PLLA/Col +n-HA and (g) to (i) PLLA/Col+n-HA +BMP-2. Note that some brown 
minerals were seen in (i).  Abbreviations – multi-nucleated giant cell (MNGC), blood 






 Fig. 6.6 illustrates the different types of cells which were present in all our 
material groups.  Some cartilage (a precursor of bone) was present.  The hallmark of the 
newly formed bone matrix consisted of chondrocytes were embedded in the lacunae, 
surrounding by blood vessels and osteoblasts laying down new bone at the borders of the 
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Fig. 6.6: Histology of new bone formation. (a) and (b) bone consists of mature bone 
(pink) and immature bone (cartilage) [H&E], (c) chondrocytes within lacunae, 
surrounding with blood vessels (capillaries) [H&E] and (d) mineralized bone (brown 
specks) surrounding with osteoid seams where osteoblasts (OB) were laying down new 





 As expected, our graft was slowly degraded with the aid of certain cells engulfing 
the material (Fig. 6.7).  Macrophages (mono-macrophages and bi-macrophages) prior to 
forming multi-nucleated giant cells (MNGCs) was seen digesting smaller graft materials, 
whereas MNGCs attacked larger graft materials.  In addition, lymphocytes also 
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Fig. 6.7: Histology of different cell types which were present in all material groups. Note 
that the graft was engulfed by (a) macrophages, (b) multi-nucleated giant cells (MNGCs) 
and (c) lymphocytes (LYM) in the presence of red blood cells (RBCs).  Hydroxyapatite 







 Our results showed that the 3D nanoyarn scaffolds were capable of inducing bone 
repair in segmental bone defects in a rabbit model.  We hypothesized that mineralized 
PLLA/Col scaffolds would improve bone repair more than pure PLLA/Col scaffolds.  We 
believed that by mimicking the scaffold closer to the native bone’s morphology and 
composition, the n-HA particles would serve as anchorage points for osteoprogenitor and 
osteoblastic cells, providing a more favorable surface for cell attachment and interaction, 
thereby improving bone mineralization.  Although the percentage of bone growth based 
on microCT results was not significantly different in all the groups, radiographically, 
mineralized PLLA/Col group performed better than pure PLLA/Col group.  In addition, 
microCT images indicated that a greater extent of bone formation was prevalent in the 
mineralized scaffold group compared to the pure scaffold group.  Large standard 
deviations were also associated with surface grafted hydroxyapatite with PLLA/PLGA 
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 Surprisingly, the BMP group did not supersede the non-BMP materials groups in 
terms of bone formation.  There could be a possibility that there was an initial burst 
release of BMP-2 during the early stages, as more new woven bone was formed in the 
BMP-2 group compared to the other scaffold groups.  Moreover, the extent of new callus 
formation at later time points was not as impressive as one would expect since BMP-2 
was loaded into the scaffold to hasten bone regeneration.  We suspected that the amount 
of BMP-2 was too low to elicit abundant bone growth to completely fill the gap.   For 
instance, different amounts of BMP-2 [17mg (100 mg/mL), 35mg (205.88 mg/mL) and 
70 mg (411.76 mg/mL)] were loaded onto PLLA scaffolds which were then implanted in 
the radii of the rabbits [297].  The amount of bone formation in all the BMP groups was 
similar to those treated with autografts and higher BMP-2 concentrations (35 mg and 70 
mg) were associated with cortices and marrow elements [297]. Besides BMP 
concentrations, other factors which influence bone regeneration are the defect size, 
presence of fixation tools, material type and so on.  In a separate study, despite a lower 
BMP-2 concentration (10 µg) in a silica-calcium phosphate nanocomposite, bone 
formation was seen after 16 weeks where the defect size in the rabbit ulna was 10 mm 
and a fixation plate was used to secure the graft in position [298].  Although our BMP 
concentration and ulnar defect size were similar to that of Kokubo’s study [295], the 
defects were radiographically repaired in Kokubo’s study.  One of the possibilities was 
that the material (PLGA-coated gelatin sponge) used was shaped into suitable sizes for 
specific defects with a scalpel prior to implantation [295], thus the graft could be more 
securely fitted into the defect site with minimal movement, preventing dislodging.  Bone 
healing would be impaired if the graft is not in touch with the native host bone during 
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implantation or movement.   Our graft sizes were standardized regardless of the size of 
the rabbits (due to animal variability even though animals were of the same age).  We 
suspected that for some animal groups, the graft acted more as a tissue spacer than an 
osteoconductive graft as there were non-osseous tissues with fibrous connective tissues.  
If the degradation process is too fast, the osteoblasts will not have a surface to migrate to 
and deposit bone matrix, resulting in fibrous repair instead of osseous regeneration [299].  
Without the addition of BMP-2 in PLLA grafts, fibrous tissue filled the defects [297]. 
 
 In some studies, the periosteum (source of osteoprogenitor cells) was present 
[297]. In our study, the periosteum  was completely removed, which could be one of the 
reasons as to why a complete union was not observed and our BMP group did not 
perform as well as expected as higher BMP concentrations might be needed to facilitate 
bone growth.  
 
When human BM-MSCs were cultured on HA ceramics, and implanted in the 
patient’s bone cavity, no adverse reactions were observed and new bone formation was 
seen after three months and complete integration with the patient’s native bone was seen 
after a year [179].  In a separate study, spinal fusion was achieved in a rabbit model when 
MSCs were employed [178].  The effects of MSCs on HA and osteogenic supplements 
were investigated.  Four out of five rabbits achieved new bone formation when MSCs 
cultured on type I Col gel with HA particles in the presence of osteogenic supplements 
were implanted, compared to only two out of six rabbits, which had fusion in the non-
osteogenic MSCs group.  One possible reason could be due to the inadequate osteogenic 
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growth factors present. Moreover, MSCs that have been directed to an osteogenic lineage 
prior to implantation may induce better fusion and bone formation as these differentiated 
MSCs are less dependent on the local growth factors.  It is noteworthy to highlight that 
the fusion rate and level of bone formation were similar in both the osteogenic 
MSC+Type I Col gel+HA particles and autologous bone group.  On the other hand, none 
of the rabbits in the HA group without MSCs had fusion but only fibrous tissue was 
observed.  Another study showed that there was a synergistic effect on the osteogenic 
differentiation of BM-MSCs on type I Col gel and HA particles when BMP and fibroblast 
growth factor (FGF) were used [27].  
 
 
 Although bone growth was observed within the defect site after three months, the 
defect site was not completely filled up in all the groups. This could possibly be due to 
the lack of immobilization of the scaffold at the defect site.  From our histology images, 
immature woven bone and bone marrow elements were evident in all the scaffold groups.  
Vascularization (blood vessels) and osteocytes in the regenerated bone was observed. 
Persuasive evidence of osteoblasts actively forming new bone was indicative of active 
bone.   The graft remnants were observed in the newly formed bone.  As the polymer 
undergoes resorption, the voids left behind allows the activated osteoblasts to deposit 
new bone and blood vessels to infiltrate into the active bone region.  
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 No obvious abnormalities were detected.  The histological evaluation showed no 
signs of infection or adverse inflammatory reactions in all the animal groups.  
Biodegradable polymers such as PLLA and PLGA undergo hydrolysis.  The 
biodegradation of PLLA elicit the recruitment of osteoclasts during the resorption process.  
In a separate study, osteoclastic resorption of the material carrier was also observed [300]. 
Furthermore, osteons (concentric lamellar structures) were present. Macrophages and 
multi-nucleated giant cells (MNGCs) participate in the phagocytosis process as well 
[299].  MNGCs were present as part of the wound healing response. In all our groups, 
lymphocytes, macrophages, MNGCs, neutrophils, granulocytes were seen.  A separate 
study involving PLLA scaffold implantation also exhibited the presence of giant cells, 
macrophages, granulocytes and lymphocytes. This could be due to the inflammatory 
response caused by the PLLA [297]. MNC infiltration was also evident in another study 
involving PLLA [301] and PLGA residues [295].  In addition, lymphocytes infiltration 
occurred at the implant region [299]. Thus, the foreign body reaction seen in this study is 
a common phenomenon associated with biodegradable polymers as observed in many 






 Our 3D mineralized and non-mineralized nanoyarn scaffolds aided in bone 
regeneration.  The amount of BMP-2 loaded into a material is important as this would 
affect the study outcome.  Future work entails evaluating the release profile of BMP-2, 
dissolution kinetics, torsional testing and performing large animal model studies for more 
in-depth evaluation of the performance of the nanoyarn scaffolds.  
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The scope of this research encompasses the in vitro osteogenic differentiation of human 
BM-MSCs using geometric cues provided by the NFS in the absence of osteogenic 
supplements.  A biomimetic approach of n-HA mineralization was achieved on NFS for 
efficient cell capture of osteoblasts and BM-MSCs.  The final product is a 3D 
mineralized nanoyarn scaffold for bone graft applications.  This product has been tested 
in a rabbit model, showing favorable bone healing without any adverse inflammation 
response.    
   
7.1 Main conclusions 
 
• Rapid biomimetic mineralization was possible on the NFS using the alternate 
dipping method, where the n-HA obtained was similar to that of natural teeth.  
Co-blending collagen in PLLA NFS was an effective way to enhance the 
mineralization of the NFS due to the nucleation sites (e.g. the amide I and II 
groups) of collagen.  Moreover, n-HA significantly improved the hydrophilicity 
of PLLA/Col NFS.  The n-HA on the PLLA and PLLA/Col NFS significantly 
enhanced osteoblast cell capture efficacy within 30 minutes.  
 
• The osteogenic differentiation potential of human BM-MSCs was confirmed and 
achieved by manipulating the biochemical, physical and environmental conditions. 
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The nanotopographical cues of the surface of mineralized PLLA and PLLA/Col 
NFS induced osteogenic differentiation of BM-MSCs without any osteogenic 
chemical intervention.  In addition, the Ca/P ratios for the mineralized PLLA and 
PLLA/Col NFS were 1.8 ± 0.12 and 1.7 ± 0.14 respectively, which was similar to 
HA (~1.67) in native bone. 
 
• n-HA alone had a positive modulation on osteogenic differentiation of BM-MSCs 
as the osteocalcin expression was comparable in mineralized PLLA NFS in both 
normal and osteogenic media conditions.  The synergistic effects of n-HA and 
collagen were evident as the osteocalcin expression and ARS levels were 
significantly enhanced in normal media but not in osteogenic media. Cell 
mineralization or bone nodules, an indicator of late-stage differentiation, was 
present on mineralized PLLA and PLLA/Col NFS in normal media at much 
earlier time points on day 14.  The Ca/P ratios of the bone nodules ranged from 
1.5 to 1.85, similar to that of natural bone.  The observations in this study showed 
that osteoinduction was demonstrated by the material characteristics of 
biomimetic nanocomposites circumventing osteogenic supplements or mechanical 
stimulation.    
 
• 3D mineralized NFS (deemed as mineralized 3D nanoyarn) was successfully 
fabricated using a dynamic electrospinning system and n-HA deposition 
technique.  The 3D mineralized nanoyarn had shown to have a close resemblance 
to native bone, in terms of morphology, composition and compressive strength.   
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• 3D mineralized NFS has shown to be an effective carrier for rapid cell capture 
from bone marrow aspirate as the nanotexture features of the NFS provided 
nanotopographical signals and biomolecular cell signals for cell-scaffold 
interactions for cell attachment.  The unique 3D nanostructural characteristics 
highly facilitated early cell capture (within less than 30 minutes), where up to 
80% of the cells were captured when rabbit bone marrow was flushed through the 
nanoyarn. The mineralized nanoyarn enriched with bone marrow cells exhibited 
promising results in a critical size defect of 15 mm in the rabbit model, and may 
serve as an in-situ therapeutic bone graft option for bone regeneration.  
 
• The 3D mineralized and non-mineralized nanoyarns were implanted in a 15 mm 
segmental ulnar defect in a rabbit model.  Bone formation was seen after two 
weeks.  Moreover, there were speckles of bone observed within the defect site, 
away from the bony ends of the fracture especially for the mineralized PLLA/Col 
nanoyarn group, suggesting the osteoinductivity potential of the scaffolds. 
 
 
7.2 Recommendations for future work 
 
 The focus of this study lies mainly in investigating the osteogenic differentiation 
of BM-MSCs on 2D nanofibrous mesh.  It is therefore necessary to conduct future work 
to understand the osteogenic differentiation of BM-MSCs on 3D nanofibrous scaffolds, 
so that the physical and biochemical properties of the scaffolds can be tailored to elicit 
specific biological responses for the effective guidance of cells to form functional tissues.   
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The NFS described in this project has shown promising results as an efficient carrier for 
cell capture and inducing osteogenic differentiation by means of geometric cues.   The 
results of the bone healing process in a rabbit model were encouraging.  However, further 
investigations are required to study the gene expression of the BM-MSCs under in vitro 
and in vivo conditions.  The mechanisms of the transdifferentiation of BM-MSCs and the 
interactions between the differentiated BM-MSCs and surrounding cells (such as 
inflammatory, vascular cells etc.) in the injured site renders further considerations.  The 
cascade of the orchestrated processes of gene expression in biological pathways render 
further investigation, so that the interplay between the various biomolecules and proteins 
can be understood and this would greatly facilitate the material selection and the choice 
of growth factors and biomolecules to be incorporated into the material constructs.   
 
 
 Extensive degradation profile of the NFS needs to be done in order to predict the 
complete resorption of the NFS in vivo. For instance, in vivo proteolysis analyses of the 
NFS can be conducted to measure the degradation behavior of the NFS in the injured site. 
Such information may be useful in optimizing the material characteristics for improving 
bone remodeling, such as supporting angiogenesis for bone healing.  
  
 
 Because our scaffolds are not tested in load-bearing sites in the rabbit ulna model, 
we would also need to conduct further animal studies for more in-depth evaluation of the 
performance of the nanoyarn scaffolds.  Large animal studies are also closer to clinical 
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relevance and are often considered to be the pre-requisite for clinical trials.  Other future 
work entails evaluating the release profile of BMP-2 and dissolution kinetics.  It was said 
that the products of a 3D porous silica-calcium phosphate nanocomposite and the 
released BMP-2 provided a conducive environment at the implant site, which promoted 
ossification and maturation of the regenerated bone in a rabbit model [298] .  Gamma 
scintigraphy can also be employed to detect the BMP dose that is retained at the 
osteotomy site at different time points after implantation, to map out the protein release 
profile [300]. The mechanical properties of the current nanoyarn scaffolds need to be 
further improved to cater for load-bearing sites. Mechanical testing of explants such as 
torsional testing can be also considered.  Such biomechanical properties such as 
maximum torque to failure, torsional stiffness and energy adsorbed to failure are 
important parameters to determine the success of the graft material in facilitate bone 
healing.   
 
 
 Incorporation of growth factors such as BMP-2 into the NFS can be achieved by 
using the co-axial or core-shell electrospinning technique as seen in Fig. 7.1. The protein 
release rate can be manipulated by adjusted the ratio of the thickness of the shell to the 
core.  Previous studies showed that a controlled release profile of FITC-BSA was 
achieved when the protein was encapsulated in the core of the core-shell nanofibers [302].   
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Fig. 7.1: Co-axial electrospinning setup.  The inset picture shows the special apparatus 
(inner and outer dopes) for the fabrication of core-shell nanofibers Reprinted from [2], 




 For a wider range of clinical applications, the graft can be more amenable to 
contouring for the implantation in different sizes and shapes of bony defects.  As such, 
improvements of the 3D nanoyarns can be made by developing an injectable form of the 
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Sample Preparation for Scanning Electron Microscopy Observations 
 
 
SEM imaging was conducted on scaffolds with or without cells at various time points of 
the study. 
 
1. Wash samples with PBS thrice. 
2. Samples with cells were fixed in 4% paraformaldehyde solution for 30 
minutes at room temperature. 
3. Wash samples with PBS thrice. 
4. Samples were dehydrated serially in various ethanol concentrations, first in 
50% and incubated for 10 minutes in room temperature 
5. Next, samples were subsequently incubated in 70%, 95%, 100% (twice) for 10 
minutes respectively at room temperature.   











   
 









Step Station Reagent Time Exact 
1 1 Xylene 5 mins No 
2 2 Xylene 5 mins No 
3 3 100% isopropanol 2 mins No 
4 4 100% isopropanol 2 mins No 
5 5 100% isopropanol 2 mins No 
6 6 95% isopropanol 2 mins No 
7 7 70% isopropanol 2 mins No 
8 Wash 1 Water 2 mins No 
9 8 Haematoxylin 4 mins Yes 
10 Wash 5 Water 2 mins No 
11 9 Clarifier 2 2 mins Yes 
12 Wash 4 Water 2 mins No 
13 10 Bluing solution 2 mins Yes 
14 Wash 3 Water 2 mins No 
15 11 70% alcohol 2 mins No 
16 12 Eosin Y 2 mins Yes 
17 13 70% isopropanol 2 mins Yes 
18 14 95% isopropanol 2 mins Yes 
19 15 100% isopropanol 2 mins No 
20 16 100% isopropanol 2 mins No 
21 17 100% isopropanol 2 mins No 
22 18 Xylene 2 mins No 






Nuclei ---------------- blue to blue black (stained by Hematoxylin)  
            Cytoplasm ----------- pink (stained by Eosin)
   
 








Chromotrope 2R ----------- 0.6 g 
Fast green FCF ------------- 0.3 g 
Phosphotungstic acid ------ 0.6 g 
Glacial acetic acid ---------- 1 ml 
Distilled water -------------- 100 ml 
 





1. Sections to water. 
2. Stain nuclei with an alum hematoxylin. 
3. Differentiate in acid-alcohol and blue as in the standard technique. 
4. Wash well in tap water, then in distilled water. 
5. Stain in the Gomori solution 5 to 20 minutes. 
6. Rinse well in the acetic acid solution. 





Nuclei ------------------------------------------------------------- Grey-blue 
Collagen ---------------------------------------------------------- Green 















   
 








1. Rinse slides well in deionized water. 
2. Incubate slides in 5% silver nitrate under UV lights for 30 minutes. 
3. Rinse slides well in deionized water. 
4. Incubate slides in 5% sodium thiosulfate for 30 seconds. 
5. Rinse in tap water 
6. Counterstain with toluidine blue for 30 seconds. 
7. Rinse well in tap water 
8. Dehydrate with 95% ethanol 
9. Dehydrate with 100% ethanol 





Minerals -------------------- Brown 
 
 
 
